<?xml version="1.0" encoding="UTF-8"?><search-results xmlns="http://www.w3.org/2005/Atom" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/"><opensearch:totalResults>2992343</opensearch:totalResults><opensearch:startIndex>200</opensearch:startIndex><opensearch:itemsPerPage>100</opensearch:itemsPerPage><opensearch:Query role="request" searchTerms="heart" startPage="200"/><link ref="self" href="http://api.elsevier.com:80/content/search/index:scopus?start=200&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="first" href="http://api.elsevier.com:80/content/search/index:scopus?start=0&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="prev" href="http://api.elsevier.com:80/content/search/index:scopus?start=100&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="next" href="http://api.elsevier.com:80/content/search/index:scopus?start=300&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><link ref="last" href="http://api.elsevier.com:80/content/search/index:scopus?start=4900&amp;count=100&amp;query=heart&amp;view=COMPLETE&amp;httpAccept=application/xml&amp;apiKey=b50e60b193e884e6d78948e916d816a0" type="application/xml"/><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926500992"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926500992?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926500992&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926500992&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0308814615003441"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926500992</prism:url><dc:identifier>SCOPUS_ID:84926500992</dc:identifier><eid>2-s2.0-84926500992</eid><dc:title>Determination of mycotoxins in pomegranate fruits and juices using a QuEChERS-based method</dc:title><dc:creator>Myresiotis C.</dc:creator><prism:publicationName>Food Chemistry</prism:publicationName><prism:issn>03088146</prism:issn><prism:eIssn>18737072</prism:eIssn><prism:volume>182</prism:volume><prism:pageRange>81-88</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>1 September 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodchem.2015.02.141</prism:doi><pii>S0308814615003441</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. A rapid and accurate analytical method for the determination of three Alternaria mycotoxins (alternariol, alternariol monomethyl ether, and tentoxin) in pomegranate samples (fruits and juices) was developed and validated. The overall average recoveries ranged for 82.0-109.4% and the relative standard deviations were from 1.2% to 10.9%. The optimized and validated method was applied to detect the presence of the target mycotoxins in real samples (fruits and juices) purchased from Greek markets. Mycotoxins were not found in any of the analyzed samples. Also, artificially inoculated pomegranate fruits with six different Alternaria alternata species complex isolates, known to produce the target mycotoxins on pure cultures, were analyzed and alternariol concentrations found ranged from 0.3 to 50.5 μg/g, alternariol monomethyl ether from 0.5 to 32.3 μg/g, while tentoxin was not detected. The developed analytical method can be used for the routine monitoring of the major Alternaria mycotoxins in pomegranates.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015331</affiliation-url><afid>60015331</afid><affilname>Aristoteleion Panepistimion Thessalonikis</affilname><name-variant>University of Thessaloniki</name-variant><affiliation-city>Thessaloniki</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015331</affiliation-url><afid>60015331</afid><affilname>Aristoteleion Panepistimion Thessalonikis</affilname><name-variant>University of Thessaloniki</name-variant><affiliation-city>Thessaloniki</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030988</affiliation-url><afid>60030988</afid><affilname>Dimokrition Panepistimion Thrakis</affilname><name-variant>Democritus University of Thrace</name-variant><affiliation-city>Komotini</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:16064159600</author-url><authid>16064159600</authid><authname>Myresiotis C.</authname><surname>Myresiotis</surname><given-name>Charalampos K.</given-name><initials>C.K.</initials><afid>60015331</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56543716400</author-url><authid>56543716400</authid><authname>Testempasis S.</authname><surname>Testempasis</surname><given-name>Stefanos</given-name><initials>S.</initials><afid>60015331</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6508045688</author-url><authid>6508045688</authid><authname>Vryzas Z.</authname><surname>Vryzas</surname><given-name>Zisis</given-name><initials>Z.</initials><afid>60030988</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6602849169</author-url><authid>6602849169</authid><authname>Karaoglanidis G.</authname><surname>Karaoglanidis</surname><given-name>George S.</given-name><initials>G.S.</initials><afid>60015331</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56586967000</author-url><authid>56586967000</authid><authname>Papadopoulou-Mourkidou E.</authname><surname>Papadopoulou-Mourkidou</surname><given-name>Euphemia</given-name><initials>E.</initials><afid>60015331</afid></author><authkeywords>Alternaria | HPLC-DAD | Mycotoxins | Pomegranates | QuEChERS</authkeywords><intid>2035449766</intid><source-id>24039</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928987364"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928987364?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928987364&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928987364&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021979715004269"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928987364</prism:url><dc:identifier>SCOPUS_ID:84928987364</dc:identifier><eid>2-s2.0-84928987364</eid><dc:title>Glutathione replenishing potential of CeO&lt;inf&gt;2&lt;/inf&gt; nanoparticles in human breast and fibrosarcoma cells</dc:title><dc:creator>Akhtar M.</dc:creator><prism:publicationName>Journal of Colloid and Interface Science</prism:publicationName><prism:issn>00219797</prism:issn><prism:eIssn>10957103</prism:eIssn><prism:volume>453</prism:volume><prism:pageRange>21-27</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>September 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jcis.2015.04.049</prism:doi><pii>S0021979715004269</pii><dc:description>© 2015 Elsevier Inc. Recently, cerium oxide nanoparticles (CeO&lt;inf&gt;2&lt;/inf&gt; NPs) has been reported for multi-enzyme mimetic activities like that of superoxide dismutase and catalase. Here, we report glutathione (GSH) replenishing response by CeO&lt;inf&gt;2&lt;/inf&gt; NPs in human breast (MCF-7) and fibrosarcoma (HT-1080) cells. CeO&lt;inf&gt;2&lt;/inf&gt; NPs were found to be mostly cuboidal in shape with average diameter of 25nm. Effects on cell viability, reactive oxygen species (ROS) generation, and mitochondrial outer membrane potential (MOMP) suggested CeO&lt;inf&gt;2&lt;/inf&gt; NPs to be reasonably non-cytotoxic. Data on membrane damage and lipid peroxidation correlated well with the cell viability results suggesting NPs of CeO&lt;inf&gt;2&lt;/inf&gt; to be biocompatible. Interestingly, CeO&lt;inf&gt;2&lt;/inf&gt; NPs significantly increased intracellular GSH in cells challenged with oxidants. Replenishment of depleted GSH in oxidatively challenged cells was comparable with the GSH restoring potential of known antioxidant N-acetyl cysteine (NAC), a precursor of GSH. Like NAC, CeO&lt;inf&gt;2&lt;/inf&gt; NPs significantly replenished depleted GSH in both cell types challenged with hydrogen peroxide (H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt;) and zinc oxide (ZnO) NPs. Moreover, CeO&lt;inf&gt;2&lt;/inf&gt; NPs treated cells were significantly protected from cytotoxicity caused by H&lt;inf&gt;2&lt;/inf&gt;O&lt;inf&gt;2&lt;/inf&gt; and ZnO NPs. Our findings, therefore, suggest CeO&lt;inf&gt;2&lt;/inf&gt; NPs as a potential antioxidant rather than a toxic material.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013183</affiliation-url><afid>60013183</afid><affilname>King Saud University</affilname><name-variant>King Saud University</name-variant><affiliation-city>Riyadh</affiliation-city><affiliation-country>Saudi Arabia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005353</affiliation-url><afid>60005353</afid><affilname>King Saud University College of Science</affilname><name-variant>King Saud University</name-variant><affiliation-city>Riyadh</affiliation-city><affiliation-country>Saudi Arabia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005353</affiliation-url><afid>60005353</afid><affilname>King Saud University College of Science</affilname><name-variant>King Saud University</name-variant><affiliation-city>Riyadh</affiliation-city><affiliation-country>Saudi Arabia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8892616600</author-url><authid>8892616600</authid><authname>Akhtar M.</authname><surname>Akhtar</surname><given-name>Mohd Javed</given-name><initials>M.J.</initials><afid>60013183</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15041853700</author-url><authid>15041853700</authid><authname>Ahamed M.</authname><surname>Ahamed</surname><given-name>Maqusood</given-name><initials>M.</initials><afid>60013183</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:9041837400</author-url><authid>9041837400</authid><authname>Alhadlaq H.</authname><surname>Alhadlaq</surname><given-name>Hisham A.</given-name><initials>H.A.</initials><afid>60013183</afid><afid>60005353</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:9041837400</author-url><authid>9041837400</authid><authname>Alhadlaq H.</authname><surname>Alhadlaq</surname><given-name>Hisham A.</given-name><initials>H.A.</initials><afid>60013183</afid><afid>60005353</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8650660500</author-url><authid>8650660500</authid><authname>Khan M.</authname><surname>Khan</surname><given-name>M. A Majeed</given-name><initials>M.A.M.</initials><afid>60013183</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:16240688600</author-url><authid>16240688600</authid><authname>Alrokayan S.</authname><surname>Alrokayan</surname><given-name>Salman A.</given-name><initials>S.A.</initials><afid>60005353</afid></author><authkeywords>Antioxidants | Biocompatible NPs | CeO&lt;inf&gt;2&lt;/inf&gt; NPs | Glutathione | Redox NPs</authkeywords><intid>35884179</intid><source-id>26950</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927938035"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927938035?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927938035&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927938035&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0747563215002460"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927938035</prism:url><dc:identifier>SCOPUS_ID:84927938035</dc:identifier><eid>2-s2.0-84927938035</eid><dc:title>Dimensions of video game behavior and their relationships with personality</dc:title><dc:creator>Worth N.</dc:creator><prism:publicationName>Computers in Human Behavior</prism:publicationName><prism:issn>07475632</prism:issn><prism:volume>50</prism:volume><prism:pageRange>132-140</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>1 September 2015</prism:coverDisplayDate><prism:doi>10.1016/j.chb.2015.03.056</prism:doi><pii>S0747563215002460</pii><dc:description>© 2015 Elsevier Ltd. As video games become increasingly popular pastimes, it becomes more important to understand how different individuals behave when they play these games. Previous research has focused mainly on behavior in massively multiplayer online role-playing games; therefore, in the current study we sought to extend on this research by examining the connections between personality traits and behaviors in video games more generally. Two hundred and nineteen university students completed measures of personality traits, psychopathic traits, and a questionnaire regarding frequency of different behaviors during video game play. A principal components analysis of the video game behavior questionnaire revealed four factors: Aggressing, Winning, Creating, and Helping. Each behavior subscale was significantly correlated with at least one personality trait. Men reported significantly more Aggressing, Winning, and Helping behavior than women. Controlling for participant sex, Aggressing was negatively correlated with Honesty-Humility, Helping was positively correlated with Agreeableness, and Creating was negatively correlated with Conscientiousness. Aggressing was also positively correlated with all psychopathic traits, while Winning and Creating were correlated with one psychopathic trait each. Frequency of playing video games online was positively correlated with the Aggressing, Winning, and Helping scales, but not with the Creating scale. The results of the current study provide support for previous research on personality and behavior in massively multiplayer online role-playing games.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001343</affiliation-url><afid>60001343</afid><affilname>Brock University</affilname><name-variant>Brock University</name-variant><affiliation-city>St Catharines</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:34880921000</author-url><authid>34880921000</authid><authname>Worth N.</authname><surname>Worth</surname><given-name>Narnia C.</given-name><initials>N.C.</initials><afid>60001343</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6701496733</author-url><authid>6701496733</authid><authname>Book A.</authname><surname>Book</surname><given-name>Angela S.</given-name><initials>A.S.</initials><afid>60001343</afid></author><authkeywords>Aggression | Massively multiplayer online role-playing games | Online | Personality | Psychopathy | Video games</authkeywords><intid>1535701604</intid><source-id>19419</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929462507"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929462507?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929462507&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929462507&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0306460315001458"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929462507</prism:url><dc:identifier>SCOPUS_ID:84929462507</dc:identifier><eid>2-s2.0-84929462507</eid><dc:title>Defining and predicting short-term alcohol use changes during a smoking cessation attempt</dc:title><dc:creator>Berg K.</dc:creator><prism:publicationName>Addictive Behaviors</prism:publicationName><prism:issn>03064603</prism:issn><prism:eIssn>18736327</prism:eIssn><prism:volume>48</prism:volume><prism:pageRange>52-57</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>September 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.addbeh.2015.04.004</prism:doi><pii>S0306460315001458</pii><dc:description>© 2015. Published by Elsevier Ltd. Introduction: Alcohol and nicotine are commonly used substances in the U.S., with significant impacts on health. Using both substances concurrently impacts quit attempts. While studies have sought to examine changes in alcohol use co-occurring with tobacco cessation, results have not been consistent. Understanding these changes has clinical implications. The objective of this study is to identify changes in alcohol consumption that occur following tobacco cessation, as well as predictors of alcohol use patterns following a smoking cessation attempt. Methods: A secondary analysis of a randomized, placebo-controlled trial evaluating the efficacy of five tobacco cessation pharmacotherapies. Participants (. N=. 1301) reported their smoking and alcohol consumption daily for two weeks prior to, and two weeks after, the target quit date (TQD). Results: Generally, alcohol use decreased post-TQD. Smokers who reported less pre-quit alcohol use, as well as smokers who were female, non-white, and had a history of alcohol dependence tended to use less alcohol post-quit. Pre- and post-quit alcohol use were more strongly related among men and among those without a history of alcohol dependence. Conclusions: For most smokers alcohol use decreased following smoking cessation. These results suggest that the expectation should be of decreased alcohol use post cessation. However, attention may be warranted for those who drink higher amounts of alcohol pre-cessation because they may be more likely to drink more in the post-quit period which may influence smoking cessation success.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025553</affiliation-url><afid>60025553</afid><affilname>University of Wisconsin School of Medicine and Public Health</affilname><name-variant>University of Wisconsin</name-variant><affiliation-city>Madison</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073942</affiliation-url><afid>60073942</afid><affilname>William S. Middleton Memorial Veterans Hospital</affilname><name-variant>William S. Middleton Memorial Veterans Hospital Madison</name-variant><affiliation-city>Madison</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55601124400</author-url><authid>55601124400</authid><authname>Berg K.</authname><surname>Berg</surname><given-name>Kristin M.</given-name><initials>K.M.</initials><afid>60025553</afid><afid>60073942</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55601124400</author-url><authid>55601124400</authid><authname>Berg K.</authname><surname>Berg</surname><given-name>Kristin M.</given-name><initials>K.M.</initials><afid>60025553</afid><afid>60073942</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005784133</author-url><authid>7005784133</authid><authname>Piper M.</authname><surname>Piper</surname><given-name>Megan E.</given-name><initials>M.E.</initials><afid>60025553</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55574213209</author-url><authid>55574213209</authid><authname>Smith S.</authname><surname>Smith</surname><given-name>Stevens S.</given-name><initials>S.S.</initials><afid>60025553</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102171773</author-url><authid>7102171773</authid><authname>Fiore M.</authname><surname>Fiore</surname><given-name>Michael C.</given-name><initials>M.C.</initials><afid>60025553</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003350001</author-url><authid>7003350001</authid><authname>Jorenby D.</authname><surname>Jorenby</surname><given-name>Douglas E.</given-name><initials>D.E.</initials><afid>60025553</afid></author><authkeywords>Alcohol use | Smoking cessation | Tobacco use</authkeywords><intid>35963655</intid><source-id>24763</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930194715"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930194715?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930194715&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930194715&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0898656815001461"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930194715</prism:url><dc:identifier>SCOPUS_ID:84930194715</dc:identifier><eid>2-s2.0-84930194715</eid><dc:title>Coronin 1A depletion protects endothelial cells from TNFα-induced apoptosis by modulating p38β expression and activation</dc:title><dc:creator>Kim G.</dc:creator><prism:publicationName>Cellular Signalling</prism:publicationName><prism:issn>08986568</prism:issn><prism:eIssn>18733913</prism:eIssn><prism:volume>27</prism:volume><prism:issueIdentifier>9</prism:issueIdentifier><prism:pageRange>1688-1693</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>September 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cellsig.2015.04.012</prism:doi><pii>S0898656815001461</pii><dc:description>© 2015 Elsevier Inc.. Coronins are conserved actin-binding proteins that regulate various cellular processes such as migration and endocytosis. Among coronin family members, coronin 1A is highly expressed in hematopoietic lineage cells where it regulates cell homeostasis. However, the expression and function of coronin 1A in endothelial cells have not yet been elucidated. We found that coronin 1A is expressed in the human umbilical vein endothelial cell (HUVEC) and human brain microvascular endothelial cell (HBMVEC). In HUVEC depleted of coronin 1A by siRNA transfection, tumor necrosis factor α (TNFα). +. cyclohexamide (CHX) treatment resulted in a decrease in the number of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positive apoptotic cells. Coronin 1A depletion also resulted in the suppression of caspase 3 and poly(ADP-ribose) polymerase cleavage and a reduction in caspase 3 activity. Next, we examined TNFα-induced activation of several pro- and anti-apoptotic signaling molecules to find the target molecule of coronin 1A and found that p38 phosphorylation was enhanced by TNFα stimulation in coronin 1A-depleted HUVEC. Among the p38 isoforms, the expression of p38β was significantly upregulated after coronin 1A depletion, suggesting that the expression and phosphorylation of anti-apoptotic p38β were significantly induced in coronin 1A-depleted HUVEC. Inhibition of p38β upregulation in coronin 1A-depleted HUVEC restored the cleavage of caspase 8 and caspase 3 and induced more apoptosis than in coronin 1A-depleted HUVEC in response to TNFα. +. CHX. These findings suggest that coronin 1A modulates endothelial cell apoptosis by regulating p38β expression and activation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60068695</affiliation-url><afid>60068695</afid><affilname>National Institute of Health, Seoul</affilname><name-variant>National Institute of Health</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55462898800</author-url><authid>55462898800</authid><authname>Kim G.</authname><surname>Kim</surname><given-name>Geun Young</given-name><initials>G.Y.</initials><afid>60068695</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56662553200</author-url><authid>56662553200</authid><authname>Kim H.</authname><surname>Kim</surname><given-name>Hanna</given-name><initials>H.</initials><afid>60068695</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35199798300</author-url><authid>35199798300</authid><authname>Lim H.</authname><surname>Lim</surname><given-name>Hyun Joung</given-name><initials>H.J.</initials><afid>60068695</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7601565632</author-url><authid>7601565632</authid><authname>Park H.</authname><surname>Park</surname><given-name>Hyun Young</given-name><initials>H.Y.</initials><afid>60068695</afid></author><authkeywords>Apoptosis | Coronin 1A | Endothelial cell | P38β | Tumor necrosis factor α</authkeywords><intid>36085657</intid><source-id>18487</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927130720"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927130720?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927130720&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927130720&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0261379415000505"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927130720</prism:url><dc:identifier>SCOPUS_ID:84927130720</dc:identifier><eid>2-s2.0-84927130720</eid><dc:title>Reevaluating the sociotropic economic voting hypothesis</dc:title><dc:creator>Hansford T.</dc:creator><prism:publicationName>Electoral Studies</prism:publicationName><prism:issn>02613794</prism:issn><prism:volume>39</prism:volume><prism:pageRange>15-25</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>September 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.electstud.2015.03.005</prism:doi><pii>S0261379415000505</pii><dc:description>© 2015 Elsevier Ltd. One of the canonical causal claims in political science links individuals' evaluations of the national economy with their votes. Yet there are reasons to expect that these economic perceptions are endogenous to vote choice, meaning that existing cross-sectional models cannot provide a valid test of the causal retrospective voting claim. Using an instrumental variables approach, we assess the effect of sociotropic evaluations on the decision to vote for the incumbent president or his party's candidate in eight recent U.S. presidential elections. In contrast with prior work, our results reveal that while there is a correlation between sociotropic evaluations and vote choice, individuals' subjective evaluations only exert a causal effect on votes when there is not an incumbent president on the ballot. These results suggest that, when incumbents are on the ballot, individuals' economic perceptions are particularly clouded by appraisals of the incumbent and thus do not operate as an exogenous influence on votes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009164</affiliation-url><afid>60009164</afid><affilname>UC MERCED</affilname><name-variant>University of California, Merced</name-variant><affiliation-city>Merced</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002092</affiliation-url><afid>60002092</afid><affilname>Florida State University</affilname><name-variant>Florida State University</name-variant><affiliation-city>Tallahassee</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603456463</author-url><authid>6603456463</authid><authname>Hansford T.</authname><surname>Hansford</surname><given-name>Thomas G.</given-name><initials>T.G.</initials><afid>60009164</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7102133803</author-url><authid>7102133803</authid><authname>Gomez B.</authname><surname>Gomez</surname><given-name>Brad T.</given-name><initials>B.T.</initials><afid>60002092</afid></author><authkeywords>Economic voting | Retrospective voting | Sociotropic evaluations | U.S. presidential elections</authkeywords><intid>2035564535</intid><source-id>16114</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926454406"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926454406?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926454406&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926454406&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S092666901500271X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926454406</prism:url><dc:identifier>SCOPUS_ID:84926454406</dc:identifier><eid>2-s2.0-84926454406</eid><dc:title>Expression profiles of rosmarinic acid biosynthesis genes in two Salvia miltiorrhiza lines with differing water-soluble phenolic contents</dc:title><dc:creator>Song Z.</dc:creator><prism:publicationName>Industrial Crops and Products</prism:publicationName><prism:issn>09266690</prism:issn><prism:volume>71</prism:volume><prism:pageRange>24-30</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>September 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.indcrop.2015.03.081</prism:doi><pii>S092666901500271X</pii><dc:description>© 2015 Elsevier B.V. Phenolic acids are among the important bioactive compounds found in Salvia miltiorrhiza Bunge. Rosmarinic acid (RA) has been identified as the core structure of most phenolic acids in this widely useful herb. This work describes a comparative analysis of the expression patterns of RA biosynthetic genes in relation to different accumulation patterns of phenolic acid contents in two danshen genotypes, DS1 (S. miltiorrhiza) and DS2 (S. miltiorrhiza f. alba C.Y.Li). Quantitative real-time PCR (qRT-PCR) showed that the transcriptional expression levels of most of the genes were significantly higher in DS1 than in DS2. The results indicated that the higher RA accumulation observed in DS1 might be a result of the up-regulation of several co-expressed genes in this metabolic pathway. SmPAL, SmC4H, Sm4CL and SmHPPD may serve as key genes in the regulation of RA accumulation in DS1. SmTAT might play a more important role in regulating the content of salvianolic acid B (SAB). Overall, our results provide new information on the expression profiles of biosynthetic genes in connection with phenolic acid accumulation at the molecular level in two danshen germplasm selections.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026852</affiliation-url><afid>60026852</afid><affilname>Shandong Agricultural University</affilname><name-variant>Shandong Agricultural University</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:14064159500</author-url><authid>14064159500</authid><authname>Song Z.</authname><surname>Song</surname><given-name>Zhenqiao</given-name><initials>Z.</initials><afid>60026852</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8891522800</author-url><authid>8891522800</authid><authname>Li X.</authname><surname>Li</surname><given-name>Xingfeng</given-name><initials>X.</initials><afid>60026852</afid></author><authkeywords>Real-time fluorescence quantitative PCR | Salvia miltiorrhiza | Tanshinone biosynthetic gene</authkeywords><intid>35454676</intid><source-id>32791</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927724701"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927724701?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927724701&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927724701&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0191886915002470"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927724701</prism:url><dc:identifier>SCOPUS_ID:84927724701</dc:identifier><eid>2-s2.0-84927724701</eid><dc:title>The origins of party identification and its relationship to political orientations</dc:title><dc:creator>Bell E.</dc:creator><prism:publicationName>Personality and Individual Differences</prism:publicationName><prism:issn>01918869</prism:issn><prism:volume>83</prism:volume><prism:pageRange>136-141</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>September 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.paid.2015.04.002</prism:doi><pii>S0191886915002470</pii><dc:description>© 2015 Elsevier Ltd. An established position, long recognized in the literature, maintains that political party identification (PID) arises mainly from familial socialization and has a major impact on political outlooks and behaviors. An alternative view, also entrenched in the literature, holds that the direction of causation may go the other way, with political orientations influencing PID insofar as individuals seek out parties that match their ideological viewpoints. Here we use univariate and multivariate twin modeling to examine the underlying etiology assumed by those two positions, and introduce a new perspective that may help researchers make sense of PID, political orientations, and the relationships between them. Our findings indicate that: (1) PID is substantially heritable; and (2) there is empirical support for a model in which genetic and environmental factors influence political orientations, which in turn affect PID.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000631</affiliation-url><afid>60000631</afid><affilname>Brescia University College</affilname><name-variant>Brescia College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015595</affiliation-url><afid>60015595</afid><affilname>Universitat Bielefeld</affilname><name-variant>Bielefeld University</name-variant><affiliation-city>Bielefeld</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:18435797000</author-url><authid>18435797000</authid><authname>Bell E.</authname><surname>Bell</surname><given-name>Edward</given-name><initials>E.</initials><afid>60000631</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:25638612900</author-url><authid>25638612900</authid><authname>Kandler C.</authname><surname>Kandler</surname><given-name>Christian</given-name><initials>C.</initials><afid>60015595</afid></author><authkeywords>Behaviour genetics | Heritability | Political attitudes | Political orientations | Political party identification | Twin study</authkeywords><intid>2035661711</intid><source-id>12807</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928725915"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928725915?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928725915&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928725915&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0997753815000273"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928725915</prism:url><dc:identifier>SCOPUS_ID:84928725915</dc:identifier><eid>2-s2.0-84928725915</eid><dc:title>Material-symmetries congruency in transversely isotropic and orthotropic hyperelastic materials</dc:title><dc:creator>Latorre M.</dc:creator><prism:publicationName>European Journal of Mechanics, A/Solids</prism:publicationName><prism:issn>09977538</prism:issn><prism:volume>53</prism:volume><prism:pageRange>99-106</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>1 September 2015</prism:coverDisplayDate><prism:doi>10.1016/j.euromechsol.2015.03.007</prism:doi><pii>S0997753815000273</pii><dc:description>© 2015 Elsevier Masson SAS. All rights reserved. In this work we present the material-symmetries congruency property for anisotropic hyperelastic materials. A transversely isotropic or orthotropic material model holding this property guarantees the recovery of the isotropic behavior when, for example, the volume of reinforcement in a composite material vanishes. A material presenting material-symmetries congruency must show it not only from an analytical, theoretical point of view, but also from a numerical, practical point of view. The former may be obtained from construction of the stored energy function, whereas the latter must be obtained guaranteeing that the parameter-fitting procedure yields material parameters which combined with the specific model results in an isotropic behavior prediction for isotropic materials. We show that some anisotropic models do not present either analytical or numerical material-symmetries congruency.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028442</affiliation-url><afid>60028442</afid><affilname>Universidad Politecnica de Madrid</affilname><name-variant>Universidad Politécnica de Madrid</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56394693500</author-url><authid>56394693500</authid><authname>Latorre M.</authname><surname>Latorre</surname><given-name>Marcos</given-name><initials>M.</initials><afid>60028442</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603100000</author-url><authid>6603100000</authid><authname>Montáns F.</authname><surname>Montáns</surname><given-name>Francisco Javier</given-name><initials>F.J.</initials><afid>60028442</afid></author><authkeywords>Anisotropy | Hyperelasticity | Incompressible materials</authkeywords><intid>1785839865</intid><source-id>13877</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921725163"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921725163?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921725163&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921725163&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921725163</prism:url><dc:identifier>SCOPUS_ID:84921725163</dc:identifier><eid>2-s2.0-84921725163</eid><dc:title>Sparse signal recovery from a mixture of linear and magnitude-only measurements</dc:title><dc:creator>Akçakaya M.</dc:creator><prism:publicationName>IEEE Signal Processing Letters</prism:publicationName><prism:issn>10709908</prism:issn><prism:volume>22</prism:volume><prism:issueIdentifier>9</prism:issueIdentifier><prism:pageRange>1220-1223</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>1 September 2015</prism:coverDisplayDate><prism:doi>10.1109/LSP.2015.2393295</prism:doi><dc:description>© 2015 IEEE. We consider the problem of exact sparse signal recovery from a combination of linear and magnitude-only (phaseless) measurements. A k-sparse signal x in ∈ ℂn is measured as r = Bx and y = |Cx|, where B in ∈ ℂm1 × n and ∈ ℂm2 × n are measurement matrices and |·| is the element-wise absolute value. We show that if max(2m1,1) + m2 ≥ 4k - 1, then a set of generic measurements are sufficient to recover every k-sparse x exactly, establishing the trade-off between the number of linear and magnitude-only measurements.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002746</affiliation-url><afid>60002746</afid><affilname>Harvard Medical School</affilname><name-variant>Harvard Medical School</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009982</affiliation-url><afid>60009982</afid><affilname>Harvard University</affilname><name-variant>Harvard University</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23003495600</author-url><authid>23003495600</authid><authname>Akçakaya M.</authname><surname>Akçakaya</surname><given-name>Mehmet</given-name><initials>M.</initials><afid>60002746</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005206764</author-url><authid>7005206764</authid><authname>Tarokh V.</authname><surname>Tarokh</surname><given-name>Vahid</given-name><initials>V.</initials><afid>60009982</afid></author><authkeywords>Compressed sensing | Phase retrieval | Sparse phase retrieval | Sparse signals</authkeywords><intid>1784689100</intid><article-number>7010925</article-number><source-id>17316</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929178693"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929178693?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929178693&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929178693&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S004484861500263X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929178693</prism:url><dc:identifier>SCOPUS_ID:84929178693</dc:identifier><eid>2-s2.0-84929178693</eid><dc:title>Control of activity patterns in crowded groups of male noble crayfish Astacus astacus (Crustacea, Astacidea) by light regimes: A way to increase the efficiency of crayfish production?</dc:title><dc:creator>Franke R.</dc:creator><prism:publicationName>Aquaculture</prism:publicationName><prism:issn>00448486</prism:issn><prism:volume>446</prism:volume><prism:pageRange>103-110</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>September 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.aquaculture.2015.05.007</prism:doi><pii>S004484861500263X</pii><dc:description>© 2015 Elsevier B.V. Most crayfish species exhibit behavioral traits (solitary lifestyle, high aggressiveness, establishment of social hierarchies) which in intensive aquaculture systems result in low survival due to cannibalism and reduced overall growth. In addition to selective breeding programs, this situation may be improved by identifying culture conditions (e.g., light regimes) which can alleviate the negative impact of specific behavioral patterns on an effective crayfish production. The present experiments demonstrate a pronounced nocturnality of male noble crayfish Astacus astacus. The circadian system seems to be of rather little relevance to the daily pattern of the collective activity in crowded crayfish groups. Parameters of the light regime (the L/D-ratio of 24-h light-dark cycles, light intensity, background illumination during nighttime) were shown to have a crucial and immediate influence on (i) the daily temporal pattern of activity, (ii) the 'effective density' (density of individuals which are simultaneously active), and (iii) the overall daily amount of activity. Except for individuals at the verge of molting, activities were restricted to the scotophase, largely independent of the LD-ratio. The effective density was negatively, the overall daily amount of activity positively, correlated with the length of the scotophase. Both parameters decreased significantly under a dim nocturnal background illumination. An optimal combination of high overall daily activity and low effective density was found under a short-day photoperiod of LD 8:16. As in the long run overall daily amount of activity and effective density may be relevant to growth and survival, respectively, manipulations of the light regime are suggested to be a promising approach to improve the efficiency of a commercial crayfish production. The present results may be useful in designing appropriate long-term experiments which actually measure survival and growth.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031514</affiliation-url><afid>60031514</afid><affilname>Universitat Gottingen</affilname><name-variant>Universität Göttingen</name-variant><affiliation-city>Gottingen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54583424200</author-url><authid>54583424200</authid><authname>Franke R.</authname><surname>Franke</surname><given-name>Robert</given-name><initials>R.</initials><afid>60031514</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603439791</author-url><authid>6603439791</authid><authname>Hörstgen-Schwark G.</authname><surname>Hörstgen-Schwark</surname><given-name>Gabriele</given-name><initials>G.</initials><afid>60031514</afid></author><authkeywords>Activity patterns | Astacus astacus | Freshwater crayfish | Light regime | RAS</authkeywords><intid>1785916952</intid><source-id>29419</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926435948"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926435948?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926435948&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926435948&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0926669015002721"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926435948</prism:url><dc:identifier>SCOPUS_ID:84926435948</dc:identifier><eid>2-s2.0-84926435948</eid><dc:title>Lipophilic phytochemicals from elderberries (Sambucus nigra L.): Influence of ripening, cultivar and season</dc:title><dc:creator>Salvador Â.</dc:creator><prism:publicationName>Industrial Crops and Products</prism:publicationName><prism:issn>09266690</prism:issn><prism:volume>71</prism:volume><prism:pageRange>15-23</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>September 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.indcrop.2015.03.082</prism:doi><pii>S0926669015002721</pii><dc:description>© 2015 Elsevier B.V. The chemical composition of the lipophilic extracts of three Portuguese elderberries cultivars belonging to the Sambucus nigra L. species ('Bastardeira', 'Sabugueira' and 'Sabugueiro'), was studied by gas chromatography-mass spectrometry. The influence of the harvesting season (2012 and 2013), cultivar and the ripening stage was evaluated. Regarding the amount of lipophilic extractives, they ranged from 0.56% to 1.84% of the dry weight. The major chemical families present in these fractions were triterpenoids and fatty acids accounting with 84.9-93.8% and 4.3-11.4% of the total amount of lipophilic components, respectively. The most abundant compounds, identified as elderberries components were ursolic and oleanolic acids, followed by smaller amounts of long chain aliphatic alcohols and sterols. During ripening, a similar profile of the studied chemical families was found for the two sampling seasons and the three cultivars, with an initial growth of their content followed by a systematic decrease until maturity, yet, a higher lipophilic content (p&lt;. 0.05) is reported for the 2013 harvest. Regarding mature elderberries, 'Sabugueira' and 'Bastardeira' showed higher contents of lipophilics, and particularly of triterpenic acids (p&lt;. 0.05), for the two sampling years. In-depth study of elderberries, lipophilic extractives can contribute to the valuation of this natural product, being in this study highlighted the profile of these bioactive compounds, as well, the parameters that affect their content. Additionally, since considerable amounts of unripe and overripe elderberries are produced on harvesting, and that our results showed considerable amounts of lipophilics for both ripening stages, this highlights that these wastes can be seen as a promising sources for the preparation of lipophilic extracts enriched in bioactive compounds.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024825</affiliation-url><afid>60024825</afid><affilname>Universidade de Aveiro</affilname><name-variant>Universidade de Aveiro</name-variant><affiliation-city>Aveiro</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024825</affiliation-url><afid>60024825</afid><affilname>Universidade de Aveiro</affilname><name-variant>Universidade de Aveiro</name-variant><affiliation-city>Aveiro</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35786580500</author-url><authid>35786580500</authid><authname>Salvador Â.</authname><surname>Salvador</surname><given-name>Ângelo C.</given-name><initials>Â.C.</initials><afid>60024825</afid><afid>60024825</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35786580500</author-url><authid>35786580500</authid><authname>Salvador Â.</authname><surname>Salvador</surname><given-name>Ângelo C.</given-name><initials>Â.C.</initials><afid>60024825</afid><afid>60024825</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006653213</author-url><authid>7006653213</authid><authname>Rocha S.</authname><surname>Rocha</surname><given-name>Sílvia M.</given-name><initials>S.M.</initials><afid>60024825</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005219944</author-url><authid>7005219944</authid><authname>Silvestre A.</authname><surname>Silvestre</surname><given-name>Armando J D</given-name><initials>A.J.D.</initials><afid>60024825</afid></author><authkeywords>Elderberries | Fatty acids | Ripening | Sambucus nigra l. | Sterols | Triterpenoids</authkeywords><intid>2035449243</intid><source-id>32791</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928532836"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928532836?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928532836&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928532836&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1469029215000321"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928532836</prism:url><dc:identifier>SCOPUS_ID:84928532836</dc:identifier><eid>2-s2.0-84928532836</eid><dc:title>COMT gene polymorphisms, cognitive performance, and physical fitness in older adults</dc:title><dc:creator>Voelcker-Rehage C.</dc:creator><prism:publicationName>Psychology of Sport and Exercise</prism:publicationName><prism:issn>14690292</prism:issn><prism:volume>20</prism:volume><prism:pageRange>20-28</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>September 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.psychsport.2015.04.001</prism:doi><pii>S1469029215000321</pii><dc:description>© 2015 Elsevier Ltd. Objective: It is well known that genetic predispositions might influence cognitive performance, particularly in older adults. One gene related to executive functioning is the COMT gene with met/met carriers outperforming val/val carriers in cognitive tasks. Further, it has been shown that fitness is positively related to cognitive functioning in older adults. As both, the COMT genotype and physical exercise have been shown to influence dopamine availability and as changes in dopamine metabolism seem to play a key role in cognitive aging, the aim of this study was to analyze the association of the COMT gene polymorphisms with the relationship between fitness and cognition. Design: We used a cross-sectional design. Method: Sixty-eight healthy older adults between 62 and 79 years of age were analyzed in this study. DNA was extracted from capillary blood samples. Participants performed a modified version of the Flanker Task as an indicator of executive control and a battery of motor and physical tests as indicators of fitness. Results: Hierarchical regression analyses revealed a positive influence of overall fitness and an interactive effect of fitness and COMT polymorphisms on Flanker accuracy performance. Val/val carriers revealed the highest positive correlation between fitness and cognition. Conclusions: Our data suggest that particularly val/val allele carriers benefit from exercise by improved cognitive functioning whereas met/met carriers already perform closer at their optimum level.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016458</affiliation-url><afid>60016458</afid><affilname>Jacobs University Bremen</affilname><name-variant>Jacobs University Bremen</name-variant><affiliation-city>Bremen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016458</affiliation-url><afid>60016458</afid><affilname>Jacobs University Bremen</affilname><name-variant>Jacobs University Bremen</name-variant><affiliation-city>Bremen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008069</affiliation-url><afid>60008069</afid><affilname>Technische Universitat Chemnitz</affilname><name-variant>Chemnitz University of Technology</name-variant><affiliation-city>Chemnitz</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015815</affiliation-url><afid>60015815</afid><affilname>Universitat Stuttgart</affilname><name-variant>University of Stuttgart</name-variant><affiliation-city>Stuttgart</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030162</affiliation-url><afid>60030162</afid><affilname>Columbia University in the City of New York</affilname><name-variant>Columbia University</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:10044451600</author-url><authid>10044451600</authid><authname>Voelcker-Rehage C.</authname><surname>Voelcker-Rehage</surname><given-name>Claudia</given-name><initials>C.</initials><afid>60016458</afid><afid>60008069</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:10044451600</author-url><authid>10044451600</authid><authname>Voelcker-Rehage C.</authname><surname>Voelcker-Rehage</surname><given-name>Claudia</given-name><initials>C.</initials><afid>60016458</afid><afid>60008069</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005736654</author-url><authid>7005736654</authid><authname>Jeltsch A.</authname><surname>Jeltsch</surname><given-name>Albert</given-name><initials>A.</initials><afid>60016458</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6604041207</author-url><authid>6604041207</authid><authname>Godde B.</authname><surname>Godde</surname><given-name>Ben</given-name><initials>B.</initials><afid>60016458</afid><afid>60015815</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6604041207</author-url><authid>6604041207</authid><authname>Godde B.</authname><surname>Godde</surname><given-name>Ben</given-name><initials>B.</initials><afid>60016458</afid><afid>60015815</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56606662300</author-url><authid>56606662300</authid><authname>Becker S.</authname><surname>Becker</surname><given-name>Sandra</given-name><initials>S.</initials><afid>60016458</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003567129</author-url><authid>7003567129</authid><authname>Staudinger U.</authname><surname>Staudinger</surname><given-name>Ursula M.</given-name><initials>U.M.</initials><afid>60016458</afid><afid>60030162</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003567129</author-url><authid>7003567129</authid><authname>Staudinger U.</authname><surname>Staudinger</surname><given-name>Ursula M.</given-name><initials>U.M.</initials><afid>60016458</afid><afid>60030162</afid></author><authkeywords>Aging | Dopamine | Executive functioning | Exercise | Genotype | Physical activity</authkeywords><intid>2035797999</intid><source-id>14033</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929299899"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929299899?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929299899&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929299899&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1751616115001320"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929299899</prism:url><dc:identifier>SCOPUS_ID:84929299899</dc:identifier><eid>2-s2.0-84929299899</eid><dc:title>On the role of SMA modeling in simulating NiTinol self-expanding stenting surgeries to assess the performance characteristics of mechanical and thermal activation schemes</dc:title><dc:creator>Saleeb A.</dc:creator><prism:publicationName>Journal of the Mechanical Behavior of Biomedical Materials</prism:publicationName><prism:issn>17516161</prism:issn><prism:eIssn>18780180</prism:eIssn><prism:volume>49</prism:volume><prism:pageRange>43-60</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>September 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jmbbm.2015.04.012</prism:doi><pii>S1751616115001320</pii><dc:description>© 2015 Elsevier Ltd. The work is focused on a detailed simulation of the key stages involved in the NiTinol self-expanding stenting surgical procedure; i.e., crimping, deployment, SMA activation, as well as post-surgery steady-state cyclic behavior mimicking the systolic-to-diastolic pressure oscillations. To this end, a general multi-mechanism SMA model was utilized, whose calibration was completed using the test data from simple isothermal uniaxial tension experiments. The emphasis in the study was placed on the comparison of two alternative SMA activation protocols, in terms of both the immediate and long-term (post-surgery) performance characteristics. The first is 'hard' mechanical activation utilizing superelasticity, and the second is 'soft' thermal activation relying upon the combined one-way shape memory effect and constrained-recovery characteristics of the NiTinol material.The important findings are (1) the thermal activation protocol is far superior compared to the mechanical counterpart, from the point of view of lower magnitudes of the induced outward chronic forces, lesser developed stresses in the host tissue, as well as higher compression ratio with lesser crimping force for the same geometry of initial stent memory configuration, (2) the thermal activation protocol completely bypassed the complications of maintaining the high restraining force during deployment of the stent, and (3) there is no indication of any detrimental functional fatigue/degradation in the cured stenotic artery during cyclic pressure oscillations.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032143</affiliation-url><afid>60032143</afid><affilname>University of Akron</affilname><name-variant>Univ of Akron</name-variant><affiliation-city>Akron</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005998391</author-url><authid>7005998391</authid><authname>Saleeb A.</authname><surname>Saleeb</surname><given-name>A. F.</given-name><initials>A.F.</initials><afid>60032143</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55538987700</author-url><authid>55538987700</authid><authname>Dhakal B.</authname><surname>Dhakal</surname><given-name>B.</given-name><initials>B.</initials><afid>60032143</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56415123800</author-url><authid>56415123800</authid><authname>Owusu-Danquah J.</authname><surname>Owusu-Danquah</surname><given-name>J. S.</given-name><initials>J.S.</initials><afid>60032143</afid></author><authkeywords>NiTinol | Pressure cycles | Self-expanding stent | Shape memory effect | Superelasticity</authkeywords><intid>535945645</intid><source-id>8000153139</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930196990"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930196990?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930196990&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930196990&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S109649591500086X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930196990</prism:url><dc:identifier>SCOPUS_ID:84930196990</dc:identifier><eid>2-s2.0-84930196990</eid><dc:title>Cloning and characterization of aquaglyceroporin genes from rainbow smelt (Osmerus mordax) and transcript expression in response to cold temperature</dc:title><dc:creator>Hall J.</dc:creator><prism:publicationName>Comparative Biochemistry and Physiology Part - B: Biochemistry and Molecular Biology</prism:publicationName><prism:issn>10964959</prism:issn><prism:eIssn>18791107</prism:eIssn><prism:volume>187</prism:volume><prism:pageRange>39-54</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>September 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cbpb.2015.05.004</prism:doi><pii>S109649591500086X</pii><dc:description>© 2015 Elsevier Inc. Aquaglyceroporins (GLPs) are integral membrane proteins that facilitate passive movement of water, glycerol and urea across cellular membranes. In this study, GLP-encoding genes were characterized in rainbow smelt (Osmerus mordax mordax), an anadromous teleost that accumulates high glycerol and modest urea levels in plasma and tissues as an adaptive cryoprotectant mechanism in sub-zero temperatures. We report the gene and promoter sequences for two aqp10b paralogs (aqp10ba, aqp10bb) that are 82% identical at the predicted amino acid level, and aqp9b. Aqp10bb and aqp9b have the 6 exon structure common to vertebrate GLPs. Aqp10ba has 8 exons; there are two additional exons at the 5' end, and the promoter sequence is different from aqp10bb. Molecular phylogenetic analysis suggests that the aqp10b paralogs arose from a gene duplication event specific to the smelt lineage. Smelt GLP transcripts are ubiquitously expressed; however, aqp10ba transcripts were highest in kidney, aqp10bb transcripts were highest in kidney, intestine, pyloric caeca and brain, and aqp9b transcripts were highest in spleen, liver, red blood cells and kidney. In cold-temperature challenge experiments, plasma glycerol and urea levels were significantly higher in cold- compared to warm-acclimated smelt; however, GLP transcript levels were generally either significantly lower or remained constant. The exception was significantly higher aqp10ba transcript levels in kidney. High aqp10ba transcripts in smelt kidney that increase significantly in response to cold temperature in congruence with plasma urea suggest that this gene duplicate may have evolved to allow the re-absorption of urea to concomitantly conserve nitrogen and prevent freezing.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019000</affiliation-url><afid>60019000</afid><affilname>Memorial University of Newfoundland</affilname><name-variant>Memorial University</name-variant><affiliation-city>St John's</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7407379701</author-url><authid>7407379701</authid><authname>Hall J.</authname><surname>Hall</surname><given-name>Jennifer R.</given-name><initials>J.R.</initials><afid>60019000</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6602157640</author-url><authid>6602157640</authid><authname>Clow K.</authname><surname>Clow</surname><given-name>Kathy A.</given-name><initials>K.A.</initials><afid>60019000</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603755912</author-url><authid>6603755912</authid><authname>Rise M.</authname><surname>Rise</surname><given-name>Matthew L.</given-name><initials>M.L.</initials><afid>60019000</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006498542</author-url><authid>7006498542</authid><authname>Driedzic W.</authname><surname>Driedzic</surname><given-name>William R.</given-name><initials>W.R.</initials><afid>60019000</afid></author><authkeywords>Aquaglyceroporin | Cold temperature | Glycerol | Rainbow smelt | Urea</authkeywords><intid>536087295</intid><source-id>9700153210</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928809204"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928809204?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928809204&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928809204&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0005791615000506"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928809204</prism:url><dc:identifier>SCOPUS_ID:84928809204</dc:identifier><eid>2-s2.0-84928809204</eid><dc:title>Heavy social drinkers score higher on implicit wanting and liking for alcohol than alcohol-dependent patients and light social drinkers</dc:title><dc:creator>Tibboel H.</dc:creator><prism:publicationName>Journal of Behavior Therapy and Experimental Psychiatry</prism:publicationName><prism:issn>00057916</prism:issn><prism:eIssn>18737943</prism:eIssn><prism:volume>48</prism:volume><prism:pageRange>185-191</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>1 September 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jbtep.2015.04.003</prism:doi><pii>S0005791615000506</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. Abstract Background and objectives Automatic hedonic ("liking") and incentive ("wanting") processes are assumed to play an important role in addiction. Whereas some neurobiological theories suggest that these processes become dissociated when drug use develops into an addiction (i.e., "liking" becomes weaker, whereas "wanting" becomes exaggerated; e.g., Robinson &amp; Berridge, 1993), other theories suggest that there is a linear relationship between these two processes (i.e., both "liking" and "wanting" increase equally; e.g., Koob &amp; Le Moal, 1997). Our aim was to examine "wanting" and "liking" in three groups of participants: alcohol-dependent patients, heavy social drinkers, and light social drinkers. Methods Participants performed two different single target implicit association tests (ST-IATs; e.g., Bluemke &amp; Friese, 2007) and explicit ratings that were designed to measure "liking" and "wanting" for alcohol. Results Our results are in sharp contrast with the theories of both Robinson and Berridge and Koob and Le Moal: heavy drinkers had higher scores than light drinkers and alcohol-dependent patients on both the wanting ST-IAT and the liking ST-IAT. There were no differences between alcohol-dependent patients and light drinkers. Explicit ratings mirrored these results. Limitations These findings suggest that our ST-IATs are not valid measures of "wanting" and "liking". Instead, they might assess more complex knowledge regarding participants' experiences and goals. Conclusions These findings suggest that the relationship between drug consumption and appetitive drug associations is not linear, highlighting the importance of testing both sub-clinical and clinical samples in future research.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033316</affiliation-url><afid>60033316</afid><affilname>Universiteit Gent</affilname><name-variant>Ghent University</name-variant><affiliation-city>Ghent</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033044</affiliation-url><afid>60033044</afid><affilname>Centre Hospitalier Universitaire Brugmann, Brussels</affilname><name-variant>Hop. Univ. Brugmann</name-variant><affiliation-city>Brussels</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115208996</affiliation-url><afid>115208996</afid><affilname>L'Orée Day Center for Alcoholism</affilname><name-variant>L'Orée Day Center for Alcoholism</name-variant><affiliation-city>Brussels</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26021531200</author-url><authid>26021531200</authid><authname>Tibboel H.</authname><surname>Tibboel</surname><given-name>Helen</given-name><initials>H.</initials><afid>60033316</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005976361</author-url><authid>7005976361</authid><authname>De Houwer J.</authname><surname>De Houwer</surname><given-name>Jan</given-name><initials>J.</initials><afid>60033316</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602187837</author-url><authid>6602187837</authid><authname>Spruyt A.</authname><surname>Spruyt</surname><given-name>Adriaan</given-name><initials>A.</initials><afid>60033316</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36951540600</author-url><authid>36951540600</authid><authname>Brevers D.</authname><surname>Brevers</surname><given-name>Damien</given-name><initials>D.</initials><afid>60033044</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:24479813400</author-url><authid>24479813400</authid><authname>Roy E.</authname><surname>Roy</surname><given-name>Emmanuel</given-name><initials>E.</initials><afid>115208996</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6602938712</author-url><authid>6602938712</authid><authname>Noël X.</authname><surname>Noël</surname><given-name>Xavier</given-name><initials>X.</initials><afid>60033044</afid></author><authkeywords>Addiction | Alcoholism | Implicit measures | Incentive sensitization | Liking | Wanting</authkeywords><intid>35851749</intid><article-number>1128</article-number><source-id>16249</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928314029"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928314029?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928314029&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928314029&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0889157515001015"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928314029</prism:url><dc:identifier>SCOPUS_ID:84928314029</dc:identifier><eid>2-s2.0-84928314029</eid><dc:title>Genetic diversity of folate profiles in seeds of common bean, lentil, chickpea and pea</dc:title><dc:creator>Jha A.</dc:creator><prism:publicationName>Journal of Food Composition and Analysis</prism:publicationName><prism:issn>08891575</prism:issn><prism:volume>42</prism:volume><prism:pageRange>134-140</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>September 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jfca.2015.03.006</prism:doi><pii>S0889157515001015</pii><dc:description>© 2015 Elsevier Inc. Folates are water-soluble B vitamins and act as cofactors in many metabolic functions in the human body. Pulses have traditionally been considered as a good dietary source of folates. The objectives of this study were (1) to determine the concentration of folates in four cultivars each of common bean, lentil, chickpea and pea, and (2) to determine the effect of growing location on folate concentration. Six folate monoglutamates were quantified by ultra-performance liquid chromatography coupled with mass spectrometry (UPLC-MS/MS). Total folate concentration ranged from 351 to 589. μg/100. g in chickpea, 165 to 232. μg/100. g in common bean, 136 to 182. μg/100. g in lentil, and 23 to 30. μg/100. g in pea. The 5-methyltetrahydrofolate (5-MTHF) and 5-formyltetrahydrofolate (5-FTHF) folates were most abundant in common bean, lentil and chickpea, whereas 5-MTHF and tetrahydrofolate (THF) were the predominant forms in pea. Significant differences were detected among cultivars for all folates across the pulses, except for 5,10-methenyltetrahydrofolate (5,10-MTHF) in lentil, 5-MTHF in chickpea, and 5,10-MTHF and folic acid (FA) in pea. Significant effects for location and cultivar by location were also observed for the majority of the folates.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015186</affiliation-url><afid>60015186</afid><affilname>University of Saskatchewan</affilname><name-variant>University of Saskatchewan</name-variant><affiliation-city>Saskatoon</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009839</affiliation-url><afid>60009839</afid><affilname>Conseil national de recherches Canada</affilname><name-variant>National Research Council Canada</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55303117700</author-url><authid>55303117700</authid><authname>Jha A.</authname><surname>Jha</surname><given-name>Ambuj B.</given-name><initials>A.B.</initials><afid>60015186</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36715801700</author-url><authid>36715801700</authid><authname>Ashokkumar K.</authname><surname>Ashokkumar</surname><given-name>Kaliyaperumal</given-name><initials>K.</initials><afid>60015186</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56320489700</author-url><authid>56320489700</authid><authname>Diapari M.</authname><surname>Diapari</surname><given-name>Marwan</given-name><initials>M.</initials><afid>60015186</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005188867</author-url><authid>7005188867</authid><authname>Ambrose S.</authname><surname>Ambrose</surname><given-name>Stephen J.</given-name><initials>S.J.</initials><afid>60009839</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56603682000</author-url><authid>56603682000</authid><authname>Zhang H.</authname><surname>Zhang</surname><given-name>Haixia</given-name><initials>H.</initials><afid>60009839</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56181765200</author-url><authid>56181765200</authid><authname>Tar'an B.</authname><surname>Tar'an</surname><given-name>Bunyamin</given-name><initials>B.</initials><afid>60015186</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8909755700</author-url><authid>8909755700</authid><authname>Bett K.</authname><surname>Bett</surname><given-name>Kirstin E.</given-name><initials>K.E.</initials><afid>60015186</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006056382</author-url><authid>7006056382</authid><authname>Vandenberg A.</authname><surname>Vandenberg</surname><given-name>Albert</given-name><initials>A.</initials><afid>60015186</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7103146209</author-url><authid>7103146209</authid><authname>Warkentin T.</authname><surname>Warkentin</surname><given-name>Thomas D.</given-name><initials>T.D.</initials><afid>60015186</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005111703</author-url><authid>7005111703</authid><authname>Purves R.</authname><surname>Purves</surname><given-name>Randall W.</given-name><initials>R.W.</initials><afid>60015186</afid><afid>60009839</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7005111703</author-url><authid>7005111703</authid><authname>Purves R.</authname><surname>Purves</surname><given-name>Randall W.</given-name><initials>R.W.</initials><afid>60015186</afid><afid>60009839</afid></author><authkeywords>Cultivars | Folates | Food analysis | Food composition | Liquid chromatography | Mass spectrometry | Pulses | Quantification</authkeywords><intid>1785768333</intid><source-id>20582</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929326329"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929326329?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929326329&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929326329&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0928493115300679"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929326329</prism:url><dc:identifier>SCOPUS_ID:84929326329</dc:identifier><eid>2-s2.0-84929326329</eid><dc:title>Two approaches to the model drug immobilization into conjugated polymer matrix</dc:title><dc:creator>Krukiewicz K.</dc:creator><prism:publicationName>Materials Science and Engineering C</prism:publicationName><prism:issn>09284931</prism:issn><prism:volume>54</prism:volume><prism:pageRange>176-181</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>1 September 2015</prism:coverDisplayDate><prism:doi>10.1016/j.msec.2015.05.017</prism:doi><pii>S0928493115300679</pii><dc:description>© 2015 Elsevier B.V. Abstract The purpose of this study is to develop biocompatible and conducting coating being carrier of biologically active compounds with the potential use in neuroprosthetics. Conducting polypyrrole matrix has been used to immobilize and release model drugs, quercetin and ciprofloxacin. Two routes of immobilization are described: drugs have been incorporated in the polymer matrix in the course of the electropolymerization process or after polymerization, in the course of polymer oxidation. Using UV/Vis spectroscopic detection we demonstrate that both immobilization approaches display different drug-loading efficiencies. In the case of ciprofloxacin, drug incorporation following synthesis is a more efficient immobilization approach (final drug concentration: 43.3 (± 9.5) μM/cm&lt;sup&gt;2&lt;/sup&gt;), while for quercetin the highest loading is accomplished by drug incorporation during synthesis (final drug concentration: 29.1 (± 5.9) μM/cm&lt;sup&gt;2&lt;/sup&gt;). The process of drug incorporation results in the variation of surface morphology with respect to the method of immobilization as well as the choice of drug. The results prove that electrochemical methods are efficient procedures for making multifunctional polymer matrices which might be perspective bioactive coatings for implantable neuroprosthetic devices.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009081</affiliation-url><afid>60009081</afid><affilname>Politechnika Slaska w Gliwicach</affilname><name-variant>Silesian University of Technology</name-variant><affiliation-city>Gliwice</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55586054000</author-url><authid>55586054000</authid><authname>Krukiewicz K.</authname><surname>Krukiewicz</surname><given-name>Katarzyna</given-name><initials>K.</initials><afid>60009081</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644755200</author-url><authid>56644755200</authid><authname>Stokfisz A.</authname><surname>Stokfisz</surname><given-name>Anna</given-name><initials>A.</initials><afid>60009081</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7102967134</author-url><authid>7102967134</authid><authname>Zak J.</authname><surname>Zak</surname><given-name>Jerzy K.</given-name><initials>J.K.</initials><afid>60009081</afid></author><authkeywords>Ciprofloxacin | Conjugated polymers | Controlled release | Drug immobilization | Polypyrrole | Quercetin</authkeywords><intid>1535943217</intid><article-number>5452</article-number><source-id>17813</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929069696"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929069696?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929069696&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929069696&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S8756328215001507"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929069696</prism:url><dc:identifier>SCOPUS_ID:84929069696</dc:identifier><eid>2-s2.0-84929069696</eid><dc:title>Change in estimated glomerular filtration rate and fracture risk in the Action to Control Cardiovascular Risk in Diabetes Trial</dc:title><dc:creator>Isakova T.</dc:creator><prism:publicationName>Bone</prism:publicationName><prism:issn>87563282</prism:issn><prism:volume>78</prism:volume><prism:pageRange>23-27</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>September 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bone.2015.04.037</prism:doi><pii>S8756328215001507</pii><dc:description>© 2015 Elsevier Inc. Objective: Patients with type 2 diabetes (T2DM) are at increased risk of fracture. High prevalence of chronic kidney disease (CKD) in T2DM may contribute to bone fragility, but whether dynamic change in kidney function is associated with fracture risk is unclear. Research design and methods: To evaluate the association of pre-randomization baseline estimated glomerular filtration (eGFR) and its change over time with subsequent fracture risk in the Bone substudy of Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial, we conducted an observational study of 2262 women and 4737 men with T2DM and with at least 2 eGFR values. Results: During a mean follow-up of 4.40. ±. 1.54. years, 235 women and 223 men sustained a new non-vertebral fracture. In multivariable adjusted sex-specific models, pre-randomization baseline eGFR was not a significant predictor of fracture risk in either men or women. However, a steeper decline in eGFR was associated with greater risk of fracture in women (hazard ratio [HR] per standard deviation [SD] decrement in eGFR slope, 1.30; 95%CI 1.17-1.44) but not men (HR per SD decrement in eGFR slope, 0.97; 95%CI 0.82-1.13). Accounting for competing risk of death modestly attenuated the association in women (HR per SD decrement in eGFR slope, 1.19; 95%CI 1.04-1.37), with the relationship in men remaining non-significant (HR per SD decrement in eGFR slope, 0.96; 95%CI 0.77-1.18). Conclusions: Declining kidney function predicts fracture risk in women but not in men with T2DM. Future studies should investigate the mechanisms for these associations.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013227</affiliation-url><afid>60013227</afid><affilname>Northwestern University Feinberg School of Medicine</affilname><name-variant>Northwestern University</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031437</affiliation-url><afid>60031437</afid><affilname>Wake Forest University School of Medicine</affilname><name-variant>Wake Forest Univ. School of Medicine</name-variant><affiliation-city>Winston Salem</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005200</affiliation-url><afid>60005200</afid><affilname>Duke University School of Medicine</affilname><name-variant>Duke University Medical Center</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027565</affiliation-url><afid>60027565</afid><affilname>Columbia University Medical Center</affilname><name-variant>Columbia University</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100326476</affiliation-url><afid>100326476</afid><affilname>University Suburban Health Center</affilname><name-variant>University Suburban Health Center</name-variant><affiliation-city>Cleveland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002339</affiliation-url><afid>60002339</afid><affilname>Emory University School of Medicine</affilname><name-variant>Emory University School of Medicine</name-variant><affiliation-city>Atlanta</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023691</affiliation-url><afid>60023691</afid><affilname>University of California, San Francisco</affilname><name-variant>University of California, San Francisco</name-variant><affiliation-city>San Francisco</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56510338500</author-url><authid>56510338500</authid><authname>Isakova T.</authname><surname>Isakova</surname><given-name>Tamara</given-name><initials>T.</initials><afid>60013227</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7007031079</author-url><authid>7007031079</authid><authname>Craven T.</authname><surname>Craven</surname><given-name>Timothy E.</given-name><initials>T.E.</initials><afid>60031437</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:10141731300</author-url><authid>10141731300</authid><authname>Scialla J.</authname><surname>Scialla</surname><given-name>Julia J.</given-name><initials>J.J.</initials><afid>60005200</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6506378513</author-url><authid>6506378513</authid><authname>Nickolas T.</authname><surname>Nickolas</surname><given-name>Thomas L.</given-name><initials>T.L.</initials><afid>60027565</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55859132200</author-url><authid>55859132200</authid><authname>Schnall A.</authname><surname>Schnall</surname><given-name>Adrian</given-name><initials>A.</initials><afid>100326476</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7006291495</author-url><authid>7006291495</authid><authname>Barzilay J.</authname><surname>Barzilay</surname><given-name>Joshua</given-name><initials>J.</initials><afid>60002339</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56506194700</author-url><authid>56506194700</authid><authname>Schwartz A.</authname><surname>Schwartz</surname><given-name>Ann V.</given-name><initials>A.V.</initials><afid>60023691</afid></author><authkeywords>Diabetes | Estimated glomerular filtration rate | Fracture</authkeywords><intid>535902097</intid><source-id>29551</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927726552"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927726552?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927726552&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927726552&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1385894715005203"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927726552</prism:url><dc:identifier>SCOPUS_ID:84927726552</dc:identifier><eid>2-s2.0-84927726552</eid><dc:title>Fabrication of cell-laden electrospun hybrid scaffolds of alginate-based bioink and PCL microstructures for tissue regeneration</dc:title><dc:creator>Yeo M.</dc:creator><prism:publicationName>Chemical Engineering Journal</prism:publicationName><prism:issn>13858947</prism:issn><prism:volume>275</prism:volume><prism:pageRange>27-35</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>September 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.cej.2015.04.038</prism:doi><pii>S1385894715005203</pii><dc:description>© 2015 Elsevier B.V. Tissue engineering scaffolds should provide appropriate mechanical properties and three-dimensional (3D) pore-structures to yield optimum cellular activities. Electrospun micro/nanofibers have been used widely in tissue engineering because of their high surface-area-to-volume ratio and structural similarity to extracellular matrix (ECM). However, low mechanical sustainability, low 3D shape-ability, and low cell infiltration have been major limitations to their use. In this work, we propose new hybrid scaffolds interlayered with cell-laden electrospun fibers and poly(ε-caprolactone) microstructures. To prepare the hybrid scaffolds, the electrospun fibrous structure should ensure adequate cell viability and stable fiber formation. Thus, we applied various concentrations of alginate and electric field strengths to determine optimal conditions for the cell-electrospinning process. The combination of cell-laden bioink (2×10&lt;sup&gt;5&lt;/sup&gt;MG63cells/mL, 2wt% alginate, 2wt% poly(ethylene oxide), and 0.7wt% lecithin) and a 0.16kV/mm electric field showed the highest cell viability and fiber formation in this process. Using these conditions and PCL microstructures, we can achieve mechanically stable hybrid scaffolds. The cells embedded in the fibrous structure were viable and proliferated. We report here the potential of the new cell-laden electrospun hybrid scaffolds, which may be appropriate for various tissue engineering applications.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007511</affiliation-url><afid>60007511</afid><affilname>Sungkyunkwan University</affilname><name-variant>Sungkyunkwan University</name-variant><affiliation-city>Jongno-gu</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:37015080700</author-url><authid>37015080700</authid><authname>Yeo M.</authname><surname>Yeo</surname><given-name>MyungGu</given-name><initials>M.</initials><afid>60007511</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7403064275</author-url><authid>7403064275</authid><authname>Kim G.</authname><surname>Kim</surname><given-name>GeunHyung</given-name><initials>G.</initials><afid>60007511</afid></author><authkeywords>Alginate | Bioink | Cell-laden nanofibers | Electrospinning | Polycaprolactone</authkeywords><intid>2035662193</intid><source-id>16398</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928691623"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928691623?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928691623&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928691623&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928691623</prism:url><dc:identifier>SCOPUS_ID:84928691623</dc:identifier><eid>2-s2.0-84928691623</eid><dc:title>Digital poison? Three studies examining the influence of violent video games on youth</dc:title><dc:creator>Ferguson C.</dc:creator><prism:publicationName>Computers in Human Behavior</prism:publicationName><prism:issn>07475632</prism:issn><prism:volume>50</prism:volume><prism:pageRange>399-410</prism:pageRange><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>1 September 2015</prism:coverDisplayDate><prism:doi>10.1016/j.chb.2015.04.021</prism:doi><pii>S0747563215003088</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. The role of violent video games in the development of aggression and mental health issues in youth continues to be controversial in the scholarly community and general public. Compared to college students, few studies have directly examined the potential impact of violent video games on youth and current evidence is mixed. The current article attempts to address this with three studies examining violent game play in youth aged 12-18. In Study 1, youth were randomized to play closely matched action games with either violent or non-violent content. Youth were given the opportunity to act aggressively using an ice water task. Study 2 was a conceptual replication of Study 1, with slower narrative games rather than action games. Study 3 examined the issue in a correlational study of youth, contrasting exposure to violent video games in youth's personal lives to their exposure to violence in controversial books while controlling for other variables including family, peer and personality variables. None of the studies provided evidence for concerns linking video game violence to aggressive behaviors or reduced empathy in youth.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021742</affiliation-url><afid>60021742</afid><affilname>Stetson University</affilname><name-variant>Stetson University</name-variant><affiliation-city>De Land</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106932264</affiliation-url><afid>106932264</afid><affilname>Texas AandM International University</affilname><name-variant>Texas AandM International University</name-variant><affiliation-city>Laredo</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35570793000</author-url><authid>35570793000</authid><authname>Ferguson C.</authname><surname>Ferguson</surname><given-name>Christopher J.</given-name><initials>C.J.</initials><afid>60021742</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56600032700</author-url><authid>56600032700</authid><authname>Barr H.</authname><surname>Barr</surname><given-name>Hayley</given-name><initials>H.</initials><afid>60021742</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56609978200</author-url><authid>56609978200</authid><authname>Figueroa G.</authname><surname>Figueroa</surname><given-name>Grace</given-name><initials>G.</initials><afid>60021742</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56038807800</author-url><authid>56038807800</authid><authname>Foley K.</authname><surname>Foley</surname><given-name>Kimberly</given-name><initials>K.</initials><afid>60021742</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56609925900</author-url><authid>56609925900</authid><authname>Gallimore A.</authname><surname>Gallimore</surname><given-name>Alexander</given-name><initials>A.</initials><afid>60021742</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56610308500</author-url><authid>56610308500</authid><authname>Laquea R.</authname><surname>Laquea</surname><given-name>Rachel</given-name><initials>R.</initials><afid>60021742</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56609908300</author-url><authid>56609908300</authid><authname>Merritt A.</authname><surname>Merritt</surname><given-name>Alexandra</given-name><initials>A.</initials><afid>60021742</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:36638012800</author-url><authid>36638012800</authid><authname>Miller S.</authname><surname>Miller</surname><given-name>Stephanie</given-name><initials>S.</initials><afid>60021742</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56610385500</author-url><authid>56610385500</authid><authname>Nguyen-Pham H.</authname><surname>Nguyen-Pham</surname><given-name>Hien</given-name><initials>H.</initials><afid>60021742</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56610272300</author-url><authid>56610272300</authid><authname>Spanogle C.</authname><surname>Spanogle</surname><given-name>Cameron</given-name><initials>C.</initials><afid>60021742</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56609656000</author-url><authid>56609656000</authid><authname>Stevens J.</authname><surname>Stevens</surname><given-name>Julie</given-name><initials>J.</initials><afid>60021742</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56600788100</author-url><authid>56600788100</authid><authname>Trigani B.</authname><surname>Trigani</surname><given-name>Benjamin</given-name><initials>B.</initials><afid>60021742</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:36981625500</author-url><authid>36981625500</authid><authname>Garza A.</authname><surname>Garza</surname><given-name>Adolfo</given-name><initials>A.</initials><afid>106932264</afid></author><authkeywords>Aggression | Mental health | Video games | Violence</authkeywords><intid>2035819190</intid><source-id>19419</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929302903"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929302903?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929302903&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929302903&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929302903</prism:url><dc:identifier>SCOPUS_ID:84929302903</dc:identifier><eid>2-s2.0-84929302903</eid><dc:title>Pool boiling enhancement by electrohydrodynamic force and diamond coated surfaces</dc:title><dc:creator>Kano I.</dc:creator><prism:publicationName>Journal of Heat Transfer</prism:publicationName><prism:issn>00221481</prism:issn><prism:eIssn>15288943</prism:eIssn><prism:volume>137</prism:volume><prism:issueIdentifier>9</prism:issueIdentifier><prism:coverDate>2015-09-01</prism:coverDate><prism:coverDisplayDate>1 September 2015</prism:coverDisplayDate><prism:doi>10.1115/1.4030217</prism:doi><dc:description>Copyright © 2015 by ASME. Boiling heat transfer enhancement via compound effect of the electrohydrodynamic (EHD) effect and microstructured surfaces has been experimentally and analytically investigated. A fluorinated dielectric liquid (Asahi Glass Co., Ltd., AE-3000) was selected as the working fluid. Pool boiling heat transfer in the saturated liquid was measured at atmospheric pressure. Microstructured surfaces, which are mainly used for cutting tools, were developed with diamond particles using electrodeposition technique. Four different particle diameters were prepared: 5, 10, 15, and a mixture of 5 and 1.5 μm. The critical heat flux (CHF) for diamond particle surfaces showed 27-30 W/cm&lt;sup&gt;2&lt;/sup&gt; which was 26-40% increase for comparing with a noncoated surface (21.5 W/cm&lt;sup&gt;2&lt;/sup&gt;). Upon application of a -5 kV/mm electric field to the microstructured surface (a mixture of 5 and 1.5 μm particles), a CHF of 70.2 W/cm&lt;sup&gt;2&lt;/sup&gt; at a superheat of 21.7 K was obtained. The previous theoretical equation of pool boiling predicted the CHF with electric field and without the electrode within 10%. Also, the CHF enhanced by the diamond coated surfaces was correlated well with the contact angle.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016074</affiliation-url><afid>60016074</afid><affilname>Yamagata University</affilname><name-variant>Yamagata Univ</name-variant><affiliation-city>Yamagata</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004389807</author-url><authid>7004389807</authid><authname>Kano I.</authname><surname>Kano</surname><given-name>Ichiro</given-name><initials>I.</initials><afid>60016074</afid></author><authkeywords>boiling | critical heat flux | electrohydrodynamic enhancement | heat transfer enhancement | surface roughness</authkeywords><intid>535945735</intid><article-number>091006</article-number><source-id>20968</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930194917"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930194917?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930194917&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930194917&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930194917</prism:url><dc:identifier>SCOPUS_ID:84930194917</dc:identifier><eid>2-s2.0-84930194917</eid><dc:title>Noncalcified Plaque in Cardiac CT: Quantification and Clinical Implications</dc:title><dc:creator>Hell M.</dc:creator><prism:publicationName>Current Cardiovascular Imaging Reports</prism:publicationName><prism:issn>19419066</prism:issn><prism:eIssn>19419074</prism:eIssn><prism:volume>8</prism:volume><prism:issueIdentifier>8</prism:issueIdentifier><prism:coverDate>2015-08-29</prism:coverDate><prism:coverDisplayDate>29 August 2015</prism:coverDisplayDate><prism:doi>10.1007/s12410-015-9343-z</prism:doi><dc:description>© 2015, Springer Science+Business Media New York. Coronary computed tomography angiography (CTA) is being increasingly used for direct, noninvasive evaluation of the coronary arteries. Beyond stenosis, coronary CTA also permits assessment of atherosclerotic plaque (including total and noncalcified plaque burden) and coronary artery remodeling, previously only measurable through invasive techniques. It has been shown that coronary plaque volume for noncalcified and mixed plaques and the arterial remodeling index correlate closely with corresponding measures from invasive intravascular ultrasound. Several studies have also shown a strong relationship between adverse plaque features imaged by coronary CTA and acute coronary syndrome, major adverse cardiovascular events, and ischemia. The aim of this review is to summarize current methods for quantitative measurement of atherosclerotic plaque features from coronary CTA and to discuss the clinical implications of noncalcified plaque as detected by CTA and reported in the current literature.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000765</affiliation-url><afid>60000765</afid><affilname>Friedrich-Alexander-Universität Erlangen-Nürnberg</affilname><name-variant>University of Erlangen-Nuremberg</name-variant><affiliation-city>Erlangen</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016173</affiliation-url><afid>60016173</afid><affilname>Cedars-Sinai Medical Center</affilname><name-variant>Cedars-Sinai Medical Center</name-variant><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016173</affiliation-url><afid>60016173</afid><affilname>Cedars-Sinai Medical Center</affilname><name-variant>Cedars-Sinai Medical Center</name-variant><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016173</affiliation-url><afid>60016173</afid><affilname>Cedars-Sinai Medical Center</affilname><name-variant>Cedars-Sinai Medical Center</name-variant><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016173</affiliation-url><afid>60016173</afid><affilname>Cedars-Sinai Medical Center</affilname><name-variant>Cedars-Sinai Medical Center</name-variant><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56662868100</author-url><authid>56662868100</authid><authname>Hell M.</authname><surname>Hell</surname><given-name>Micheala M.</given-name><initials>M.M.</initials><afid>60000765</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005749805</author-url><authid>7005749805</authid><authname>Achenbach S.</authname><surname>Achenbach</surname><given-name>Stephan</given-name><initials>S.</initials><afid>60000765</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7403284867</author-url><authid>7403284867</authid><authname>Shah P.</authname><surname>Shah</surname><given-name>Prediman K.</given-name><initials>P.K.</initials><afid>60016173</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35376162800</author-url><authid>35376162800</authid><authname>Berman D.</authname><surname>Berman</surname><given-name>Daniel S.</given-name><initials>D.S.</initials><afid>60016173</afid><afid>60016173</afid><afid>60016173</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35376162800</author-url><authid>35376162800</authid><authname>Berman D.</authname><surname>Berman</surname><given-name>Daniel S.</given-name><initials>D.S.</initials><afid>60016173</afid><afid>60016173</afid><afid>60016173</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35376162800</author-url><authid>35376162800</authid><authname>Berman D.</authname><surname>Berman</surname><given-name>Daniel S.</given-name><initials>D.S.</initials><afid>60016173</afid><afid>60016173</afid><afid>60016173</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7101867655</author-url><authid>7101867655</authid><authname>Dey D.</authname><surname>Dey</surname><given-name>Damini</given-name><initials>D.</initials><afid>60016173</afid></author><authkeywords>Coronary artery plaque | Coronary computed tomography angiography | Noncalcified plaque | Plaque characterization | Plaque quantification</authkeywords><intid>1786088288</intid><article-number>27</article-number><source-id>19600157307</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84907190409"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84907190409?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84907190409&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84907190409&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0956566314006563"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84907190409</prism:url><dc:identifier>SCOPUS_ID:84907190409</dc:identifier><eid>2-s2.0-84907190409</eid><dc:title>Construction of a biotinylated cameloid-like antibody for lable-free detection of apolipoprotein B-100</dc:title><dc:creator>Li H.</dc:creator><prism:publicationName>Biosensors and Bioelectronics</prism:publicationName><prism:issn>09565663</prism:issn><prism:eIssn>18734235</prism:eIssn><prism:volume>64</prism:volume><prism:pageRange>111-118</prism:pageRange><prism:coverDate>2015-08-27</prism:coverDate><prism:coverDisplayDate>August 27, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bios.2014.08.060</prism:doi><pii>S0956566314006563</pii><dc:description>© 2014 Elsevier B.V. Nanobodies (Nbs), also known as the variable domain of the heavy-chain-only antibody (VHH), are single-domain antigen-binding fragments derived from heavy-chain antibodies that occur naturally in sera of camelids. Due to their unique properties of small size (15kD), intrinsic stability, high affinity and specificity, Nbs are suitable for detecting clinical relevant antigens. Apolipoprotein B-100 (ApoB-100) is a highly predictive marker for coronary artery disease (CAD), which is frequently detected in clinical diagnosis. Herein, we successfully obtained anti-ApoB-100 Nbs for the first time and further fabricated a label-free and sensitive immunosensor for ApoB-100 based on isolated anti-ApoB-100 nanobody (Nb) using the electrochemical impedance spectroscopy (EIS) technique. We have generated an immunized phage display library against ApoB-100 and isolated four anti-ApoB-100 Nbs with high affinity and stability. The Nb with the highest affinity was biotinylated based on in vivo BirA system. Further, we developed a label-free electrochemical impedance immunosensor for ApoB-100 using this anti-ApoB-100 Nb. The attachment of ApoB-100 onto the anti-ApoB-100 Nb-immobilized sensing layer led to the increased electron-transfer resistance, which was proportional to ApoB-100 concentration in the range from 0.05 to 5ngmL-1 with a detection limit of 0.03ngmL-1. This proposed immunosensor revealed high specificity to detect ApoB-100, acceptable intra-assay precision and good stability, functioning as a feasible technique for CAD diagnosis.</dc:description><citedby-count>2</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005244</affiliation-url><afid>60005244</afid><affilname>Southeast University</affilname><name-variant>Southeast University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005244</affiliation-url><afid>60005244</afid><affilname>Southeast University</affilname><name-variant>Southeast University</name-variant><affiliation-city>Nanjing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114416800</affiliation-url><afid>114416800</afid><affilname>Jiangsu Nanobody Engineering and Research Center</affilname><name-variant>Jiangsu Nanobody Engineering and Research Center</name-variant><affiliation-city>Nantong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114656428</affiliation-url><afid>114656428</afid><affilname>Plexera LLC</affilname><name-variant>Plexera LLC</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55695451600</author-url><authid>55695451600</authid><authname>Li H.</authname><surname>Li</surname><given-name>Henan</given-name><initials>H.</initials><afid>60005244</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56364339900</author-url><authid>56364339900</authid><authname>Yan J.</authname><surname>Yan</surname><given-name>Junrong</given-name><initials>J.</initials><afid>60005244</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56364122800</author-url><authid>56364122800</authid><authname>Ou W.</authname><surname>Ou</surname><given-name>Weijun</given-name><initials>W.</initials><afid>114416800</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56365006500</author-url><authid>56365006500</authid><authname>Liu H.</authname><surname>Liu</surname><given-name>Hong</given-name><initials>H.</initials><afid>114656428</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:26662000600</author-url><authid>26662000600</authid><authname>Liu S.</authname><surname>Liu</surname><given-name>Songqin</given-name><initials>S.</initials><afid>60005244</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:24328930500</author-url><authid>24328930500</authid><authname>Wan Y.</authname><surname>Wan</surname><given-name>Yakun</given-name><initials>Y.</initials><afid>60005244</afid><afid>114416800</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:24328930500</author-url><authid>24328930500</authid><authname>Wan Y.</authname><surname>Wan</surname><given-name>Yakun</given-name><initials>Y.</initials><afid>60005244</afid><afid>114416800</afid></author><authkeywords>Apolipoprotein B-100 | Coronary artery disease | Electrochemical impedance spectroscopy | Immunosensor | Nanobody</authkeywords><intid>532272683</intid><source-id>15437</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927134771"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927134771?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927134771&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927134771&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0196978115000893"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927134771</prism:url><dc:identifier>SCOPUS_ID:84927134771</dc:identifier><eid>2-s2.0-84927134771</eid><dc:title>Attenuation of renovascular hypertension by cyclooxygenase-2 inhibitor partly through ANP release</dc:title><dc:creator>Park B.</dc:creator><prism:publicationName>Peptides</prism:publicationName><prism:issn>01969781</prism:issn><prism:eIssn>18735169</prism:eIssn><prism:volume>69</prism:volume><prism:pageRange>1-8</prism:pageRange><prism:coverDate>2015-08-20</prism:coverDate><prism:coverDisplayDate>20 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.peptides.2015.03.022</prism:doi><pii>S0196978115000893</pii><dc:description>© 2015 Elsevier Inc. All rights reserved. Angiotensin II (Ang II) is an important inflammatory mediator. Ang II induces cyclooxygenase-2 (COX-2) expression and prostaglandin F2α release followed by cardiac hypertrophy. Inhibition of COX-2 may modulate high blood pressure but controversy still exists. The aim of this study was to determine the role of COX-2 in the regulation of blood pressure and to define the mechanisms in two kidney one-clip hypertensive (2K1C) rats. Chronic treatment with nimesulide or NS-398 (5 mg/kg/day) for 3 weeks lowered high blood pressure and cardiac hypertrophy with decreased expression levels of cardiac hypertrophy markers [atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP)], Ang type 1 receptor, urotensin II, and urotensin II receptor in 2K1C rats. Plasma level of ANP was markedly increased and plasma levels of Ang II and aldosterone were decreased by treatment with nimesulide or NS-398. In both in vitro and in vivo experiments, nimesulide or NS-398 augmented ANP release in 2K1C rats. The inhibitory effect of NS-398 on blood pressure was attenuated by the pretreatment with natriuretic peptide receptor-A (NPR-A) antagonist (A71915, 30 μg/kg/day). These results suggest that chronic treatment with nimesulide or NS-398 attenuated hypertension and cardiac hypertrophy partly through ANP release in 2K1C rats.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001187</affiliation-url><afid>60001187</afid><affilname>Chonbuk National University</affilname><name-variant>Chonbuk National University</name-variant><affiliation-city>Jeonju</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027963</affiliation-url><afid>60027963</afid><affilname>Taishan Medical University</affilname><name-variant>Taishan Medical College</name-variant><affiliation-city>Tainan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55232240900</author-url><authid>55232240900</authid><authname>Park B.</authname><surname>Park</surname><given-name>Byung Mun</given-name><initials>B.M.</initials><afid>60001187</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:34876633100</author-url><authid>34876633100</authid><authname>Gao S.</authname><surname>Gao</surname><given-name>Shan</given-name><initials>S.</initials><afid>60027963</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55614035300</author-url><authid>55614035300</authid><authname>Cha S.</authname><surname>Cha</surname><given-name>Seung Ah</given-name><initials>S.A.</initials><afid>60001187</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35307582400</author-url><authid>35307582400</authid><authname>Kim S.</authname><surname>Kim</surname><given-name>Suhn Hee</given-name><initials>S.H.</initials><afid>60001187</afid></author><authkeywords>Angiotensin | ANP | Cyclooxygenase | Nimesulide | NS-398 | Renal hypertension</authkeywords><intid>535571056</intid><source-id>14222</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928487257"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928487257?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928487257&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928487257&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167732214003729"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928487257</prism:url><dc:identifier>SCOPUS_ID:84928487257</dc:identifier><eid>2-s2.0-84928487257</eid><dc:title>Organic solvent-luteolin interactions studied by FT-Raman, Vis-Raman, UV-Raman spectroscopy and DFT calculations</dc:title><dc:creator>Marrassini C.</dc:creator><prism:publicationName>Journal of Molecular Liquids</prism:publicationName><prism:issn>01677322</prism:issn><prism:volume>205</prism:volume><prism:pageRange>2-8</prism:pageRange><prism:coverDate>2015-08-20</prism:coverDate><prism:coverDisplayDate>20 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.molliq.2014.08.014</prism:doi><pii>S0167732214003729</pii><dc:description>© 2014 Elsevier B.V. All rights reserved. The interactions of luteolin with three alcohols (methanol, 1-propanol, 1-butanol) and dimethylsulfoxide (DMSO) were studied by FT-Raman, Vis-Raman and UV-Raman spectroscopies, coupled to density functional theory calculations. No large shift was observed for the bands in the spectra of luteolin in alcohols or DMSO in the 1700-1550 cm&lt;sup&gt;- 1&lt;/sup&gt; region. This is possibly related to the presence of a strong intramolecular hydrogen bond involving the 5-OH and the carbonyl of luteolin, as suggested by literature data [V. Exarchou, A. Troganis, I.P. Gerothanassis, M. Tsimidou, D. Boskou, Tetrahedron 2002, 58, 7423-7429] and DFT calculations. Furthermore, DFT calculations suggest that the CO stretching of luteolin is implicated in several vibrational modes, whereas the most upshifted band in the 1700-1550 cm&lt;sup&gt;- 1&lt;/sup&gt; can be interpreted as arising mainly from a 5-OH bending. The results are discussed in the framework of vibrational spectroscopy studies on flavonoids, of the photophysical properties of luteolin, and of the reported literature of vibrational spectra of luteolin under different conditions, in particular when interacting with biomolecules.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009448</affiliation-url><afid>60009448</afid><affilname>Universite des Sciences et Technologies de Lille</affilname><name-variant>Université des Sciences et Technologies de Lille</name-variant><affiliation-city>Villeneuve d'Ascq Cedex</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001563</affiliation-url><afid>60001563</afid><affilname>Universidad de Buenos Aires</affilname><name-variant>University of Buenos Aires</name-variant><affiliation-city>Buenos Aires</affiliation-city><affiliation-country>Argentina</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:108434532</affiliation-url><afid>108434532</afid><affilname>Université des Sciences et de la Technologie D'Oran MB</affilname><name-variant>Université des Sciences et de la Technologie d'Oran-MB</name-variant><affiliation-city/><affiliation-country>Algeria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101384020</affiliation-url><afid>101384020</afid><affilname>USTOMB</affilname><name-variant>USTO-MB</name-variant><affiliation-city>Oran</affiliation-city><affiliation-country>Algeria</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115188215</affiliation-url><afid>115188215</afid><affilname>Service de Bioénérgetique, Biologie Structurale et Mécanismes</affilname><name-variant>Service de Bioénérgetique, Biologie Structurale et Mécanismes</name-variant><affiliation-city>Saclay</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36656214000</author-url><authid>36656214000</authid><authname>Marrassini C.</authname><surname>Marrassini</surname><given-name>Carla</given-name><initials>C.</initials><afid>60009448</afid><afid>60001563</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36656214000</author-url><authid>36656214000</authid><authname>Marrassini C.</authname><surname>Marrassini</surname><given-name>Carla</given-name><initials>C.</initials><afid>60009448</afid><afid>60001563</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004188293</author-url><authid>7004188293</authid><authname>Idrissi A.</authname><surname>Idrissi</surname><given-name>Abdenacer</given-name><initials>A.</initials><afid>60009448</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56032743500</author-url><authid>56032743500</authid><authname>De Waele I.</authname><surname>De Waele</surname><given-name>Isabelle</given-name><initials>I.</initials><afid>60009448</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56344353500</author-url><authid>56344353500</authid><authname>Smail K.</authname><surname>Smail</surname><given-name>Khadidja</given-name><initials>K.</initials><afid>108434532</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56344279100</author-url><authid>56344279100</authid><authname>Tchouar N.</authname><surname>Tchouar</surname><given-name>Noureddine</given-name><initials>N.</initials><afid>101384020</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56385102500</author-url><authid>56385102500</authid><authname>Moreau M.</authname><surname>Moreau</surname><given-name>Myriam</given-name><initials>M.</initials><afid>60009448</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004988893</author-url><authid>7004988893</authid><authname>Mezzetti A.</authname><surname>Mezzetti</surname><given-name>Alberto</given-name><initials>A.</initials><afid>60009448</afid><afid>115188215</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004988893</author-url><authid>7004988893</authid><authname>Mezzetti A.</authname><surname>Mezzetti</surname><given-name>Alberto</given-name><initials>A.</initials><afid>60009448</afid><afid>115188215</afid></author><authkeywords>DFT | FT-Raman | Hydrogen bond | Luteolin | UV-Raman | Vis-Raman</authkeywords><intid>2035788805</intid><source-id>26965</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924387992"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924387992?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924387992&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924387992&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167931715000866"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924387992</prism:url><dc:identifier>SCOPUS_ID:84924387992</dc:identifier><eid>2-s2.0-84924387992</eid><dc:title>Fabrication of cardiac patch by using electrospun collagen fibers</dc:title><dc:creator>Kitsara M.</dc:creator><prism:publicationName>Microelectronic Engineering</prism:publicationName><prism:issn>01679317</prism:issn><prism:volume>144</prism:volume><prism:pageRange>46-50</prism:pageRange><prism:coverDate>2015-08-16</prism:coverDate><prism:coverDisplayDate>16 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.mee.2015.02.034</prism:doi><pii>S0167931715000866</pii><dc:description>© 2015 Elsevier B.V. Synergy between micro-nanotechnology and regenerative medicine can lead to new tools for health improvement. In this study, we investigate the efficacy of electrospun scaffolds - fabricated using clinically approved collagen - as supports for cardiomyoblast culture. The scaffolds were prepared using non-toxic solvents and crosslinking agents and characterized by scanning electron microscopy and contact angle measurements. Among different types of collagen samples, we found that atelocollagen can produce better quality of electrospun fibers than acid and basic fibrous collagen. Our results also show that the cell culture performance can be improved by adjusting the crosslinking conditions. Typically, increasing the concentration of citric acid of the cross-link agents from 5% to 10% w/w and the post-crosslink baking time from 1.5 to 2.5 h led to significant increases of the cellular colonization of the scaffold, showing three-dimensional growth of cardiac cells due to the specific morphology of the fibrous scaffolds. Finally, in vivo tests of the biocompatibility of the fabricated scaffolds have been done using a mouse model of dilated cardiomyopathy. As expected, the biocompatibility of the scaffold was found excellent and no visible inflammation was observed after the implantation up to two weeks. However, 5% citric acid electrospun collagen scaffolds was less resistant in vivo, proving again the importance of the processing parameter optimization of the electrospun scaffolds.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000179</affiliation-url><afid>60000179</afid><affilname>Ecole Normale Superieure</affilname><name-variant>Ecole Normale Supérieure</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001422</affiliation-url><afid>60001422</afid><affilname>Universite Pierre et Marie Curie</affilname><name-variant>Université Pierre et Marie Curie</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030857</affiliation-url><afid>60030857</afid><affilname>Hopital Europeen Georges-Pompidou</affilname><name-variant>Hôpital Européen Georges Pompidou</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028950</affiliation-url><afid>60028950</afid><affilname>Universite Paris Descartes</affilname><name-variant>Université Paris Descartes</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Biom'Up</affilname><affiliation-city>Saint Priest</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011001</affiliation-url><afid>60011001</afid><affilname>Kyoto University</affilname><name-variant>Kyoto University</name-variant><affiliation-city>Kyoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:22134859200</author-url><authid>22134859200</authid><authname>Kitsara M.</authname><surname>Kitsara</surname><given-name>Maria</given-name><initials>M.</initials><afid>60000179</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:32667632100</author-url><authid>32667632100</authid><authname>Joanne P.</authname><surname>Joanne</surname><given-name>Pierre</given-name><initials>P.</initials><afid>60001422</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55840919800</author-url><authid>55840919800</authid><authname>Boitard S.</authname><surname>Boitard</surname><given-name>Solène Emmanuelle</given-name><initials>S.E.</initials><afid>60001422</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56543601000</author-url><authid>56543601000</authid><authname>Ben Dhiab I.</authname><surname>Ben Dhiab</surname><given-name>Ibtihel</given-name><initials>I.</initials><afid>60000179</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56543501500</author-url><authid>56543501500</authid><authname>Poinard B.</authname><surname>Poinard</surname><given-name>Barbara</given-name><initials>B.</initials><afid>60001422</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102635294</author-url><authid>7102635294</authid><authname>Menasché P.</authname><surname>Menasché</surname><given-name>Philippe</given-name><initials>P.</initials><afid>60030857</afid><afid>60028950</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7102635294</author-url><authid>7102635294</authid><authname>Menasché P.</authname><surname>Menasché</surname><given-name>Philippe</given-name><initials>P.</initials><afid>60030857</afid><afid>60028950</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6506733506</author-url><authid>6506733506</authid><authname>Gagnieu C.</authname><surname>Gagnieu</surname><given-name>Christian</given-name><initials>C.</initials><afid/></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:16686140400</author-url><authid>16686140400</authid><authname>Forest P.</authname><surname>Forest</surname><given-name>Patricia</given-name><initials>P.</initials><afid/></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6603564053</author-url><authid>6603564053</authid><authname>Agbulut O.</authname><surname>Agbulut</surname><given-name>Onnik</given-name><initials>O.</initials><afid>60001422</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56542776100</author-url><authid>56542776100</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yong</given-name><initials>Y.</initials><afid>60000179</afid><afid>60011001</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56542776100</author-url><authid>56542776100</authid><authname>Chen Y.</authname><surname>Chen</surname><given-name>Yong</given-name><initials>Y.</initials><afid>60000179</afid><afid>60011001</afid></author><authkeywords>Biocompatibility | Cardiac cell therapy | Collagen scaffold | Electrospinning | Tissue engineering</authkeywords><intid>1535133284</intid><source-id>26696</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929378351"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929378351?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929378351&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929378351&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014299915003787"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929378351</prism:url><dc:identifier>SCOPUS_ID:84929378351</dc:identifier><eid>2-s2.0-84929378351</eid><dc:title>Post-infarct treatment with [Pyr&lt;sup&gt;1&lt;/sup&gt;]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats</dc:title><dc:creator>Azizi Y.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>761</prism:volume><prism:pageRange>101-108</prism:pageRange><prism:coverDate>2015-08-15</prism:coverDate><prism:coverDisplayDate>15 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.04.034</prism:doi><pii>S0014299915003787</pii><dc:description>© 2015 Elsevier B.V.All rights reserved. Ischemic heart disease is the leading cause of mortality in the world. Angiogenesis is important for cardiac repair after myocardial infarction (MI) as restores blood supply to the ischemic myocardium and preserves cardiac function. Apelin is a peptide that has been recently shown to potentiate angiogenesis. The aim of this study was to investigate angiogenic effects of [Pyr&lt;sup&gt;1&lt;/sup&gt;]apelin-13 in the rat model of post-MI. Male Wistar rats (n=36) were randomly divided into three groups: (1) sham (2) MI and (3) MI treated with [Pyr&lt;sup&gt;1&lt;/sup&gt;]apelin-13 (MI+Apel). MI animals were subjected to 30 min left anterior descending coronary artery (LAD) ligation and 14 days of reperfusion. Twenty-four hours after LAD ligation, [Pyr&lt;sup&gt;1&lt;/sup&gt;]apelin-13 (10 nmol/kg/day) was administered i.p. for 5 days. Hemodynamic functions by catheter introduced into the left ventricle (LV), myocardial fibrosis by Masson?s trichrome staining, gene expression of vascular endothelial growth factor-A (VEGFA), VEGF receptor-2 (Kdr), Ang-1 (angiopoietin-1), Tie2 (tyrosine kinase with immunoglobulin and epidermal growth factor homology domains 2) and eNOS by Real-time polymerase chain reaction (Real-Time PCR) and myocardial angiogenesis by CD31 imunostaining were assessed at day 14 post-MI. Post-infarct treatment with [Pyr&lt;sup&gt;1&lt;/sup&gt;]apelin-13 improved LV function and decreased myocardial fibrosis. [Pyr&lt;sup&gt;1&lt;/sup&gt;]apelin-13 treatment led to a significant increase in the expression of VEGFA, Kdr, Ang-1, Tie2 and eNOS. Further, treatment with [Pyr&lt;sup&gt;1&lt;/sup&gt;]apelin-13 promoted capillary density. [Pyr&lt;sup&gt;1&lt;/sup&gt;]apelin-13 has angiogenic and anti-fibrotic activity via formation of new blood vessels and overexpression of VEGFA, Kdr, Ang-1, Tie2 and eNOS in the infarcted myocardium which could in turn repair myocardium and improve LV function.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027708</affiliation-url><afid>60027708</afid><affilname>Tehran University of Medical Sciences</affilname><name-variant>Tehran University of Medical Sciences</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016972</affiliation-url><afid>60016972</afid><affilname>Shahed University</affilname><name-variant>Shahed University</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027708</affiliation-url><afid>60027708</afid><affilname>Tehran University of Medical Sciences</affilname><name-variant>Tehran University of Medical Sciences</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027708</affiliation-url><afid>60027708</afid><affilname>Tehran University of Medical Sciences</affilname><name-variant>Tehran University of Medical Sciences</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60089223</affiliation-url><afid>60089223</afid><affilname>Gonabad University of Medical Sciences</affilname><name-variant>Gonabad University of Medical Sciences</name-variant><affiliation-city>Gonabad</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36086110800</author-url><authid>36086110800</authid><authname>Azizi Y.</authname><surname>Azizi</surname><given-name>Yaser</given-name><initials>Y.</initials><afid>60027708</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23666909200</author-url><authid>23666909200</authid><authname>Faghihi M.</authname><surname>Faghihi</surname><given-name>Mahdieh</given-name><initials>M.</initials><afid>60027708</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23667734000</author-url><authid>23667734000</authid><authname>Imani A.</authname><surname>Imani</surname><given-name>Alireza</given-name><initials>A.</initials><afid>60027708</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56243588000</author-url><authid>56243588000</authid><authname>Roghani M.</authname><surname>Roghani</surname><given-name>Mehrdad</given-name><initials>M.</initials><afid>60016972</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55253026700</author-url><authid>55253026700</authid><authname>Zekri A.</authname><surname>Zekri</surname><given-name>Ali</given-name><initials>A.</initials><afid>60027708</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:13806021500</author-url><authid>13806021500</authid><authname>Mobasheri M.</authname><surname>Mobasheri</surname><given-name>Maryam Beigom</given-name><initials>M.B.</initials><afid>60027708</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56644710300</author-url><authid>56644710300</authid><authname>Rastgar T.</authname><surname>Rastgar</surname><given-name>Tayebeh</given-name><initials>T.</initials><afid>60027708</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:36473907500</author-url><authid>36473907500</authid><authname>Moghimian M.</authname><surname>Moghimian</surname><given-name>Maryam</given-name><initials>M.</initials><afid>60089223</afid></author><authkeywords>Ang-1 | eNOS | Myocardial angiogenesis | Rat | VEGFA | [Pyr1]apelin-13</authkeywords><intid>1535945160</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929580893"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929580893?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929580893&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929580893&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014299915004033"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929580893</prism:url><dc:identifier>SCOPUS_ID:84929580893</dc:identifier><eid>2-s2.0-84929580893</eid><dc:title>Relaxation effect of a novel Danshensu/tetramethylpyrazine derivative on rat mesenteric arteries</dc:title><dc:creator>Li R.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>761</prism:volume><prism:pageRange>153-160</prism:pageRange><prism:coverDate>2015-08-15</prism:coverDate><prism:coverDisplayDate>15 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.04.041</prism:doi><pii>S0014299915004033</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Danshen (Radix Salviae miltiorrhizae) and ChuanXiong (Ligusticum wallichii) are two traditional herbal medicines commonly used in China for the treatment of cardiovascular diseases. The active components in Danshen and ChuanXiong are Danshensu (DSS, (R)-3, 4-dihydroxyphenyllactic acid) and tetramethylpyrazine (TMP), respectively. In the present study, a new compound named ADTM, which is a conjugation of DSS and TMP, was synthesized and its effect on the contractility of rat mesenteric arteries was examined. The relaxation effect of ADTM on rat mesenteric arteries was studied using myography. The effects of ADTM on Ca&lt;sup&gt;2+&lt;/sup&gt; channels were measured by Ca&lt;sup&gt;2+&lt;/sup&gt; imaging and patch-clamp techniques. The results showed that ADTM caused a concentration-dependent relaxation of rat mesenteric arteries. This relaxation effect was not affected by the removal of endothelium or inhibitors of nitric oxide synthase, cyclooxygenase, guanylyl cyclase and adenylyl cyclase. Potassium channel blockers including tetraethylammonium, iberiotoxin, apamin, 4-aminopyridine, BaCl&lt;inf&gt;2&lt;/inf&gt; and glibenclamide also failed to inhibit the relaxation response to ADTM. ADTM inhibited CaCl&lt;inf&gt;2&lt;/inf&gt;-induced contractions and reduced the Ca&lt;sup&gt;2+&lt;/sup&gt; influx in isolated mesenteric arterial muscle cells. Our results suggest that ADTM may be a novel relaxing agent. Its mechanism of action involves the direct blockade of voltage-gated Ca&lt;sup&gt;2+&lt;/sup&gt; channels in vascular smooth muscle cells, resulting in a decrease in Ca&lt;sup&gt;2+&lt;/sup&gt; influx into the cells.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006541</affiliation-url><afid>60006541</afid><affilname>The University of Hong Kong</affilname><name-variant>University of Hong Kong</name-variant><affiliation-city>Pokfulam</affiliation-city><affiliation-country>Hong Kong</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001604</affiliation-url><afid>60001604</afid><affilname>Ministry of Education China</affilname><name-variant>Ministry of Education</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103801</affiliation-url><afid>60103801</afid><affilname>University of Jinan</affilname><name-variant>Jinan University</name-variant><affiliation-city>Jinan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002798</affiliation-url><afid>60002798</afid><affilname>Chinese University of Hong Kong</affilname><name-variant>The Chinese University of Hong Kong</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022317</affiliation-url><afid>60022317</afid><affilname>University of Macau</affilname><name-variant>University of Macau</name-variant><affiliation-city>Taipa</affiliation-city><affiliation-country>Macao</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008928</affiliation-url><afid>60008928</afid><affilname>Hong Kong Polytechnic University</affilname><name-variant>The Hong Kong Polytechnic University</name-variant><affiliation-city>Hong Kong</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006541</affiliation-url><afid>60006541</afid><affilname>The University of Hong Kong</affilname><name-variant>University of Hong Kong</name-variant><affiliation-city>Pokfulam</affiliation-city><affiliation-country>Hong Kong</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56371385300</author-url><authid>56371385300</authid><authname>Li R.</authname><surname>Li</surname><given-name>Rachel Wai Sum</given-name><initials>R.W.S.</initials><afid>60006541</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56371563300</author-url><authid>56371563300</authid><authname>Yang C.</authname><surname>Yang</surname><given-name>C.</given-name><initials>C.</initials><afid>60001604</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:40361635500</author-url><authid>40361635500</authid><authname>Shan L.</authname><surname>Shan</surname><given-name>Luchen</given-name><initials>L.</initials><afid>60103801</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:24342569600</author-url><authid>24342569600</authid><authname>Zhang Z.</authname><surname>Zhang</surname><given-name>Zaijun</given-name><initials>Z.</initials><afid>60103801</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56591942600</author-url><authid>56591942600</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yuqiang</given-name><initials>Y.</initials><afid>60103801</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005662153</author-url><authid>7005662153</authid><authname>Kwan Y.</authname><surname>Kwan</surname><given-name>Y. W.</given-name><initials>Y.W.</initials><afid>60002798</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55922412400</author-url><authid>55922412400</authid><authname>Lee S.</authname><surname>Lee</surname><given-name>Simon M Y</given-name><initials>S.M.Y.</initials><afid>60022317</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:36607867300</author-url><authid>36607867300</authid><authname>Hoi M.</authname><surname>Hoi</surname><given-name>Maggie P M</given-name><initials>M.P.M.</initials><afid>60022317</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56647280500</author-url><authid>56647280500</authid><authname>Chan S.</authname><surname>Chan</surname><given-name>S. W.</given-name><initials>S.W.</initials><afid>60008928</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56650557900</author-url><authid>56650557900</authid><authname>Cheung A.</authname><surname>Cheung</surname><given-name>Alex Chun</given-name><initials>A.C.</initials><afid>60006541</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56650540400</author-url><authid>56650540400</authid><authname>Cheung K.</authname><surname>Cheung</surname><given-name>K. H.</given-name><initials>K.H.</initials><afid>60006541</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:35963668200</author-url><authid>35963668200</authid><authname>Leung G.</authname><surname>Leung</surname><given-name>George P H</given-name><initials>G.P.H.</initials><afid>60006541</afid></author><authkeywords>Calcium channel | Danshensu tetramethylpyrazine | Mesenteric artery | Relaxation</authkeywords><intid>1035977219</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929581454"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929581454?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929581454&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929581454&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014299915004379"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929581454</prism:url><dc:identifier>SCOPUS_ID:84929581454</dc:identifier><eid>2-s2.0-84929581454</eid><dc:title>The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2</dc:title><dc:creator>Yang H.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>761</prism:volume><prism:pageRange>135-143</prism:pageRange><prism:coverDate>2015-08-15</prism:coverDate><prism:coverDisplayDate>15 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.05.001</prism:doi><pii>S0014299915004379</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. S-propargyl-cysteine (SPRC) is a novel synthetic molecule exerting antioxidant effects via elevating generation of endogenous H&lt;inf&gt;2&lt;/inf&gt;S. Our study aimed to elucidate possible antioxidant mechanisms of SPRC in hyperglycemia-induced oxidative stress. H9C2 cells were treated with SPRC or NaHS at the indicated concentration before being treated with high glucose for 48 h. Follow-up experiments were based on detailed description given in Section 2. SD rats were injected with Streptozocin (STZ) to induce diabetes as previously reported. Diabetic rats were administrated with SPRC, NaHS or solution respectively for one week before the rats were killed for follow-up experiments. Our work found that SPRC remarkably attenuated high glucose induced generation of reactive oxygen species and apoptosis in H9C2 cells. SPRC increased stability and nuclear translocation of Nuclear factor erythroid 2-related factor 2 (Nrf2), up-regulated expression of antioxidant enzyme superoxide dismutase (SOD) and interfered with the interaction between Kelch-like ECH-associated protein 1 (KEAP1) and Nrf2. SPRC activated Nrf2 via Cystathionase-γ-lyase (CSE) and Akt pathway. CSE inhibitor PAG and Akt inhibitor LY294002 could reverse the protective effects of SPRC. Knockdown of Nrf2 by shRNA also blocked SPRC up-regulated expression of CSE. Similar results of protein expression and hypoglycemic activity of SPRC were observed in STZ induced diabetic rats.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009860</affiliation-url><afid>60009860</afid><affilname>Fudan University</affilname><name-variant>Fudan University</name-variant><affiliation-city>Shanghai</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017161</affiliation-url><afid>60017161</afid><affilname>National University of Singapore</affilname><name-variant>National University of Singapore</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:54990426000</author-url><authid>54990426000</authid><authname>Yang H.</authname><surname>Yang</surname><given-name>Hebei</given-name><initials>H.</initials><afid>60009860</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56650461500</author-url><authid>56650461500</authid><authname>Mao Y.</authname><surname>Mao</surname><given-name>Yicheng</given-name><initials>Y.</initials><afid>60009860</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56650519500</author-url><authid>56650519500</authid><authname>Tan B.</authname><surname>Tan</surname><given-name>Bo</given-name><initials>B.</initials><afid>60009860</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56302703600</author-url><authid>56302703600</authid><authname>Luo S.</authname><surname>Luo</surname><given-name>Shanshan</given-name><initials>S.</initials><afid>60009860</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55588736500</author-url><authid>55588736500</authid><authname>Zhu Y.</authname><surname>Zhu</surname><given-name>Yizhun</given-name><initials>Y.</initials><afid>60009860</afid><afid>60017161</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55588736500</author-url><authid>55588736500</authid><authname>Zhu Y.</authname><surname>Zhu</surname><given-name>Yizhun</given-name><initials>Y.</initials><afid>60009860</afid><afid>60017161</afid></author><authkeywords>Cystathionase-γ-lyase | High glucose | NF-E2-related factor 2 | Reactive oxygen species | S-propargyl-cysteine</authkeywords><intid>1535981027</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929582912"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929582912?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929582912&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929582912&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014299915300054"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929582912</prism:url><dc:identifier>SCOPUS_ID:84929582912</dc:identifier><eid>2-s2.0-84929582912</eid><dc:title>Protective effects of tirofiban on ischemia/reperfusion-induced renal injury in vivo and in vitro</dc:title><dc:creator>Guan W.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>761</prism:volume><prism:pageRange>144-152</prism:pageRange><prism:coverDate>2015-08-15</prism:coverDate><prism:coverDisplayDate>15 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.05.009</prism:doi><pii>S0014299915300054</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Tirofiban, a glycoprotein IIb/IIIa receptor inhibitor, is widely used in the management of patients with unstable angina or myocardial infarction, and shows protective effects on ischemia/reperfusion (I/R) injured heart. Whether or not it has protective effect on I/R injured kidney is not known. The present in vivo and in vitro study found that serum creatinine (SCR) and blood urea nitrogen (BUN) were significantly increased in I/R rats, accompanied by histopathological damage of the kidney. Apoptotic cells, leukocyte infiltration and ROS production were increased in I/R rats. Pretreatment by intravenous injection of tirofiban (200 μg/kg) reduced SCR and BUN levels, ameliorated renal histopathological changes, and decreased ROS production, cell apoptosis and leukocyte infiltration in I/R injured kidney. Our further study showed that the protection of tirofiban might be associated with the restoration of eNOS/iNOS balance, since inhibition of NO production blocked the tirofiban-mediated renal protection on I/R injury. The present in vivo and in vitro study indicated that tirofiban pretreatment exerts a protective effect on I/R injury in kidney through regulation of eNOS/iNOS balance.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60089803</affiliation-url><afid>60089803</afid><affilname>Daping Hospital, the Third Military Medical University</affilname><name-variant>Third Military Medical University</name-variant><affiliation-city>Chongqing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100629981</affiliation-url><afid>100629981</afid><affilname>Chongqing Institute of Cardiology</affilname><name-variant>Chongqing Institute of Cardiology</name-variant><affiliation-city>Chongqing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">18</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55917909900</author-url><authid>55917909900</authid><authname>Guan W.</authname><surname>Guan</surname><given-name>Weiwei</given-name><initials>W.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55917909900</author-url><authid>55917909900</authid><authname>Guan W.</authname><surname>Guan</surname><given-name>Weiwei</given-name><initials>W.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55848102100</author-url><authid>55848102100</authid><authname>Wang Z.</authname><surname>Wang</surname><given-name>Zhen</given-name><initials>Z.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55848102100</author-url><authid>55848102100</authid><authname>Wang Z.</authname><surname>Wang</surname><given-name>Zhen</given-name><initials>Z.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55806594600</author-url><authid>55806594600</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yukai</given-name><initials>Y.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55806594600</author-url><authid>55806594600</authid><authname>Liu Y.</authname><surname>Liu</surname><given-name>Yukai</given-name><initials>Y.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56395727100</author-url><authid>56395727100</authid><authname>Han Y.</authname><surname>Han</surname><given-name>Yu</given-name><initials>Y.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56395727100</author-url><authid>56395727100</authid><authname>Han Y.</authname><surname>Han</surname><given-name>Yu</given-name><initials>Y.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35316418200</author-url><authid>35316418200</authid><authname>Ren H.</authname><surname>Ren</surname><given-name>Hongmei</given-name><initials>H.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35316418200</author-url><authid>35316418200</authid><authname>Ren H.</authname><surname>Ren</surname><given-name>Hongmei</given-name><initials>H.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56650973000</author-url><authid>56650973000</authid><authname>Eric Wang W.</authname><surname>Eric Wang</surname><given-name>Wei</given-name><initials>W.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56650973000</author-url><authid>56650973000</authid><authname>Eric Wang W.</authname><surname>Eric Wang</surname><given-name>Wei</given-name><initials>W.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55179587800</author-url><authid>55179587800</authid><authname>Yang J.</authname><surname>Yang</surname><given-name>Jian</given-name><initials>J.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55179587800</author-url><authid>55179587800</authid><authname>Yang J.</authname><surname>Yang</surname><given-name>Jian</given-name><initials>J.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56650333800</author-url><authid>56650333800</authid><authname>Zhou L.</authname><surname>Zhou</surname><given-name>Lin</given-name><initials>L.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56650333800</author-url><authid>56650333800</authid><authname>Zhou L.</authname><surname>Zhou</surname><given-name>Lin</given-name><initials>L.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7103181354</author-url><authid>7103181354</authid><authname>Zeng C.</authname><surname>Zeng</surname><given-name>Chunyu</given-name><initials>C.</initials><afid>60089803</afid><afid>100629981</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7103181354</author-url><authid>7103181354</authid><authname>Zeng C.</authname><surname>Zeng</surname><given-name>Chunyu</given-name><initials>C.</initials><afid>60089803</afid><afid>100629981</afid></author><authkeywords>Apoptosis | Oxidative stress | Renal ischemia-reperfusion | Tirofiban</authkeywords><intid>2035976159</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924067947"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924067947?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924067947&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924067947&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0308814615002824"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924067947</prism:url><dc:identifier>SCOPUS_ID:84924067947</dc:identifier><eid>2-s2.0-84924067947</eid><dc:title>Amino acid sequence of Japanese quail (Coturnix japonica) and northern bobwhite (Colinus virginianus) myoglobin</dc:title><dc:creator>Goodson J.</dc:creator><prism:publicationName>Food Chemistry</prism:publicationName><prism:issn>03088146</prism:issn><prism:eIssn>18737072</prism:eIssn><prism:volume>181</prism:volume><prism:pageRange>256-262</prism:pageRange><prism:coverDate>2015-08-15</prism:coverDate><prism:coverDisplayDate>15 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodchem.2015.02.091</prism:doi><pii>S0308814615002824</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. Myoglobin has an important physiological role in vertebrates, and as the primary sarcoplasmic pigment in meat, influences quality perception and consumer acceptability. In this study, the amino acid sequences of Japanese quail and northern bobwhite myoglobin were deduced by cDNA cloning of the coding sequence from mRNA. Japanese quail myoglobin was isolated from quail cardiac muscles, purified using ammonium sulphate precipitation and gel-filtration, and subjected to multiple enzymatic digestions. Mass spectrometry corroborated the deduced protein amino acid sequence at the protein level. Sequence analysis revealed both species' myoglobin structures consist of 153 amino acids, differing at only three positions. When compared with chicken myoglobin, Japanese quail showed 98% sequence identity, and northern bobwhite 97% sequence identity. The myoglobin in both quail species contained eight histidine residues instead of the nine present in chicken and turkey.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029747</affiliation-url><afid>60029747</afid><affilname>The University of Georgia</affilname><name-variant>University of Georgia</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029747</affiliation-url><afid>60029747</afid><affilname>The University of Georgia</affilname><name-variant>University of Georgia</name-variant><affiliation-city>Athens</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56536141200</author-url><authid>56536141200</authid><authname>Goodson J.</authname><surname>Goodson</surname><given-name>John</given-name><initials>J.</initials><afid>60029747</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36805409600</author-url><authid>36805409600</authid><authname>Beckstead R.</authname><surname>Beckstead</surname><given-name>Robert B.</given-name><initials>R.B.</initials><afid>60029747</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56535901800</author-url><authid>56535901800</authid><authname>Payne J.</authname><surname>Payne</surname><given-name>Jason</given-name><initials>J.</initials><afid>60029747</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:54913203500</author-url><authid>54913203500</authid><authname>Singh R.</authname><surname>Singh</surname><given-name>Rakesh K.</given-name><initials>R.K.</initials><afid>60029747</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35484991500</author-url><authid>35484991500</authid><authname>Mohan A.</authname><surname>Mohan</surname><given-name>Anand</given-name><initials>A.</initials><afid>60029747</afid></author><authkeywords>Colinus virginianus | Coturnix japonica | Japanese quail | Myoglobin | Northern bobwhite | Primary structure</authkeywords><intid>35081952</intid><source-id>24039</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927627627"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927627627?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927627627&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927627627&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0304885315300275"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927627627</prism:url><dc:identifier>SCOPUS_ID:84927627627</dc:identifier><eid>2-s2.0-84927627627</eid><dc:title>Pulsatile flow of blood and heat transfer with variable viscosity under magnetic and vibration environment</dc:title><dc:creator>Shit G.</dc:creator><prism:publicationName>Journal of Magnetism and Magnetic Materials</prism:publicationName><prism:issn>03048853</prism:issn><prism:volume>388</prism:volume><prism:pageRange>106-115</prism:pageRange><prism:coverDate>2015-08-15</prism:coverDate><prism:coverDisplayDate>15 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jmmm.2015.04.026</prism:doi><pii>S0304885315300275</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Unsteady flow of blood and heat transfer characteristics in the neighborhood of an overlapping constricted artery have been investigated in the presence of magnetic field and whole body vibration. The laminar flow of blood is taken to be incompressible and Newtonian fluid with variable viscosity depending upon temperature with an aim to provide resemblance to the real situation in the physiological system. The unsteady flow mechanism in the constricted artery is subjected to a pulsatile pressure gradient arising from systematic functioning of the heart and from the periodic body acceleration. The numerical computation has been performed using finite difference method by developing Crank-Nicolson scheme. The results show that the volumetric flow rate, skin-friction and the rate of heat transfer at the wall are significantly altered in the downstream of the constricted region. The axial velocity profile, temperature and flow rate increases with increase in temperature dependent viscosity, while the opposite trend is observed in the case of skin-friction and flow impedance.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Jadavpur University</affilname><name-variant>Department of Mathematics</name-variant><affiliation-city>Kolkata</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55960745800</author-url><authid>55960745800</authid><authname>Shit G.</authname><surname>Shit</surname><given-name>G. C.</given-name><initials>G.C.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56156863700</author-url><authid>56156863700</authid><authname>Majee S.</authname><surname>Majee</surname><given-name>Sreeparna</given-name><initials>S.</initials><afid/></author><authkeywords>Body acceleration | Heat transfer | Magnetic field | Overlapping constriction | Variable blood viscosity</authkeywords><intid>2035641804</intid><source-id>28526</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929078851"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929078851?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929078851&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929078851&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0165032715002359"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929078851</prism:url><dc:identifier>SCOPUS_ID:84929078851</dc:identifier><eid>2-s2.0-84929078851</eid><dc:title>Diagnostic accuracy of the Whooley depression tool in older adults in UK primary care</dc:title><dc:creator>Bosanquet K.</dc:creator><prism:publicationName>Journal of Affective Disorders</prism:publicationName><prism:issn>01650327</prism:issn><prism:eIssn>15732517</prism:eIssn><prism:volume>182</prism:volume><prism:pageRange>39-43</prism:pageRange><prism:coverDate>2015-08-15</prism:coverDate><prism:coverDisplayDate>15 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jad.2015.04.020</prism:doi><pii>S0165032715002359</pii><dc:description>© 2015 Elsevier B.V. Abstract Purpose of research To validate the Whooley questions as a screening tool for depression amongst a population of older adults in UK primary care. Objective To assess the diagnostic performance of the Whooley questions as a screening tool for depression amongst older adults in UK primary care. Participants A cross-sectional validation study was conducted with 766 patients aged ≥75 from UK primary care, recruited via 17 general practices based in the North of England during the pilot phase of a randomized controlled trial. Main outcome measures Sensitivity, specificity and likelihood ratios comparing the index test (two Whooley questions) with a diagnosis of major depressive disorder (MDD) ascertained by the reference standard Mini International Neuropsychiatric Interview (MINI). Results The two screening questions had a sensitivity of 94.3% (95% confidence interval, 80.8-99.3%) and specificity of 62.7% (95% confidence interval, 59.0-66.2%). The likelihood ratio for a positive test was 2.5 (95% confidence interval, 2.2-2.9) and the likelihood ratio for a negative test was 0.09 (95% confidence interval, 0.02-0.35). Conclusion The two Whooley questions missed few cases of depression. However, they were responsible for a high rate of false positives. This creates additional burden on general practitioners, to conduct more detailed investigation on patients who screen positive, but many of whom turn out not to have MDD.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016418</affiliation-url><afid>60016418</afid><affilname>University of York</affilname><name-variant>University of York</name-variant><affiliation-city>York</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016418</affiliation-url><afid>60016418</afid><affilname>University of York</affilname><name-variant>University of York</name-variant><affiliation-city>York</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60022175</affiliation-url><afid>60022175</afid><affilname>University of Durham</affilname><name-variant>University of Durham</name-variant><affiliation-city>Durham</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55763513400</author-url><authid>55763513400</authid><authname>Bosanquet K.</authname><surname>Bosanquet</surname><given-name>Katharine</given-name><initials>K.</initials><afid>60016418</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23397725400</author-url><authid>23397725400</authid><authname>Mitchell N.</authname><surname>Mitchell</surname><given-name>Natasha</given-name><initials>N.</initials><afid>60016418</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55864632000</author-url><authid>55864632000</authid><authname>Gabe R.</authname><surname>Gabe</surname><given-name>Rhian</given-name><initials>R.</initials><afid>60016418</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55763034600</author-url><authid>55763034600</authid><authname>Lewis H.</authname><surname>Lewis</surname><given-name>Helen</given-name><initials>H.</initials><afid>60016418</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7201699631</author-url><authid>7201699631</authid><authname>McMillan D.</authname><surname>McMillan</surname><given-name>Dean</given-name><initials>D.</initials><afid>60016418</afid><afid>60016418</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7201699631</author-url><authid>7201699631</authid><authname>McMillan D.</authname><surname>McMillan</surname><given-name>Dean</given-name><initials>D.</initials><afid>60016418</afid><afid>60016418</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507109697</author-url><authid>6507109697</authid><authname>Ekers D.</authname><surname>Ekers</surname><given-name>David</given-name><initials>D.</initials><afid>60022175</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56637623200</author-url><authid>56637623200</authid><authname>Bailey D.</authname><surname>Bailey</surname><given-name>Della</given-name><initials>D.</initials><afid>60016418</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003612713</author-url><authid>7003612713</authid><authname>Gilbody S.</authname><surname>Gilbody</surname><given-name>Simon</given-name><initials>S.</initials><afid>60016418</afid><afid>60016418</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003612713</author-url><authid>7003612713</authid><authname>Gilbody S.</authname><surname>Gilbody</surname><given-name>Simon</given-name><initials>S.</initials><afid>60016418</afid><afid>60016418</afid></author><authkeywords>Depression | Diagnostic accuracy | Older adults | Primary health care | Screening</authkeywords><intid>2035897073</intid><article-number>7397</article-number><source-id>16245</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928109679"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928109679?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928109679&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928109679&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0039914015001988"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928109679</prism:url><dc:identifier>SCOPUS_ID:84928109679</dc:identifier><eid>2-s2.0-84928109679</eid><dc:title>Ultrasound-assisted emulsification-extraction of orange peel metabolites prior to tentative identification by LC-QTOF MS/MS</dc:title><dc:creator>Molina-Calle M.</dc:creator><prism:publicationName>Talanta</prism:publicationName><prism:issn>00399140</prism:issn><prism:volume>141</prism:volume><prism:pageRange>150-157</prism:pageRange><prism:coverDate>2015-08-15</prism:coverDate><prism:coverDisplayDate>15 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.talanta.2015.03.045</prism:doi><pii>S0039914015001988</pii><dc:description>© 2015 Elsevier B.V. An optimized method for extraction and characterization of compounds present in orange peel has been developed. The extraction method allows the simultaneous extraction of polar and non-polar compounds by using two immiscible extractants (a polar extractant - an 80:20 (v/v) methanol-water mixture, and a non-polar extractant - n-hexane). The method is ultrasound-assisted, thus facilitating both formation of a stable emulsion between the two immiscible extractants and favoring mass-transfer from the solid sample to the liquid phases by a wide contact surface. Optimization of the ultrasound-assisted emulsification-extraction (USAEE) led to the following values as desirability conditions for both extracts: 32% amplitude, 0.75 s/s duty cycle and 7.5 min of extraction time. The extracts obtained under these conditions were analyzed by LC-QTOF MS/MS in positive and negative ionization modes. Tentative identification of the most significant compounds present in each extract allowed their characterization by using high resolution tandem mass spectrometry. The optimum extracts provided by USAEE were compared by using Principal Component Analysis to those obtained by conventional extraction based on maceration. Thus, the composition of the polar extracts obtained after 7.5 min ultrasonication was similar to that of conventional maceration for 4 h in both the ionization modes. On the contrary, the analysis of non-polar extracts led to different results depending on the ionization mode: the ultrasound-assisted extract was similar to those of conventional maceration for 10 h in negative and positive ionization. This behavior could be explained by the contribution of different groups of compounds to each ionization mode.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003138</affiliation-url><afid>60003138</afid><affilname>Universidad de Cordoba</affilname><name-variant>University of Cordoba</name-variant><affiliation-city>Cordoba</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031142</affiliation-url><afid>60031142</afid><affilname>Hospital Universitario Reina Sofia</affilname><name-variant>Hospital Reina Sofía</name-variant><affiliation-city>Cordoba</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003138</affiliation-url><afid>60003138</afid><affilname>Universidad de Cordoba</affilname><name-variant>University of Cordoba</name-variant><affiliation-city>Cordoba</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56600874400</author-url><authid>56600874400</authid><authname>Molina-Calle M.</authname><surname>Molina-Calle</surname><given-name>María</given-name><initials>M.</initials><afid>60003138</afid><afid>60031142</afid><afid>60003138</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56600874400</author-url><authid>56600874400</authid><authname>Molina-Calle M.</authname><surname>Molina-Calle</surname><given-name>María</given-name><initials>M.</initials><afid>60003138</afid><afid>60031142</afid><afid>60003138</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56600874400</author-url><authid>56600874400</authid><authname>Molina-Calle M.</authname><surname>Molina-Calle</surname><given-name>María</given-name><initials>M.</initials><afid>60003138</afid><afid>60031142</afid><afid>60003138</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8272818500</author-url><authid>8272818500</authid><authname>Priego-Capote F.</authname><surname>Priego-Capote</surname><given-name>Feliciano</given-name><initials>F.</initials><afid>60003138</afid><afid>60031142</afid><afid>60003138</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8272818500</author-url><authid>8272818500</authid><authname>Priego-Capote F.</authname><surname>Priego-Capote</surname><given-name>Feliciano</given-name><initials>F.</initials><afid>60003138</afid><afid>60031142</afid><afid>60003138</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8272818500</author-url><authid>8272818500</authid><authname>Priego-Capote F.</authname><surname>Priego-Capote</surname><given-name>Feliciano</given-name><initials>F.</initials><afid>60003138</afid><afid>60031142</afid><afid>60003138</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7101731978</author-url><authid>7101731978</authid><authname>Luque De Castro M.</authname><surname>Luque De Castro</surname><given-name>María D.</given-name><initials>M.D.</initials><afid>60003138</afid><afid>60031142</afid><afid>60003138</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7101731978</author-url><authid>7101731978</authid><authname>Luque De Castro M.</authname><surname>Luque De Castro</surname><given-name>María D.</given-name><initials>M.D.</initials><afid>60003138</afid><afid>60031142</afid><afid>60003138</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7101731978</author-url><authid>7101731978</authid><authname>Luque De Castro M.</authname><surname>Luque De Castro</surname><given-name>María D.</given-name><initials>M.D.</initials><afid>60003138</afid><afid>60031142</afid><afid>60003138</afid></author><authkeywords>Industrial wastes | LCQTOF analysis | Metabolic profile | Orange peel | Ultrasound-assisted emulsificationextrac- tion</authkeywords><intid>1785734773</intid><source-id>24555</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927157235"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927157235?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927157235&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927157235&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0378437115003192"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927157235</prism:url><dc:identifier>SCOPUS_ID:84927157235</dc:identifier><eid>2-s2.0-84927157235</eid><dc:title>Volatility behavior of visibility graph EMD financial time series from Ising interacting system</dc:title><dc:creator>Zhang B.</dc:creator><prism:publicationName>Physica A: Statistical Mechanics and its Applications</prism:publicationName><prism:issn>03784371</prism:issn><prism:volume>432</prism:volume><prism:pageRange>301-314</prism:pageRange><prism:coverDate>2015-08-15</prism:coverDate><prism:coverDisplayDate>15 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.physa.2015.03.057</prism:doi><pii>S0378437115003192</pii><dc:description>© 2015 Elsevier B.V. A financial market dynamics model is developed and investigated by stochastic Ising system, where the Ising model is the most popular ferromagnetic model in statistical physics systems. Applying two graph based analysis and multiscale entropy method, we investigate and compare the statistical volatility behavior of return time series and the corresponding IMF series derived from the empirical mode decomposition (EMD) method. And the real stock market indices are considered to be comparatively studied with the simulation data of the proposed model. Further, we find that the degree distribution of visibility graph for the simulation series has the power law tails, and the assortative network exhibits the mixing pattern property. All these features are in agreement with the real market data, the research confirms that the financial model established by the Ising system is reasonable.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Beijing Jiaotong University</affilname><name-variant>Department of Mathematics</name-variant><name-variant>School of Science</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Beijing Jiaotong University</affilname><name-variant>Department of Finance</name-variant><name-variant>School of Economics and Management</name-variant><affiliation-city>Beijing</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56587011500</author-url><authid>56587011500</authid><authname>Zhang B.</authname><surname>Zhang</surname><given-name>Bo</given-name><initials>B.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55946707000</author-url><authid>55946707000</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jun</given-name><initials>J.</initials><afid/></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:42361194900</author-url><authid>42361194900</authid><authname>Fang W.</authname><surname>Fang</surname><given-name>Wen</given-name><initials>W.</initials><afid/></author><authkeywords>Empirical mode decomposition | Financial time series model | Horizontal visibility graph | Ising system | Stochastic | Visibility graph | Volatility analysis</authkeywords><intid>1035565050</intid><source-id>29115</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929095967"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929095967?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929095967&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929095967&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0308814615002848"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929095967</prism:url><dc:identifier>SCOPUS_ID:84929095967</dc:identifier><eid>2-s2.0-84929095967</eid><dc:title>Phytochemicals and antioxidant capacities of Mao-Luang (Antidesma bunius L.) cultivars from Northeastern Thailand</dc:title><dc:creator>Jorjong S.</dc:creator><prism:publicationName>Food Chemistry</prism:publicationName><prism:issn>03088146</prism:issn><prism:eIssn>18737072</prism:eIssn><prism:volume>181</prism:volume><prism:pageRange>248-255</prism:pageRange><prism:coverDate>2015-08-15</prism:coverDate><prism:coverDisplayDate>15 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.foodchem.2015.02.093</prism:doi><pii>S0308814615002848</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. Phenolic compounds extracted from fourteen Mao-Luang (Antidesma bunius) cultivars grown in Northeastern Thailand were quantified using HPLC analysis and the antioxidant capacity of the extracts was determined by ABTS&lt;sup&gt;+&lt;/sup&gt;, DPPH radical, and FRAP assays. This study showed that there were differences (p &lt; 0.05) in phenolic compounds and antioxidant activities among Mao-Luang cultivars. Gallic acid, (-)-epicatechin, (+)-catechin, and cyanidin-3-O-glucoside were the major polyphenolic components in all Mao-Luang cultivars. The highest contents were found in 'Kumlai' with values of 281.30, 949.73, 127.60 and 54.67 mg/100 g DW, respectively. 'Kumlai' also exhibited the highest antioxidant activity with the values of 103.04 mmol VCEAC/g DW (DPPH assay), 35.35 mmol Fe(II)/g DW (FRAP assay), and 46.37 mmol TE/g DW (ABTS&lt;sup&gt;+&lt;/sup&gt; assay). Correlation analyses revealed that gallic acid, ferulic acid and some anthocyanins, mainly cyanidin-3-O-glucoside, were responsible for the antioxidant capacity of Mao-Luang fruits.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002875</affiliation-url><afid>60002875</afid><affilname>Mahasarakham University</affilname><name-variant>Mahasarakham University</name-variant><affiliation-city>Mahasarakham</affiliation-city><affiliation-country>Thailand</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:53163957800</author-url><authid>53163957800</authid><authname>Jorjong S.</authname><surname>Jorjong</surname><given-name>Sujitar</given-name><initials>S.</initials><afid>60002875</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:25227241500</author-url><authid>25227241500</authid><authname>Butkhup L.</authname><surname>Butkhup</surname><given-name>Luchai</given-name><initials>L.</initials><afid>60002875</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506786548</author-url><authid>6506786548</authid><authname>Samappito S.</authname><surname>Samappito</surname><given-name>Supachai</given-name><initials>S.</initials><afid>60002875</afid></author><authkeywords>Antidesma bunius | Antioxidant activity | Cultivars | Phenolic compound</authkeywords><intid>1035898054</intid><source-id>24039</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929346953"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929346953?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929346953&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929346953&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0008621515001329"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929346953</prism:url><dc:identifier>SCOPUS_ID:84929346953</dc:identifier><eid>2-s2.0-84929346953</eid><dc:title>Determination of the structure of the O-antigen and the lipid A from the entomopathogenic bacterium Pseudomonas entomophila lipopolysaccharide along with its immunological properties</dc:title><dc:creator>Speciale I.</dc:creator><prism:publicationName>Carbohydrate Research</prism:publicationName><prism:issn>00086215</prism:issn><prism:eIssn>1873426X</prism:eIssn><prism:volume>412</prism:volume><prism:pageRange>20-27</prism:pageRange><prism:coverDate>2015-08-14</prism:coverDate><prism:coverDisplayDate>14 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.carres.2015.04.017</prism:doi><pii>S0008621515001329</pii><dc:description>© 2015 Elsevier Ltd. All rights reserved. The structure and the immunology of the lipopolysaccharide (LPS) of Pseudomonas entomophila, an entomopathogenic bacterium isolated from the fruit fly Drosophila melanogaster, was characterized. The O-antigen portion was established and resulted to be built up of a repetitive unit constituted by four monosaccharide residues, all L configured, all deoxy at C-6 and with an acetamido function at C-2: →3)-α-l-FucNAc-(1→4)-α-l-FucNAc-(1→3)-α-l-FucNAc-(1→3)-β-l-QuiNAc-(1→ The structural analysis of lipid A, showed a mixture of different species. The diphosphorylated glucosamine backbone carries six fatty acids consistent with the composition C10:0 3(OH), C12:0 2(OH) and C12:0 3(OH), whereas other species differs by the number of phosphates and/or of fatty acids. The immunology experiments demonstrated that the LPS structure of P. entomophila displayed a low ability to engage the TLR4-mediated signaling correlated to a significant antagonistic activity toward hexa-acylated LPS structures.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017293</affiliation-url><afid>60017293</afid><affilname>Universita degli Studi di Napoli Federico II</affilname><name-variant>University of Naples Federico II</name-variant><affiliation-city>Naples</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032350</affiliation-url><afid>60032350</afid><affilname>Universita degli Studi di Roma La Sapienza</affilname><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000523</affiliation-url><afid>60000523</afid><affilname>Istituto di Chimica e Tecnologia dei Polimeri</affilname><name-variant>CNR</name-variant><affiliation-city>Pozzuoli</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028186</affiliation-url><afid>60028186</afid><affilname>Ecole Polytechnique Federale de Lausanne</affilname><name-variant>EPFL</name-variant><affiliation-city>Lausanne</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60032350</affiliation-url><afid>60032350</afid><affilname>Universita degli Studi di Roma La Sapienza</affilname><affiliation-city>Rome</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115015222</affiliation-url><afid>115015222</afid><affilname>Università 100</affilname><name-variant>Università 100</name-variant><affiliation-city/><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">14</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644756000</author-url><authid>56644756000</authid><authname>Speciale I.</authname><surname>Speciale</surname><given-name>Immacolata</given-name><initials>I.</initials><afid>60017293</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36630826400</author-url><authid>36630826400</authid><authname>Paciello I.</authname><surname>Paciello</surname><given-name>Ida</given-name><initials>I.</initials><afid>60032350</afid><afid>60032350</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36630826400</author-url><authid>36630826400</authid><authname>Paciello I.</authname><surname>Paciello</surname><given-name>Ida</given-name><initials>I.</initials><afid>60032350</afid><afid>60032350</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:8573708300</author-url><authid>8573708300</authid><authname>Fazio L.</authname><surname>Fazio</surname><given-name>Luigi Lembo</given-name><initials>L.L.</initials><afid>60032350</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6603392918</author-url><authid>6603392918</authid><authname>Sturiale L.</authname><surname>Sturiale</surname><given-name>Luisa</given-name><initials>L.</initials><afid>60000523</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:25226347300</author-url><authid>25226347300</authid><authname>Palmigiano A.</authname><surname>Palmigiano</surname><given-name>Angelo</given-name><initials>A.</initials><afid>60000523</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004028626</author-url><authid>7004028626</authid><authname>Lanzetta R.</authname><surname>Lanzetta</surname><given-name>Rosa</given-name><initials>R.</initials><afid>60017293</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005064727</author-url><authid>7005064727</authid><authname>Parrilli M.</authname><surname>Parrilli</surname><given-name>Michelangelo</given-name><initials>M.</initials><afid>60017293</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003555779</author-url><authid>7003555779</authid><authname>Garozzo D.</authname><surname>Garozzo</surname><given-name>Domenico</given-name><initials>D.</initials><afid>60000523</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7006561187</author-url><authid>7006561187</authid><authname>Lemaitre B.</authname><surname>Lemaitre</surname><given-name>Bruno</given-name><initials>B.</initials><afid>60028186</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56265001600</author-url><authid>56265001600</authid><authname>Bernardini M.</authname><surname>Bernardini</surname><given-name>Maria Lina</given-name><initials>M.L.</initials><afid>60032350</afid><afid>60032350</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56265001600</author-url><authid>56265001600</authid><authname>Bernardini M.</authname><surname>Bernardini</surname><given-name>Maria Lina</given-name><initials>M.L.</initials><afid>60032350</afid><afid>60032350</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7005836602</author-url><authid>7005836602</authid><authname>Molinaro A.</authname><surname>Molinaro</surname><given-name>Antonio</given-name><initials>A.</initials><afid>60017293</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7102437031</author-url><authid>7102437031</authid><authname>De Castro C.</authname><surname>De Castro</surname><given-name>Cristina</given-name><initials>C.</initials><afid>115015222</afid></author><authkeywords>Drosophila melanogaster | Innate immunity | Lipopolysaccharide | Pseudomonas entomophila | Structural analysis</authkeywords><intid>535945149</intid><source-id>25803</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84918506420"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84918506420?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84918506420&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84918506420&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0378437114009777"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84918506420</prism:url><dc:identifier>SCOPUS_ID:84918506420</dc:identifier><eid>2-s2.0-84918506420</eid><dc:title>Wavelet-based analysis of spectral rearrangements of EEG patterns and of non-stationary correlations</dc:title><dc:creator>Bozhokin S.</dc:creator><prism:publicationName>Physica A: Statistical Mechanics and its Applications</prism:publicationName><prism:issn>03784371</prism:issn><prism:volume>421</prism:volume><prism:pageRange>151-160</prism:pageRange><prism:coverDate>2015-08-09</prism:coverDate><prism:coverDisplayDate>9 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.physa.2014.11.026</prism:doi><pii>S0378437114009777</pii><dc:description>© 2014 Elsevier B.V. In this paper we present a novel technique of studying EEG signals taking into account their essential nonstationarity. The bursts of activity in EEG rhythm are modeled as a superposition of specially designed elementary signals against the background of a real EEG record at rest. To calculate the time variation of quantitative characteristics of EEG patterns we propose the algorithm based on continuous wavelet transform (CWT) followed by the analysis of spectral integral dynamics in a given frequency range. We introduce new quantitative parameters to describe the dynamics of spectral properties both for each burst of brain activity and for their ensemble. Based on the given model we have identified the appearance and disappearance of patterns in EEG rhythm. The problem of non-stationary correlation of different EEG channels is solved. The use of the techniques for analyzing and classifying transient processes related to the activity of human central nervous system is also discussed.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017103</affiliation-url><afid>60017103</afid><affilname>St. Petersburg State Polytechnical University</affilname><name-variant>St. Petersburg State Polytechnical University</name-variant><affiliation-city>St. Petersburg</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017103</affiliation-url><afid>60017103</afid><affilname>St. Petersburg State Polytechnical University</affilname><name-variant>St. Petersburg State Polytechnical University</name-variant><affiliation-city>St. Petersburg</affiliation-city><affiliation-country>Russian Federation</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7801624630</author-url><authid>7801624630</authid><authname>Bozhokin S.</authname><surname>Bozhokin</surname><given-name>S. V.</given-name><initials>S.V.</initials><afid>60017103</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56005329200</author-url><authid>56005329200</authid><authname>Suslova I.</authname><surname>Suslova</surname><given-name>I. B.</given-name><initials>I.B.</initials><afid>60017103</afid></author><authkeywords>Continuous wavelet transform | Correlation of | EEG channels | Pattern recognition | Spectral integrals</authkeywords><intid>2034160975</intid><source-id>29115</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84920972827"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84920972827?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84920972827&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84920972827&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84920972827</prism:url><dc:identifier>SCOPUS_ID:84920972827</dc:identifier><eid>2-s2.0-84920972827</eid><dc:title>Risk of venous and arterial thrombotic events in patients diagnosed with superficial vein thrombosis: A nationwide cohort study</dc:title><dc:creator>Cannegieter S.</dc:creator><prism:publicationName>Blood</prism:publicationName><prism:issn>00064971</prism:issn><prism:eIssn>15280020</prism:eIssn><prism:volume>125</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>229-235</prism:pageRange><prism:coverDate>2015-08-08</prism:coverDate><prism:coverDisplayDate>8 August 2015</prism:coverDisplayDate><prism:doi>10.1182/blood-2014-06-577783</prism:doi><dc:description>© 2015 by The American Society of Hematology. Recently, it has become apparent that superficial vein thrombosis (SVT) can have serious complications. However, themagnitude of the risk of subsequent deep venous and arterial thrombotic events remains unknown.We examined this in a nationwide population-based setting duringa periodwhenSVT was not treated routinely with anticoagulants. TheDanish National Registry of Patients, covering all Danish hospitals, was used to identify 10 973 patientswith a first-time diagnosis of SVT between 1980 and 2012. A comparison cohort of 515 067 subjects, matched by age, gender, and calendar year, was selected from the general Danish population. Outcomes were venous thromboembolism, acute myocardial infarction, ischemic stroke, and death. Duringmedian follow-up of 7 years, the incidence rate of venous thromboembolismwas 18.0/1000 person-years (95%confidence interval [CI], 17.2-18.9). The highest risk occurred in the first 3 months (3.4%; 95% CI, 3.0-3.7). Comparedwith thegeneral population, thehazard ratio was 71.4 (95%CI, 60.2-84.7) in this period, steadily decreasing to 5.1 (95% CI 4.6-5.5), 5 years after the SVT. The hazard ratios for acute myocardial infarction, stroke, and death were 1.2 (95% CI, 1.1-1.3), 1.3 (95% CI, 1.2-1.4), and 1.3 (95% CI, 1.2-1.3), respectively, with the highest risk also shortly after SVT. These data indicate the prognostic importance of SVT and may form the basis for clinical decisionmaking regarding anticoagulation.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015618</affiliation-url><afid>60015618</afid><affilname>Leiden University Medical Center - LUMC</affilname><name-variant>University Hospital</name-variant><affiliation-city>Leiden</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023882</affiliation-url><afid>60023882</afid><affilname>Arhus Universitetshospital</affilname><name-variant>Aarhus University Hospital</name-variant><affiliation-city>Arhus</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023882</affiliation-url><afid>60023882</afid><affilname>Arhus Universitetshospital</affilname><name-variant>Aarhus University Hospital</name-variant><affiliation-city>Arhus</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019816</affiliation-url><afid>60019816</afid><affilname>Leiden University</affilname><name-variant>University of Leiden</name-variant><affiliation-city>Leiden</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><pubmed-id>25398934</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6603381281</author-url><authid>6603381281</authid><authname>Cannegieter S.</authname><surname>Cannegieter</surname><given-name>Suzanne C.</given-name><initials>S.C.</initials><afid>60015618</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:8982129100</author-url><authid>8982129100</authid><authname>Horváth-Puhó E.</authname><surname>Horváth-Puhó</surname><given-name>Erzsébet</given-name><initials>E.</initials><afid>60023882</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55472612400</author-url><authid>55472612400</authid><authname>Schmidt M.</authname><surname>Schmidt</surname><given-name>Morten</given-name><initials>M.</initials><afid>60023882</afid><afid>60023882</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55472612400</author-url><authid>55472612400</authid><authname>Schmidt M.</authname><surname>Schmidt</surname><given-name>Morten</given-name><initials>M.</initials><afid>60023882</afid><afid>60023882</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:12792905600</author-url><authid>12792905600</authid><authname>Dekkers O.</authname><surname>Dekkers</surname><given-name>Olaf M.</given-name><initials>O.M.</initials><afid>60015618</afid><afid>60019816</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:12792905600</author-url><authid>12792905600</authid><authname>Dekkers O.</authname><surname>Dekkers</surname><given-name>Olaf M.</given-name><initials>O.M.</initials><afid>60015618</afid><afid>60019816</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7201717857</author-url><authid>7201717857</authid><authname>Pedersen L.</authname><surname>Pedersen</surname><given-name>Lars</given-name><initials>L.</initials><afid>60023882</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56400314900</author-url><authid>56400314900</authid><authname>Vandenbroucke J.</authname><surname>Vandenbroucke</surname><given-name>Jan P.</given-name><initials>J.P.</initials><afid>60015618</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:36038149900</author-url><authid>36038149900</authid><authname>Sørensen H.</authname><surname>Sørensen</surname><given-name>Henrik T.</given-name><initials>H.T.</initials><afid>60023882</afid></author><intid>534568719</intid><source-id>25454</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921044634"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921044634?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921044634&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921044634&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921044634</prism:url><dc:identifier>SCOPUS_ID:84921044634</dc:identifier><eid>2-s2.0-84921044634</eid><dc:title>Complications in children and adolescents with Chuvash polycythemia</dc:title><dc:creator>Sergueeva A.</dc:creator><prism:publicationName>Blood</prism:publicationName><prism:issn>00064971</prism:issn><prism:eIssn>15280020</prism:eIssn><prism:volume>125</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>414-415</prism:pageRange><prism:coverDate>2015-08-08</prism:coverDate><prism:coverDisplayDate>8 August 2015</prism:coverDisplayDate><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:102008578</affiliation-url><afid>102008578</afid><affilname>Cheboksary Children's Hospital</affilname><name-variant>Cheboksary Children's Hospital</name-variant><affiliation-city/><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113085791</affiliation-url><afid>113085791</afid><affilname>Chuvash Republic Clinical Hospital</affilname><name-variant>Chuvash Republic Clinical Hospital</name-variant><affiliation-city/><affiliation-country>Russian Federation</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012771</affiliation-url><afid>60012771</afid><affilname>Howard University</affilname><name-variant>Howard University</name-variant><affiliation-city>Washington</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012445</affiliation-url><afid>60012445</afid><affilname>University of Utah Health Care</affilname><name-variant>University of Utah</name-variant><affiliation-city>Salt Lake City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027561</affiliation-url><afid>60027561</afid><affilname>University of Illinois at Chicago</affilname><name-variant>University of Illinois at Chicago</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114893543</affiliation-url><afid>114893543</afid><affilname>Sickle Cell Center (M/C 712)</affilname><name-variant>Sickle Cell Center (M/C 712)</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701840464</author-url><authid>6701840464</authid><authname>Sergueeva A.</authname><surname>Sergueeva</surname><given-name>Adelina I.</given-name><initials>A.I.</initials><afid>102008578</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603026532</author-url><authid>6603026532</authid><authname>Miasnikova G.</authname><surname>Miasnikova</surname><given-name>Galina Y.</given-name><initials>G.Y.</initials><afid>113085791</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006624373</author-url><authid>7006624373</authid><authname>Polyakova L.</authname><surname>Polyakova</surname><given-name>Lydia A.</given-name><initials>L.A.</initials><afid>113085791</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6507723796</author-url><authid>6507723796</authid><authname>Nouraie M.</authname><surname>Nouraie</surname><given-name>Mehdi</given-name><initials>M.</initials><afid>60012771</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7103030279</author-url><authid>7103030279</authid><authname>Prchal J.</authname><surname>Prchal</surname><given-name>Josef T.</given-name><initials>J.T.</initials><afid>60012445</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7007053560</author-url><authid>7007053560</authid><authname>Gordeuk V.</authname><surname>Gordeuk</surname><given-name>Victor R.</given-name><initials>V.R.</initials><afid>60027561</afid><afid>114893543</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7007053560</author-url><authid>7007053560</authid><authname>Gordeuk V.</authname><surname>Gordeuk</surname><given-name>Victor R.</given-name><initials>V.R.</initials><afid>60027561</afid><afid>114893543</afid></author><intid>1034571227</intid><source-id>25454</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84920971232"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84920971232?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84920971232&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84920971232&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84920971232</prism:url><dc:identifier>SCOPUS_ID:84920971232</dc:identifier><eid>2-s2.0-84920971232</eid><dc:title>Breast cancer risk in metabolically healthy but overweight postmenopausal women</dc:title><dc:creator>Gunter M.</dc:creator><prism:publicationName>Cancer Research</prism:publicationName><prism:issn>00085472</prism:issn><prism:eIssn>15387445</prism:eIssn><prism:volume>75</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>270-274</prism:pageRange><prism:coverDate>2015-08-08</prism:coverDate><prism:coverDisplayDate>8 August 2015</prism:coverDisplayDate><prism:doi>10.1158/0008-5472.CAN-14-2317</prism:doi><dc:description>© 2014 AACR. Adiposity is an established risk factor for postmenopausal breast cancer. Recent data suggest that high insulin levels in overweight women may play a major role in this relationship, due to insulin's mitogenic/antiapoptotic activity. However, whether overweight women who are metabolically healthy (i.e., normal insulin sensitivity) have elevated risk of breast cancer is unknown. We investigated whether overweight women with normal insulin sensitivity [i.e., homeostasis model assessment of insulin resistance (HOMA-IR) index, or fasting insulin level, within the lowest quartile (q1)] have increased breast cancer risk. Subjects were incident breast cancer cases ( N = 497) and a subcohort ( N = 2,830) of Women's Health Initiative (WHI) participants with available fasting insulin and glucose levels. In multivariate Cox models, metabolically healthy overweight women, defined using HOMA-IR, were not at elevated risk of breast cancer compared with metabolically healthy normal weight women [HR HOMA-IR, 0.96; 95% confidence interval (CI), 0.64-1.42]. In contrast, the risk among women with high (q3-4) HOMA-IRs was elevated whether they were overweight (HRHOMA-IR, 1.76; 95% CI, 1.19-2.60) or normal weight ( HRHOMA-IR , 1.80; 95% CI, 0.88 - 3.70). Similarly, using fasting insulin to define metabolic health, metabolically unhealthy women (insulin q3-4) were at higher risk of breast cancer regardless of whether they were normal weight (HRinsulin, 2.06; 95% CI, 1.01-4.22) or overweight (HRinsulin, 2.01; 95% CI, 1.35- 2.99), whereas metabolically healthy overweight women did not have significantly increased risk of breast cancer (HRinsulin , 0.96; 95% CI, 0.64- 1.42) relative to metabolically healthy normal weight women. Metabolic health (e.g., HOMA-IR or fasting insulin) may be more biologically relevant and more useful for breast cancer risk stratification than adiposity per se .</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015150</affiliation-url><afid>60015150</afid><affilname>Imperial College London</affilname><name-variant>Imperial College</name-variant><affiliation-city>London</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60002388</affiliation-url><afid>60002388</afid><affilname>Albert Einstein College of Medicine of Yeshiva University</affilname><name-variant>Albert Einstein College of Medicine</name-variant><affiliation-city>New York</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012708</affiliation-url><afid>60012708</afid><affilname>Stanford University</affilname><name-variant>Stanford University</name-variant><affiliation-city>Palo Alto</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013791</affiliation-url><afid>60013791</afid><affilname>University of Hawaii at Manoa</affilname><name-variant>University of Hawaii at Manoa</name-variant><affiliation-city>Honolulu</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><pubmed-id>25593034</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8245299200</author-url><authid>8245299200</authid><authname>Gunter M.</authname><surname>Gunter</surname><given-name>Marc J.</given-name><initials>M.J.</initials><afid>60015150</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:35365571000</author-url><authid>35365571000</authid><authname>Xie X.</authname><surname>Xie</surname><given-name>Xianhong</given-name><initials>X.</initials><afid>60002388</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7202712164</author-url><authid>7202712164</authid><authname>Xue X.</authname><surname>Xue</surname><given-name>Xiaonan</given-name><initials>X.</initials><afid>60002388</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004688011</author-url><authid>7004688011</authid><authname>Kabat G.</authname><surname>Kabat</surname><given-name>Geoffrey C.</given-name><initials>G.C.</initials><afid>60002388</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005205148</author-url><authid>7005205148</authid><authname>Rohan T.</authname><surname>Rohan</surname><given-name>Thomas E.</given-name><initials>T.E.</initials><afid>60002388</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35228209800</author-url><authid>35228209800</authid><authname>Wassertheil-Smoller S.</authname><surname>Wassertheil-Smoller</surname><given-name>Sylvia</given-name><initials>S.</initials><afid>60002388</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7102389981</author-url><authid>7102389981</authid><authname>Ho G.</authname><surname>Ho</surname><given-name>Gloria Y F</given-name><initials>G.Y.F.</initials><afid>60002388</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7006818381</author-url><authid>7006818381</authid><authname>Wylie-Rosett J.</authname><surname>Wylie-Rosett</surname><given-name>Judith</given-name><initials>J.</initials><afid>60002388</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56481280800</author-url><authid>56481280800</authid><authname>Greco T.</authname><surname>Greco</surname><given-name>Theresa</given-name><initials>T.</initials><afid>60012708</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56480886700</author-url><authid>56480886700</authid><authname>Yu H.</authname><surname>Yu</surname><given-name>Herbert</given-name><initials>H.</initials><afid>60013791</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:24821342100</author-url><authid>24821342100</authid><authname>Beasley J.</authname><surname>Beasley</surname><given-name>Jeannette</given-name><initials>J.</initials><afid>60002388</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7006307770</author-url><authid>7006307770</authid><authname>Strickler H.</authname><surname>Strickler</surname><given-name>Howard D.</given-name><initials>H.D.</initials><afid>60002388</afid></author><intid>1034560507</intid><source-id>29183</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84920971376"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84920971376?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84920971376&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84920971376&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84920971376</prism:url><dc:identifier>SCOPUS_ID:84920971376</dc:identifier><eid>2-s2.0-84920971376</eid><dc:title>IDH2 mutation-induced histone and DNA hypermethylation is progressively reversed by small-molecule inhibition</dc:title><dc:creator>Kernytsky A.</dc:creator><prism:publicationName>Blood</prism:publicationName><prism:issn>00064971</prism:issn><prism:eIssn>15280020</prism:eIssn><prism:volume>125</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>296-303</prism:pageRange><prism:coverDate>2015-08-08</prism:coverDate><prism:coverDisplayDate>8 August 2015</prism:coverDisplayDate><prism:doi>10.1182/blood-2013-10-533604</prism:doi><dc:description>© 2015 by The American Society of Hematology Mutations of IDH1 and IDH2, which produce the oncometabolite 2-hydroxyglutarate (2HG), have been identified in several tumors, including acute myeloid leukemia. Recent studies have shown that expression of the IDH mutant enzymes results in high levels of 2HG and a block in cellular differentiation that can be reversed with IDH mutant-specific small-molecule inhibitors. To further understand the role of IDH mutations in cancer, we conducted mechanistic studies in the TF-1 IDH2 R140Q erythroleukemia model system and found that IDH2 mutant expression caused both histone and genomic DNA methylation changes that can be reversed when IDH2mutant activity is inhibited. Specifically, histone hypermethylation is rapidly reversed within days, whereas reversal of DNA hypermethylation proceeds in a progressive manner over the course of weeks. We identified several gene signatures implicated in tumorigenesis of leukemia and lymphoma, indicating a selective modulation of relevant cancer genes by IDH mutations. As methylation of DNA and histones is closely linked to mRNA expression and differentiation, these results indicate that IDH2 mutant inhibition may function as a cancer therapy via histone and DNA demethylation at genes involved in differentiation and tumorigenesis.</dc:description><citedby-count>1</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:108062420</affiliation-url><afid>108062420</afid><affilname>Agios Pharmaceuticals</affilname><name-variant>Agios Pharmaceuticals</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112788455</affiliation-url><afid>112788455</afid><affilname>Blueprint Medicines</affilname><name-variant>Blueprint Medicines</name-variant><affiliation-city>Cambridge</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">17</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6507512013</author-url><authid>6507512013</authid><authname>Kernytsky A.</authname><surname>Kernytsky</surname><given-name>Andrew</given-name><initials>A.</initials><afid>108062420</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56480865900</author-url><authid>56480865900</authid><authname>Wang F.</authname><surname>Wang</surname><given-name>Fang</given-name><initials>F.</initials><afid>108062420</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:34876945400</author-url><authid>34876945400</authid><authname>Hansen E.</authname><surname>Hansen</surname><given-name>Erica</given-name><initials>E.</initials><afid>108062420</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55273666800</author-url><authid>55273666800</authid><authname>Schalm S.</authname><surname>Schalm</surname><given-name>Stefanie</given-name><initials>S.</initials><afid>108062420</afid><afid>112788455</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55273666800</author-url><authid>55273666800</authid><authname>Schalm S.</authname><surname>Schalm</surname><given-name>Stefanie</given-name><initials>S.</initials><afid>108062420</afid><afid>112788455</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6508160788</author-url><authid>6508160788</authid><authname>Straley K.</authname><surname>Straley</surname><given-name>Kimberly</given-name><initials>K.</initials><afid>108062420</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55637072800</author-url><authid>55637072800</authid><authname>Gliser C.</authname><surname>Gliser</surname><given-name>Camelia</given-name><initials>C.</initials><afid>108062420</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56480865100</author-url><authid>56480865100</authid><authname>Yang H.</authname><surname>Yang</surname><given-name>Hua</given-name><initials>H.</initials><afid>108062420</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6507798067</author-url><authid>6507798067</authid><authname>Travins J.</authname><surname>Travins</surname><given-name>Jeremy</given-name><initials>J.</initials><afid>108062420</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:36949690100</author-url><authid>36949690100</authid><authname>Murray S.</authname><surname>Murray</surname><given-name>Stuart</given-name><initials>S.</initials><afid>108062420</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7006654720</author-url><authid>7006654720</authid><authname>Dorsch M.</authname><surname>Dorsch</surname><given-name>Marion</given-name><initials>M.</initials><afid>108062420</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:22033717500</author-url><authid>22033717500</authid><authname>Agresta S.</authname><surname>Agresta</surname><given-name>Sam</given-name><initials>S.</initials><afid>108062420</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7003786956</author-url><authid>7003786956</authid><authname>Schenkein D.</authname><surname>Schenkein</surname><given-name>David P.</given-name><initials>D.P.</initials><afid>108062420</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7006656574</author-url><authid>7006656574</authid><authname>Biller S.</authname><surname>Biller</surname><given-name>Scott A.</given-name><initials>S.A.</initials><afid>108062420</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:56481020300</author-url><authid>56481020300</authid><authname>Su S.</authname><surname>Su</surname><given-name>Shinsan M.</given-name><initials>S.M.</initials><afid>108062420</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:36077269600</author-url><authid>36077269600</authid><authname>Liu W.</authname><surname>Liu</surname><given-name>Wei</given-name><initials>W.</initials><afid>108062420</afid></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:35486402300</author-url><authid>35486402300</authid><authname>Yen K.</authname><surname>Yen</surname><given-name>Katharine E.</given-name><initials>K.E.</initials><afid>108062420</afid></author><intid>1034561457</intid><source-id>25454</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84920971147"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84920971147?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84920971147&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84920971147&amp;origin=inward"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84920971147</prism:url><dc:identifier>SCOPUS_ID:84920971147</dc:identifier><eid>2-s2.0-84920971147</eid><dc:title>Cytoadhesion of Plasmodium falciparum - Infected erythrocytes to chondroitin-4-sulfate is cooperative and shear enhanced</dc:title><dc:creator>Rieger H.</dc:creator><prism:publicationName>Blood</prism:publicationName><prism:issn>00064971</prism:issn><prism:eIssn>15280020</prism:eIssn><prism:volume>125</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>383-391</prism:pageRange><prism:coverDate>2015-08-08</prism:coverDate><prism:coverDisplayDate>8 August 2015</prism:coverDisplayDate><prism:doi>10.1182/blood-2014-03-561019</prism:doi><dc:description>© 2015 by The American Society of Hematology Infections with the human malaria parasite Plasmodium falciparum during pregnancy can lead to severe complications for both mother and child, resulting from the cytoadhesion of parasitized erythrocytes in the intervillous space of the placenta. Cytoadherence is conferred by the specific interaction of the parasite-encoded adhesin VAR2CSA with chondroitin-4-sulfate (CSA) present on placental proteoglycans. CSA presented elsewhere in the microvasculature does not afford VAR2CSA-mediated cytoadhesion of parasitized erythrocytes. To address the placenta-specific binding tropism, we investigated the effect of the receptor/ligand arrangement on cytoadhesion, using artificial membranes with different CSA spacing intervals.We found that cytoadhesion is strongly dependent on the CSA distance, with half-maximal adhesion occurring at a CSA distance of 9 ± 1 nm at all hydrodynamic conditions. Moreover, binding to CSA was cooperative and shear stress induced. These findings suggest that the CSA density, together with allosteric effects in VAR2CSA, aid in discriminating between different CSA milieus.</dc:description><citedby-count>2</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016908</affiliation-url><afid>60016908</afid><affilname>Universitat Heidelberg</affilname><name-variant>Universität Heidelberg</name-variant><affiliation-city>Heidelberg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016908</affiliation-url><afid>60016908</afid><affilname>Universitat Heidelberg</affilname><name-variant>Universität Heidelberg</name-variant><affiliation-city>Heidelberg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028263</affiliation-url><afid>60028263</afid><affilname>Saitama University</affilname><name-variant>Saitama University</name-variant><affiliation-city>Saitama</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030840</affiliation-url><afid>60030840</afid><affilname>Kobenhavns Universitet</affilname><name-variant>University of Copenhagen</name-variant><affiliation-city>Copenhagen</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60011001</affiliation-url><afid>60011001</afid><affilname>Kyoto University</affilname><name-variant>Kyoto University</name-variant><affiliation-city>Kyoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55337432200</author-url><authid>55337432200</authid><authname>Rieger H.</authname><surname>Rieger</surname><given-name>Harden</given-name><initials>H.</initials><afid>60016908</afid><afid>60016908</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55337432200</author-url><authid>55337432200</authid><authname>Rieger H.</authname><surname>Rieger</surname><given-name>Harden</given-name><initials>H.</initials><afid>60016908</afid><afid>60016908</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56481049700</author-url><authid>56481049700</authid><authname>Yoshikawa H.</authname><surname>Yoshikawa</surname><given-name>Hiroshi Y.</given-name><initials>H.Y.</initials><afid>60016908</afid><afid>60028263</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56481049700</author-url><authid>56481049700</authid><authname>Yoshikawa H.</authname><surname>Yoshikawa</surname><given-name>Hiroshi Y.</given-name><initials>H.Y.</initials><afid>60016908</afid><afid>60028263</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55365572000</author-url><authid>55365572000</authid><authname>Quadt K.</authname><surname>Quadt</surname><given-name>Katharina</given-name><initials>K.</initials><afid>60016908</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7402929540</author-url><authid>7402929540</authid><authname>Nielsen M.</authname><surname>Nielsen</surname><given-name>Morten A.</given-name><initials>M.A.</initials><afid>60030840</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7401448639</author-url><authid>7401448639</authid><authname>Sanchez C.</authname><surname>Sanchez</surname><given-name>Cecilia P.</given-name><initials>C.P.</initials><afid>60016908</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6602328173</author-url><authid>6602328173</authid><authname>Salanti A.</authname><surname>Salanti</surname><given-name>Ali</given-name><initials>A.</initials><afid>60030840</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7408425261</author-url><authid>7408425261</authid><authname>Tanaka M.</authname><surname>Tanaka</surname><given-name>Motomu</given-name><initials>M.</initials><afid>60016908</afid><afid>60011001</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7408425261</author-url><authid>7408425261</authid><authname>Tanaka M.</authname><surname>Tanaka</surname><given-name>Motomu</given-name><initials>M.</initials><afid>60016908</afid><afid>60011001</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7003535488</author-url><authid>7003535488</authid><authname>Lanzer M.</authname><surname>Lanzer</surname><given-name>Michael</given-name><initials>M.</initials><afid>60016908</afid></author><intid>534569742</intid><source-id>25454</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928884144"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928884144?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928884144&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928884144&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0168160515002330"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928884144</prism:url><dc:identifier>SCOPUS_ID:84928884144</dc:identifier><eid>2-s2.0-84928884144</eid><dc:title>Characterisation of biofilms formed by Lactobacillus plantarum WCFS1 and food spoilage isolates</dc:title><dc:creator>Fernández Ramírez M.</dc:creator><prism:publicationName>International Journal of Food Microbiology</prism:publicationName><prism:issn>01681605</prism:issn><prism:eIssn>18793460</prism:eIssn><prism:volume>207</prism:volume><prism:pageRange>23-29</prism:pageRange><prism:coverDate>2015-08-07</prism:coverDate><prism:coverDisplayDate>August 07, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijfoodmicro.2015.04.030</prism:doi><pii>S0168160515002330</pii><dc:description>© 2015 Elsevier B.V. Lactobacillus plantarum has been associated with food spoilage in a wide range of products and the biofilm growth mode has been implicated as a possible source of contamination.In this study we analysed the biofilm forming capacity of L. plantarum WCFS1 and six food spoilage isolates. Biofilm formation as quantified by crystal violet staining and colony forming units was largely affected by the medium composition, growth temperature and maturation time and by strain specific features. All strains showed highest biofilm formation in Brain Heart Infusion medium supplemented with manganese and glucose. For L. plantarum biofilms the crystal violet (CV) assay, that is routinely used to quantify total biofilm formation, correlates poorly with the number of culturable cells in the biofilm. This can in part be explained by cell death and lysis resulting in CV stainable material, conceivably extracellular DNA (eDNA), contributing to the extracellular matrix. The strain to strain variation may in part be explained by differences in levels of eDNA, likely as result of differences in lysis behaviour. In line with this, biofilms of all strains tested, except for one spoilage isolate, were sensitive to DNase treatment. In addition, biofilms were highly sensitive to treatment with Proteinase K suggesting a role for proteins and/or proteinaceous material in surface colonisation. This study shows the impact of a range of environmental factors and enzyme treatments on biofilm formation capacity for selected L. plantarum isolates associated with food spoilage, and may provide clues for disinfection strategies in food industry.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60084278</affiliation-url><afid>60084278</afid><affilname>TI Food and Nutrition</affilname><name-variant>TI Food and Nutrition</name-variant><affiliation-city>Wageningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004156</affiliation-url><afid>60004156</afid><affilname>Wageningen University and Research Centre</affilname><name-variant>Wageningen University and Research Centre</name-variant><affiliation-city>Wageningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004156</affiliation-url><afid>60004156</afid><affilname>Wageningen University and Research Centre</affilname><name-variant>Wageningen University and Research Centre</name-variant><affiliation-city>Wageningen</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56622994300</author-url><authid>56622994300</authid><authname>Fernández Ramírez M.</authname><surname>Fernández Ramírez</surname><given-name>Mónica D.</given-name><initials>M.D.</initials><afid>60084278</afid><afid>60004156</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56622994300</author-url><authid>56622994300</authid><authname>Fernández Ramírez M.</authname><surname>Fernández Ramírez</surname><given-name>Mónica D.</given-name><initials>M.D.</initials><afid>60084278</afid><afid>60004156</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003862754</author-url><authid>7003862754</authid><authname>Smid E.</authname><surname>Smid</surname><given-name>Eddy J.</given-name><initials>E.J.</initials><afid>60084278</afid><afid>60004156</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003862754</author-url><authid>7003862754</authid><authname>Smid E.</authname><surname>Smid</surname><given-name>Eddy J.</given-name><initials>E.J.</initials><afid>60084278</afid><afid>60004156</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006273828</author-url><authid>7006273828</authid><authname>Abee T.</authname><surname>Abee</surname><given-name>Tjakko</given-name><initials>T.</initials><afid>60084278</afid><afid>60004156</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7006273828</author-url><authid>7006273828</authid><authname>Abee T.</authname><surname>Abee</surname><given-name>Tjakko</given-name><initials>T.</initials><afid>60084278</afid><afid>60004156</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6507459104</author-url><authid>6507459104</authid><authname>Nierop Groot M.</authname><surname>Nierop Groot</surname><given-name>Masja N.</given-name><initials>M.N.</initials><afid>60084278</afid><afid>60004156</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6507459104</author-url><authid>6507459104</authid><authname>Nierop Groot M.</authname><surname>Nierop Groot</surname><given-name>Masja N.</given-name><initials>M.N.</initials><afid>60084278</afid><afid>60004156</afid></author><authkeywords>Biofilm | Dispersion | Food spoilage | Lactobacillus plantarum</authkeywords><intid>1535861328</intid><source-id>19760</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929575716"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929575716?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929575716&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929575716&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0300483X1500089X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929575716</prism:url><dc:identifier>SCOPUS_ID:84929575716</dc:identifier><eid>2-s2.0-84929575716</eid><dc:title>Stimulating basal mitochondrial respiration decreases doxorubicin apoptotic signaling in H9c2 cardiomyoblasts</dc:title><dc:creator>Deus C.</dc:creator><prism:publicationName>Toxicology</prism:publicationName><prism:issn>0300483X</prism:issn><prism:eIssn>18793185</prism:eIssn><prism:volume>334</prism:volume><prism:pageRange>1-11</prism:pageRange><prism:coverDate>2015-08-06</prism:coverDate><prism:coverDisplayDate>August 06, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.tox.2015.05.001</prism:doi><pii>S0300483X1500089X</pii><dc:description>© 2015 Elsevier Ireland Ltd. Doxorubicin (DOX) is currently used in cancer chemotherapy, however, its use often results in adverse effects highlighted by the development of cardiomyopathy and ultimately heart failure. Interestingly, DOX cardiotoxicity is decreased by resveratrol or by physical activity, suggesting that increased mitochondrial activity may be protective. Conversely, recent studies showed that troglitazone, a PPARγ agonist, increases the cytotoxicity of DOX against breast cancer cells by up-regulating mitochondrial biogenesis. The hypothesis for the current investigation was that DOX cytotoxicity in H9c2 cardiomyoblasts is decreased when mitochondrial capacity is increased. We focused on several end-points for DOX cytotoxicity, including loss of cell mass, apoptotic signaling and alterations of autophagic-related proteins. Our results show that a galactose-based, modified cell culture medium increased H9c2 basal mitochondrial respiration, protein content, and mtDNA copy number without increasing maximal or spare respiratory capacity. H9c2 cardiomyoblasts cultured in the galactose-modified media showed lower DOX-induced activation of the apoptotic pathway, measured by decreased caspase-3 and -9 activation, and lower p53 expression, although ultimately loss of cells was not prevented. Treatment with the PPARγ agonist troglitazone had no effect on DOX toxicity in this cardiac cell line, which agrees with the fact that troglitazone did not increase mitochondrial DNA content or capacity at the concentrations and duration of exposure used in this investigation. Our results show that mitochondrial remodeling caused by stimulating basal rates of oxidative phosphorylation decreased DOX-induced apoptotic signaling and increased DOX-induced autophagy in H9c2 cardiomyoblasts. The differential effect on cytotoxicity in cardiac versus breast cancer cell lines suggests a possible overall improvement in the clinical efficacy for doxorubicin in treating cancer.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020985</affiliation-url><afid>60020985</afid><affilname>Universidade de Coimbra</affilname><name-variant>Universidade de Coimbra</name-variant><affiliation-city>Coimbra</affiliation-city><affiliation-country>Portugal</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008772</affiliation-url><afid>60008772</afid><affilname>University of Minnesota Medical School</affilname><name-variant>Univ. of Minnesota Medical School</name-variant><affiliation-city>Minneapolis</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35798090400</author-url><authid>35798090400</authid><authname>Deus C.</authname><surname>Deus</surname><given-name>Cláudia M.</given-name><initials>C.M.</initials><afid>60020985</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56650971000</author-url><authid>56650971000</authid><authname>Zehowski C.</authname><surname>Zehowski</surname><given-name>Cheryl</given-name><initials>C.</initials><afid>60008772</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:41862300700</author-url><authid>41862300700</authid><authname>Nordgren K.</authname><surname>Nordgren</surname><given-name>Kendra</given-name><initials>K.</initials><afid>60008772</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56650646300</author-url><authid>56650646300</authid><authname>Wallace K.</authname><surname>Wallace</surname><given-name>Kendall B.</given-name><initials>K.B.</initials><afid>60008772</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:8765437000</author-url><authid>8765437000</authid><authname>Skildum A.</authname><surname>Skildum</surname><given-name>Andrew</given-name><initials>A.</initials><afid>60008772</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55751743890</author-url><authid>55751743890</authid><authname>Oliveira P.</authname><surname>Oliveira</surname><given-name>Paulo J.</given-name><initials>P.J.</initials><afid>60020985</afid></author><authkeywords>Doxorubicin | H9c2 myoblasts | Mitochondrial capacity | Toxicity | Troglitazone</authkeywords><intid>1785982698</intid><source-id>25219</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929583357"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929583357?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929583357&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929583357&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0306452215004364"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929583357</prism:url><dc:identifier>SCOPUS_ID:84929583357</dc:identifier><eid>2-s2.0-84929583357</eid><dc:title>Covariation of pupillary and auditory cortical activity in rats under isoflurane anesthesia</dc:title><dc:creator>Takahashi H.</dc:creator><prism:publicationName>Neuroscience</prism:publicationName><prism:issn>03064522</prism:issn><prism:eIssn>18737544</prism:eIssn><prism:volume>300</prism:volume><prism:pageRange>29-38</prism:pageRange><prism:coverDate>2015-08-06</prism:coverDate><prism:coverDisplayDate>August 06, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neuroscience.2015.05.004</prism:doi><pii>S0306452215004364</pii><dc:description>© 2015 IBRO. Very slow fluctuations of spontaneous activities significantly influence not only behavioral performance in a conscious state, but also neural activities in an unconscious state. Covariation of pupil and cortical activities may lend important insights into the state-dependent modulation of stimulus encoding, yet this phenomenon has received little attention, especially with regard to non-visual cortices. In the present study, we investigated co-fluctuation of pupil size and neural activity in the auditory cortex of rats under isoflurane anesthesia. Pupil fluctuation consisted of longitudinal irregular shifts, and 1-min cyclic modulations. Both spontaneous and auditory-evoked potentials (AEPs) covaried with the longitudinal fluctuation of pupil size, but not with the 1-min cycle. Pupil size exhibited a positive correlation with spontaneous activity and negative correlation with AEP amplitude, particularly when the pupil size was beyond the normal range. Stimulus-specific adaptation characterized using an oddball paradigm was less dependent on pupil size than AEP. In contrast to the cortical activity, heart rate covaried with pupil size with the 1-min oscillatory component, but not the non-oscillatory component. Furthermore, light exposure induced the pupil reflex through the autonomic system, but did not modify cortical activity, indicating that autonomic activity was not causing the cortical modulation. These results together suggest that cortical activities spontaneously covary with pupillary activity through central cholinergic modulation that triggers sympathetic nerve activation. Such a state-dependent property may be a confounding factor in cortical electrophysiology studies.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025272</affiliation-url><afid>60025272</afid><affilname>University of Tokyo</affilname><name-variant>University of Tokyo</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60103899</affiliation-url><afid>60103899</afid><affilname>University of Tokyo, Research Center for Advanced Science and Technology</affilname><name-variant>University of Tokyo</name-variant><affiliation-city/><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55711761700</author-url><authid>55711761700</authid><authname>Takahashi H.</authname><surname>Takahashi</surname><given-name>H.</given-name><initials>H.</initials><afid>60025272</afid><afid>60103899</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55711761700</author-url><authid>55711761700</authid><authname>Takahashi H.</authname><surname>Takahashi</surname><given-name>H.</given-name><initials>H.</initials><afid>60025272</afid><afid>60103899</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56650831300</author-url><authid>56650831300</authid><authname>Tokushige H.</authname><surname>Tokushige</surname><given-name>H.</given-name><initials>H.</initials><afid>60025272</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55839494200</author-url><authid>55839494200</authid><authname>Shiramatsu T.</authname><surname>Shiramatsu</surname><given-name>T. I.</given-name><initials>T.I.</initials><afid>60025272</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56650552100</author-url><authid>56650552100</authid><authname>Noda T.</authname><surname>Noda</surname><given-name>T.</given-name><initials>T.</initials><afid>60025272</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:18133980000</author-url><authid>18133980000</authid><authname>Kanzaki R.</authname><surname>Kanzaki</surname><given-name>R.</given-name><initials>R.</initials><afid>60025272</afid><afid>60103899</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:18133980000</author-url><authid>18133980000</authid><authname>Kanzaki R.</authname><surname>Kanzaki</surname><given-name>R.</given-name><initials>R.</initials><afid>60025272</afid><afid>60103899</afid></author><authkeywords>Auditory cortex | Auditory-evoked potential (AEP) | Isoflurane | Pupil | Spontaneous activity | Stimulus-specific adaptation (SSA)</authkeywords><intid>35981342</intid><source-id>18042</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929316985"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929316985?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929316985&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929316985&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0306452215004194"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929316985</prism:url><dc:identifier>SCOPUS_ID:84929316985</dc:identifier><eid>2-s2.0-84929316985</eid><dc:title>MTHFR deficiency or reduced intake of folate or choline in pregnant mice results in impaired short-term memory and increased apoptosis in the hippocampus of wild-type offspring</dc:title><dc:creator>Jadavji N.</dc:creator><prism:publicationName>Neuroscience</prism:publicationName><prism:issn>03064522</prism:issn><prism:eIssn>18737544</prism:eIssn><prism:volume>300</prism:volume><prism:pageRange>1-9</prism:pageRange><prism:coverDate>2015-08-06</prism:coverDate><prism:coverDisplayDate>August 06, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.neuroscience.2015.04.067</prism:doi><pii>S0306452215004194</pii><dc:description>© 2015 IBRO. Genetic or nutritional disturbances in one-carbon metabolism, with associated hyperhomocysteinemia, can result in complex disorders including pregnancy complications and neuropsychiatric diseases. In earlier work, we showed that mice with a complete deficiency of methylenetetrahydrofolate reductase (MTHFR), a critical enzyme in folate and homocysteine metabolism, had cognitive impairment with disturbances in choline metabolism. Maternal demands for folate and choline are increased during pregnancy and deficiencies of these nutrients result in several negative outcomes including increased resorption and delayed development. The goal of this study was to investigate the behavioral and neurobiological impact of a maternal genetic deficiency in MTHFR or maternal nutritional deficiency of folate or choline during pregnancy on 3-week-old Mthfr&lt;sup&gt;+/+&lt;/sup&gt; offspring. Mthfr&lt;sup&gt;+/+&lt;/sup&gt; and Mthfr&lt;sup&gt;+/-&lt;/sup&gt; females were placed on control diets (CD); and Mthfr&lt;sup&gt;+/+&lt;/sup&gt; females were placed on folate-deficient diets (FD) or choline-deficient diets (ChDD) throughout pregnancy and lactation until their offspring were 3weeks of age. Short-term memory was assessed in offspring, and hippocampal tissue was evaluated for morphological changes, apoptosis, proliferation and choline metabolism. Maternal MTHFR deficiency resulted in short-term memory impairment in offspring. These dams had elevated levels of plasma homocysteine when compared with wild-type dams. There were no differences in plasma homocysteine in offspring. Increased apoptosis and proliferation was observed in the hippocampus of offspring from Mthfr&lt;sup&gt;+/-&lt;/sup&gt; mothers. In the maternal FD and ChDD study, offspring also showed short-term memory impairment with increased apoptosis in the hippocampus; increased neurogenesis was observed in ChDD offspring. Choline acetyltransferase protein was increased in the offspring hippocampus of both dietary groups and betaine was decreased in the hippocampus of FD offspring. Our results reveal short-term memory deficits in the offspring of dams with MTHFR deficiency or dietary deficiencies of critical methyl donors. We suggest that deficiencies in maternal one-carbon metabolism during pregnancy can contribute to hippocampal dysfunction in offspring through apoptosis or altered choline metabolism.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006558</affiliation-url><afid>60006558</afid><affilname>McGill University Health Centre, Montreal</affilname><name-variant>McGill University Health Centre</name-variant><affiliation-city>Montreal</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007776</affiliation-url><afid>60007776</afid><affilname>Cornell University</affilname><name-variant>Cornell University</name-variant><affiliation-city>Ithaca</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8866064800</author-url><authid>8866064800</authid><authname>Jadavji N.</authname><surname>Jadavji</surname><given-name>N. M.</given-name><initials>N.M.</initials><afid>60006558</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56622006500</author-url><authid>56622006500</authid><authname>Deng L.</authname><surname>Deng</surname><given-name>L.</given-name><initials>L.</initials><afid>60006558</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55188666300</author-url><authid>55188666300</authid><authname>Malysheva O.</authname><surname>Malysheva</surname><given-name>O.</given-name><initials>O.</initials><afid>60007776</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7004293356</author-url><authid>7004293356</authid><authname>Caudill M.</authname><surname>Caudill</surname><given-name>M. A.</given-name><initials>M.A.</initials><afid>60007776</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7102522469</author-url><authid>7102522469</authid><authname>Rozen R.</authname><surname>Rozen</surname><given-name>R.</given-name><initials>R.</initials><afid>60006558</afid></author><authkeywords>Apoptosis | Maternal choline deficiency | Maternal folate deficiency | MTHFR deficiency | Short-term memory</authkeywords><intid>2035939371</intid><source-id>18042</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929399034"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929399034?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929399034&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929399034&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0304423815002435"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929399034</prism:url><dc:identifier>SCOPUS_ID:84929399034</dc:identifier><eid>2-s2.0-84929399034</eid><dc:title>Interacting effects of high light and elevated CO&lt;inf&gt;2&lt;/inf&gt; on the nutraceutical quality of two differently pigmented Lactuca sativa cultivars (Blonde of Paris Batavia and Oak Leaf)</dc:title><dc:creator>Pérez-López U.</dc:creator><prism:publicationName>Scientia Horticulturae</prism:publicationName><prism:issn>03044238</prism:issn><prism:volume>191</prism:volume><prism:pageRange>38-48</prism:pageRange><prism:coverDate>2015-08-06</prism:coverDate><prism:coverDisplayDate>August 06, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.scienta.2015.04.030</prism:doi><pii>S0304423815002435</pii><dc:description>© 2015 Elsevier B.V. This study presents changes in the nutraceutical quality and biomass production of two differently pigmented Lactuca sativa (L.) cultivars grown under various combinations of high light (700μmolphotonsm&lt;sup&gt;-2&lt;/sup&gt;s&lt;sup&gt;-1&lt;/sup&gt;) and elevated CO&lt;inf&gt;2&lt;/inf&gt; (700μmolmol&lt;sup&gt;-1&lt;/sup&gt;) conditions. In an ambient CO&lt;inf&gt;2&lt;/inf&gt; atmosphere, high light intensity increased biomass production in the green cultivar (Blonde of Paris Batavia) but not in the red cultivar (Oak Leaf). In both cultivars, high light intensity increased the concentration of soluble proteins and sugars. High light intensities also increased the levels of carotenoids, glutathione, total phenols and anthocyanins, which was most likely due to oxidative stress. Conversely, the levels of almost all minerals remained unchanged compared with the values detected for control light intensity and ambient CO&lt;inf&gt;2&lt;/inf&gt; conditions. When a high light intensity was applied at elevated CO&lt;inf&gt;2&lt;/inf&gt; conditions, the biomass production increased in both cultivars. The concentrations of minerals (except Fe and Mg), glutathione and ascorbate remained constant compared with the high light and ambient CO&lt;inf&gt;2&lt;/inf&gt; conditions, which indicated that these components and biomass accumulated at comparable rates. The decreases in the levels of Chl-a, carotenoids, total phenols and anthocyanins in response to elevated CO&lt;inf&gt;2&lt;/inf&gt; levels at high light conditions could indicate a relief of oxidative stress due to an improved balance between ATP and NADPH production and consumption at elevated CO&lt;inf&gt;2&lt;/inf&gt; levels. These results demonstrate that the biomass production and the nutritional quality of lettuce can be improved, but the response is cultivar-specific, and the choice of the best cultivation practice (using high light intensity alone or in combination with elevated CO&lt;inf&gt;2&lt;/inf&gt; levels) depends on the attributes that are targeted for improvement.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027856</affiliation-url><afid>60027856</afid><affilname>Universidad del Pais Vasco</affilname><name-variant>Universidad del País Vasco</name-variant><affiliation-city>Leioa</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15766132700</author-url><authid>15766132700</authid><authname>Pérez-López U.</authname><surname>Pérez-López</surname><given-name>Usue</given-name><initials>U.</initials><afid>60027856</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:37011086500</author-url><authid>37011086500</authid><authname>Miranda-Apodaca J.</authname><surname>Miranda-Apodaca</surname><given-name>Jon</given-name><initials>J.</initials><afid>60027856</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603462507</author-url><authid>6603462507</authid><authname>Muñoz-Rueda A.</authname><surname>Muñoz-Rueda</surname><given-name>Alberto</given-name><initials>A.</initials><afid>60027856</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:6506338192</author-url><authid>6506338192</authid><authname>Mena-Petite A.</authname><surname>Mena-Petite</surname><given-name>Amaia</given-name><initials>A.</initials><afid>60027856</afid></author><authkeywords>Antioxidants | Elevated CO&lt;inf&gt;2&lt;/inf&gt; | High light | Lettuce | Minerals | Nutraceutical value</authkeywords><intid>35954300</intid><source-id>26751</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929579542"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929579542?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929579542&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929579542&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0300483X15000906"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929579542</prism:url><dc:identifier>SCOPUS_ID:84929579542</dc:identifier><eid>2-s2.0-84929579542</eid><dc:title>The relationship between selected VDR, HFE and ALAD gene polymorphisms and several basic toxicological parameters among persons occupationally exposed to lead</dc:title><dc:creator>Szymańska-Chabowska A.</dc:creator><prism:publicationName>Toxicology</prism:publicationName><prism:issn>0300483X</prism:issn><prism:eIssn>18793185</prism:eIssn><prism:volume>334</prism:volume><prism:pageRange>12-21</prism:pageRange><prism:coverDate>2015-08-06</prism:coverDate><prism:coverDisplayDate>August 06, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.tox.2015.05.002</prism:doi><pii>S0300483X15000906</pii><dc:description>© 2015 Elsevier Ireland Ltd. The aim of this study was to find a relationship between polymorphisms of ALAD rs1805313, rs222808, rs1139488, VDR FokI and HFE C282Y and H63D and basic toxicological parameters (lead and ZnPP blood concentration) in people occupationally exposed to lead. We collected data of 101 workers (age 25-63 years) directly exposed to lead. The toxicological lab tests included blood lead, cadmium and ZnPP concentration measurement and arsenic urine concentration measurement. Workers were genotyped for ALAD (rs1805313, rs222808, rs1139488), HFE (C282Y, H63D) and VDR (FokI). Individuals with the lead exposure and coexisting F allel in the locus Fok-I of VDR gene are suspected of higher zinc protoporphyrins concentrations. Workers exposed to the lead with the Y allel in the locus C282Y of the HFE gene are predisposed to lower ZnPP levels and individuals with coexisting H allel in the locus H63D HFE gene are predisposed to lower Pb-B levels. The T allel in the locus rs1805313 of the ALAD gene determines lower Pb-B and ZnPP levels in lead-exposed individuals. The heterozigosity of the locus rs2228083 of the ALAD gene has a strong predilection to higher Pb-B levels. The carriage of the C allel in the locus rs1139488 of the ALAD gene might determine higher Pb-B levels and the heterozigosity of the locus rs1139488 of the ALAD gene might result in higher ZnPP levels. Conclusion. The study revealed relationship between VDR, HFE and ALAD genes polymorphism and basic toxicological parameters in occupationally exposed workers.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007108</affiliation-url><afid>60007108</afid><affilname>AKademia Medyczna Wroclawiu</affilname><name-variant>Wroclaw Medical University</name-variant><affiliation-city>Wroclaw</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007108</affiliation-url><afid>60007108</afid><affilname>AKademia Medyczna Wroclawiu</affilname><name-variant>Wroclaw Medical University</name-variant><affiliation-city>Wroclaw</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60086276</affiliation-url><afid>60086276</afid><affilname>4th Military Clinical Hospital, Wroclaw</affilname><name-variant>4th Military Clinical Hospital</name-variant><affiliation-city>Wroclaw</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60086276</affiliation-url><afid>60086276</afid><affilname>4th Military Clinical Hospital, Wroclaw</affilname><name-variant>4th Military Clinical Hospital</name-variant><affiliation-city>Wroclaw</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6507820527</author-url><authid>6507820527</authid><authname>Szymańska-Chabowska A.</authname><surname>Szymańska-Chabowska</surname><given-name>Anna</given-name><initials>A.</initials><afid>60007108</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:22934825800</author-url><authid>22934825800</authid><authname>Łaczmański Ł.</authname><surname>Łaczmański</surname><given-name>Łukasz</given-name><initials>Ł.</initials><afid>60007108</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23392583000</author-url><authid>23392583000</authid><authname>Jedrychowska I.</authname><surname>Jedrychowska</surname><given-name>Iwona</given-name><initials>I.</initials><afid>60007108</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56650849600</author-url><authid>56650849600</authid><authname>Chabowski M.</authname><surname>Chabowski</surname><given-name>Mariusz</given-name><initials>M.</initials><afid>60086276</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:14037331200</author-url><authid>14037331200</authid><authname>Gać P.</authname><surname>Gać</surname><given-name>Paweł</given-name><initials>P.</initials><afid>60007108</afid><afid>60086276</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:14037331200</author-url><authid>14037331200</authid><authname>Gać P.</authname><surname>Gać</surname><given-name>Paweł</given-name><initials>P.</initials><afid>60007108</afid><afid>60086276</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:9036359800</author-url><authid>9036359800</authid><authname>Janus A.</authname><surname>Janus</surname><given-name>Agnieszka</given-name><initials>A.</initials><afid>60007108</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56459097400</author-url><authid>56459097400</authid><authname>Gosławska K.</authname><surname>Gosławska</surname><given-name>Katarzyna</given-name><initials>K.</initials><afid>60007108</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56650850700</author-url><authid>56650850700</authid><authname>Smyk B.</authname><surname>Smyk</surname><given-name>Beata</given-name><initials>B.</initials><afid>60007108</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:24403093000</author-url><authid>24403093000</authid><authname>Solska U.</authname><surname>Solska</surname><given-name>Urszula</given-name><initials>U.</initials><afid>60007108</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7004867939</author-url><authid>7004867939</authid><authname>Mazur G.</authname><surname>Mazur</surname><given-name>Grzegorz</given-name><initials>G.</initials><afid>60007108</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7004954646</author-url><authid>7004954646</authid><authname>Poreba R.</authname><surname>Poreba</surname><given-name>Rafał</given-name><initials>R.</initials><afid>60007108</afid></author><authkeywords>Gene polymorphisms | Lead | Occupationally exposure</authkeywords><intid>1785982675</intid><source-id>25219</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84918505143"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84918505143?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84918505143&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84918505143&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0378517314008497"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84918505143</prism:url><dc:identifier>SCOPUS_ID:84918505143</dc:identifier><eid>2-s2.0-84918505143</eid><dc:title>Size and diffusion phenomena of AOT/alcohol/water system in the presence of morin by dynamic light scattering</dc:title><dc:creator>Bhattarai A.</dc:creator><prism:publicationName>International Journal of Pharmaceutics</prism:publicationName><prism:issn>03785173</prism:issn><prism:eIssn>18733476</prism:eIssn><prism:volume>478</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>610-616</prism:pageRange><prism:coverDate>2015-08-06</prism:coverDate><prism:coverDisplayDate>6 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijpharm.2014.11.037</prism:doi><pii>S0378517314008497</pii><dc:description>© 2014 Elsevier B.V. All rights reserved. Presented paper is a continuation of our studies on morin interaction with AOT (sodium bis(2-ethylhexyl) sulfosuccinate) reversed micelles solutions in two solvents: ethanol and n-decanol. Now we focused on morin influence on size and diffusion phenomena in the system morin/solvent/AOT/water. In this paper precise measurements of dynamic light scattering (DLS) of the effects of temperature, solvents (alcohols), water on the size and diffusion of AOT reversed micelles in the morin/AOT/alcohol/water system are reported. The concentrations of AOT were varied from 0.51 to 0.78 mol/L. Morin concentration in during auto-correlation function registration was not the same in each solvent because of its different solubility depending on the solvent. Water concentration in the studied systems was defined by R parameter according to relation: R = (H2O)/(AOT) and was equal 0 and 30 in ethanol, and 0 in n-decanol. DLS measurements were done at 298.15 and 308.15 K. DLS experiment involved on detection two relaxation modes (fast and slow) in the systems containing AOT reversed micelles, water, morin and solvents (ethanol and n-decanol). The DLS data clearly show the solvent influence as well as morin presence on AOT reversed micelles size and consequently their diffusion coefficients. Contrary to n-decanol strong competition between morin and ethanol molecules in AOT reversed micelles palisade layer has been found. It suggests that morin molecules replaced ethanol in AOT reversed micelles and locate in their palisade layer strongly increasing AOT reversed micelles size. Furthermore, it was found a sharp increase in correlation radii of slow modes of AOT reversed micelles containing morin molecules and their diffusion coefficients diminishing.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013756</affiliation-url><afid>60013756</afid><affilname>Uniwersytet Warszawski</affilname><name-variant>Warsaw University</name-variant><affiliation-city>Warsaw</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:14826484900</author-url><authid>14826484900</authid><authname>Bhattarai A.</authname><surname>Bhattarai</surname><given-name>Ajaya</given-name><initials>A.</initials><afid>60013756</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506101078</author-url><authid>6506101078</authid><authname>Wilczura-Wachnik H.</authname><surname>Wilczura-Wachnik</surname><given-name>Hanna</given-name><initials>H.</initials><afid>60013756</afid></author><authkeywords>DLS | Ethanol | Hydrodynamic radius | Morin | n-Decanol | Surfactant</authkeywords><intid>1034158372</intid><source-id>22454</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928910473"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928910473?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928910473&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928910473&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014299915003271"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928910473</prism:url><dc:identifier>SCOPUS_ID:84928910473</dc:identifier><eid>2-s2.0-84928910473</eid><dc:title>Vasopressin attenuates ischemia-reperfusion injury via reduction of oxidative stress and inhibition of mitochondrial permeability transition pore opening in rat hearts</dc:title><dc:creator>Nazari A.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>760</prism:volume><prism:pageRange>96-102</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>5 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.04.006</prism:doi><pii>S0014299915003271</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Aim of this study was to investigate the involvement of the mitochondrial permeability transition pore (MPTP) and oxidative stress in the cardioprotective effect of vasopressin (AVP) on ischemia/reperfusion (I/R) injury. Anesthetized male wistar rats were subjected to regional 30 min ischemia and 120 min reperfusion and randomly divided into nine groups: (1) Control; saline was administered intravenously before ischemia, (2) vasopressin was administrated 10 min prior to ischemia, (3, 4) Atractyloside as MPTP opener, was injected 5 min prior to reperfusion without and with vasopressin, (5, 6) Cyclosporine A as a MPTP closer, was injected 5 min prior to reperfusion without and with vasopressin, (7) mitochondria were isolated from control group and CaCl&lt;inf&gt;2&lt;/inf&gt; was added as MPTP opener and swelling inducer, (8) isolated mitochondria from Control hearts was incubated with Cyclosporine A before adding the CaCl&lt;inf&gt;2&lt;/inf&gt; (9) CaCl&lt;inf&gt;2&lt;/inf&gt; was added to isolated mitochondria from vasopressin group. Infusion of vasopressin decreased infarct size (18.6±1.7% vs. control group 37.6±2.4%), biochemical parameters [LDH (Lactate Dehydrogenase), CK-MB (Creatine Kinase-MB) and MDA (Malondialdehyde) plasma levels, PAB (Prooxidant-antioxidant balance)] compared to control group. Atactyloside suppressed the cardioprotective effect of vasopressin (32.5±1.9% vs. 18.6±1.7%) but administration of the Cyclosporine A without and with vasopressin significantly reduced infarct size to 17.7±4% (P&lt;0.001) and 22.7±3% (P&lt;0.01) respectively, vs. 37.6±2.4% in control group. Also, vasopressin, similar to Cyclosporine A, led to decrease in CaCl&lt;inf&gt;2&lt;/inf&gt;-induced swelling. It seems that vasopressin through antioxidant effect and MPTP inhibition has created a cardioprotection against ischemia/reperfusion injuries.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015746</affiliation-url><afid>60015746</afid><affilname>Lorestan University of Medical Sciences</affilname><name-variant>Lorestan University of Medical Sciences</name-variant><affiliation-city/><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027708</affiliation-url><afid>60027708</afid><affilname>Tehran University of Medical Sciences</affilname><name-variant>Tehran University of Medical Sciences</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027708</affiliation-url><afid>60027708</afid><affilname>Tehran University of Medical Sciences</affilname><name-variant>Tehran University of Medical Sciences</name-variant><affiliation-city>Tehran</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012874</affiliation-url><afid>60012874</afid><affilname>Zanjan University of Medical Sciences</affilname><name-variant>Zanjan University of Medical Sciences</name-variant><affiliation-city>Zanjan</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60016689</affiliation-url><afid>60016689</afid><affilname>Golestan University of Medical Sciences</affilname><name-variant>Gorgan University of Medical Sciences</name-variant><affiliation-city>Gorgan</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021948</affiliation-url><afid>60021948</afid><affilname>Shiraz University of Medical Sciences</affilname><name-variant>Shiraz University of Medical Sciences</name-variant><affiliation-city>Shiraz</affiliation-city><affiliation-country>Iran</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56541019600</author-url><authid>56541019600</authid><authname>Nazari A.</authname><surname>Nazari</surname><given-name>Afshin</given-name><initials>A.</initials><afid>60015746</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55403576600</author-url><authid>55403576600</authid><authname>Sadr S.</authname><surname>Sadr</surname><given-name>Seyed Shahabeddin</given-name><initials>S.S.</initials><afid>60027708</afid><afid>60027708</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55403576600</author-url><authid>55403576600</authid><authname>Sadr S.</authname><surname>Sadr</surname><given-name>Seyed Shahabeddin</given-name><initials>S.S.</initials><afid>60027708</afid><afid>60027708</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:23666909200</author-url><authid>23666909200</authid><authname>Faghihi M.</authname><surname>Faghihi</surname><given-name>Mahdieh</given-name><initials>M.</initials><afid>60027708</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36086110800</author-url><authid>36086110800</authid><authname>Azizi Y.</authname><surname>Azizi</surname><given-name>Yaser</given-name><initials>Y.</initials><afid>60027708</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56622227700</author-url><authid>56622227700</authid><authname>Hosseini M.</authname><surname>Hosseini</surname><given-name>Mir Jamal</given-name><initials>M.J.</initials><afid>60012874</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36190265900</author-url><authid>36190265900</authid><authname>Mobarra N.</authname><surname>Mobarra</surname><given-name>Naser</given-name><initials>N.</initials><afid>60016689</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56622516800</author-url><authid>56622516800</authid><authname>Tavakoli A.</authname><surname>Tavakoli</surname><given-name>Asadollah</given-name><initials>A.</initials><afid>60021948</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:23667734000</author-url><authid>23667734000</authid><authname>Imani A.</authname><surname>Imani</surname><given-name>Alireza</given-name><initials>A.</initials><afid>60027708</afid></author><authkeywords>Free radical | Heart | Ischemia/reperfusion | Mitochondrial swelling | Vasopressin</authkeywords><intid>1535860947</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928887184"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928887184?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928887184&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928887184&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014299915003313"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928887184</prism:url><dc:identifier>SCOPUS_ID:84928887184</dc:identifier><eid>2-s2.0-84928887184</eid><dc:title>Differences in the profile of protection afforded by TRO40303 and mild hypothermia in models of cardiac ischemia/reperfusion injury</dc:title><dc:creator>Hansson M.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>760</prism:volume><prism:pageRange>7-19</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>5 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.04.009</prism:doi><pii>S0014299915003313</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. The mode of protection against cardiac reperfusion injury by mild hypothermia and TRO40303 was investigated in various experimental models and compared to MitoQ in vitro. In isolated cardiomyocytes subjected to hypoxia/reoxygenation, TRO40303, MitoQ and mild hypothermia delayed mPTP opening, inhibited generation of mitochondrial superoxide anions at reoxygenation and improved cell survival. Mild hypothermia, but not MitoQ and TRO40303, provided protection in a metabolic starvation model in H9c2 cells and preserved respiratory function in isolated rat heart mitochondria submitted to anoxia/reoxygenation. In the Langendorff-perfused rat heart, only mild hypothermia provided protection of hemodynamic function and reduced infarct size following ischemia/reperfusion. In biopsies from the left ventricle of pigs subjected to in vivo occlusion/reperfusion, TRO40303 specifically preserved respiratory functions in the peri-infarct zone whereas mild hypothermia preserved both the ischemic core area and the peri-infarct zones. Additionally in this pig model, only hypothermia reduced infarct size. We conclude that mild hypothermia provided protection in all models by reducing the detrimental effects of ischemia, and when initiated before occlusion, reduced subsequent reperfusion damage leading to a smaller infarct. By contrast, although TRO40303 provided similar protection to MitoQ in vitro and offered specific protection against some aspects of reperfusion injury in vivo, this was insufficient to reduce infarct size.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029170</affiliation-url><afid>60029170</afid><affilname>Lunds Universitet</affilname><name-variant>University of Lund</name-variant><affiliation-city>Lund</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020650</affiliation-url><afid>60020650</afid><affilname>University of Bristol</affilname><name-variant>University of Bristol</name-variant><affiliation-city>Bristol</affiliation-city><affiliation-country>United Kingdom</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60085092</affiliation-url><afid>60085092</afid><affilname>Universite Paris-Est</affilname><name-variant>Université Paris-Est</name-variant><affiliation-city>Marne-la-Vallee</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>Luminy Biotech Entreprises</affilname><name-variant>Trophos</name-variant><affiliation-city>Marseille Cedex 9</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029170</affiliation-url><afid>60029170</afid><affilname>Lunds Universitet</affilname><name-variant>University of Lund</name-variant><affiliation-city>Lund</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029170</affiliation-url><afid>60029170</afid><affilname>Lunds Universitet</affilname><name-variant>University of Lund</name-variant><affiliation-city>Lund</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7102798410</author-url><authid>7102798410</authid><authname>Hansson M.</authname><surname>Hansson</surname><given-name>Magnus J.</given-name><initials>M.J.</initials><afid>60029170</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56623196400</author-url><authid>56623196400</authid><authname>Llwyd O.</authname><surname>Llwyd</surname><given-name>Osian</given-name><initials>O.</initials><afid>60020650</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7101955826</author-url><authid>7101955826</authid><authname>Morin D.</authname><surname>Morin</surname><given-name>Didier</given-name><initials>D.</initials><afid>60085092</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:51664929800</author-url><authid>51664929800</authid><authname>De Paulis D.</authname><surname>De Paulis</surname><given-name>Damien</given-name><initials>D.</initials><afid/></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:13614379400</author-url><authid>13614379400</authid><authname>Arnoux T.</authname><surname>Arnoux</surname><given-name>Thomas</given-name><initials>T.</initials><afid/></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6507531227</author-url><authid>6507531227</authid><authname>Gouarné C.</authname><surname>Gouarné</surname><given-name>Caroline</given-name><initials>C.</initials><afid/></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35487941200</author-url><authid>35487941200</authid><authname>Koul S.</authname><surname>Koul</surname><given-name>Sasha</given-name><initials>S.</initials><afid>60029170</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:35609712800</author-url><authid>35609712800</authid><authname>Engblom H.</authname><surname>Engblom</surname><given-name>Henrik</given-name><initials>H.</initials><afid>60029170</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6505894561</author-url><authid>6505894561</authid><authname>Bordet T.</authname><surname>Bordet</surname><given-name>Thierry</given-name><initials>T.</initials><afid/></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55903839100</author-url><authid>55903839100</authid><authname>Tissier R.</authname><surname>Tissier</surname><given-name>Renaud</given-name><initials>R.</initials><afid>60085092</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:6701346483</author-url><authid>6701346483</authid><authname>Arheden H.</authname><surname>Arheden</surname><given-name>Haakan</given-name><initials>H.</initials><afid>60029170</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7005319185</author-url><authid>7005319185</authid><authname>Erlinge D.</authname><surname>Erlinge</surname><given-name>David</given-name><initials>D.</initials><afid>60029170</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:56622565500</author-url><authid>56622565500</authid><authname>Halestrap A.</authname><surname>Halestrap</surname><given-name>Andrew P.</given-name><initials>A.P.</initials><afid>60020650</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:55229994500</author-url><authid>55229994500</authid><authname>Berdeaux A.</authname><surname>Berdeaux</surname><given-name>Alain</given-name><initials>A.</initials><afid>60085092</afid></author><author seq="15"><author-url>http://api.elsevier.com/content/author/author_id:35243350500</author-url><authid>35243350500</authid><authname>Pruss R.</authname><surname>Pruss</surname><given-name>Rebecca M.</given-name><initials>R.M.</initials><afid/></author><author seq="16"><author-url>http://api.elsevier.com/content/author/author_id:10540870300</author-url><authid>10540870300</authid><authname>Schaller S.</authname><surname>Schaller</surname><given-name>Sophie</given-name><initials>S.</initials><afid/></author><authkeywords>Mode of protection | Myocardial infarction | Reperfusion injury</authkeywords><intid>2035856638</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929485452"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929485452?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929485452&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929485452&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014299915003325"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929485452</prism:url><dc:identifier>SCOPUS_ID:84929485452</dc:identifier><eid>2-s2.0-84929485452</eid><dc:title>Possible mechanisms of C-reactive protein mediated acute myocardial infarction</dc:title><dc:creator>Fordjour P.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>760</prism:volume><prism:pageRange>72-80</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>5 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.04.010</prism:doi><pii>S0014299915003325</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Abstract Myocardial infarction is a relevant cardiovascular event worldwide for morbidity and mortality. It has been theorized that acute myocardial infarctions (AMIs) and other acute coronary events that are precipitated by atherosclerosis are due to arterial blockage from fat deposits. It is now known, however, that atherosclerosis involves more than just lipids. Inflammation has also been studied extensively to play a substantial role in myocardial infarction. There have been debates and conflicting reports over the past few years about the value of assessing levels of C-reactive protein and other biomarkers of inflammation for the prediction of cardiovascular events. Several studies have shown that CRP is not only an inflammatory marker, but also involved in the pathogenesis of myocardial infarction. Studies have linked atherogenesis and rupture of atherosclerotic lesion to endothelial dysfunction. CRP directly inhibits endothelial cell nitric oxide (NO) production via destabilizing endothelial NO synthase (eNOS). Decreased NO release causes CRP mediated inhibition of angiogenesis, stimulating endothelial cell apoptosis. CRP can also activate the complement system through the classical pathway. Complement activation plays an important role in mediating monocyte and neutrophil recruitment in an injured myocardium and may therefore lead to increase in infarct size. This article discusses the possible roles of CRP in complement activation, endothelial dysfunction and its impact on the development of myocardial infarction. We also reviewed the possible therapeutic approaches to myocardial infarction.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012594</affiliation-url><afid>60012594</afid><affilname>Tianjin University of Traditional Chinese Medicine</affilname><name-variant>Tianjin University of Traditional Chinese Medicine</name-variant><affiliation-city>Tianjin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012594</affiliation-url><afid>60012594</afid><affilname>Tianjin University of Traditional Chinese Medicine</affilname><name-variant>Tianjin University of Traditional Chinese Medicine</name-variant><affiliation-city>Tianjin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012594</affiliation-url><afid>60012594</afid><affilname>Tianjin University of Traditional Chinese Medicine</affilname><name-variant>Tianjin University of Traditional Chinese Medicine</name-variant><affiliation-city>Tianjin</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">21</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56648006500</author-url><authid>56648006500</authid><authname>Fordjour P.</authname><surname>Fordjour</surname><given-name>Patrick Asare</given-name><initials>P.A.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56648006500</author-url><authid>56648006500</authid><authname>Fordjour P.</authname><surname>Fordjour</surname><given-name>Patrick Asare</given-name><initials>P.A.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56648006500</author-url><authid>56648006500</authid><authname>Fordjour P.</authname><surname>Fordjour</surname><given-name>Patrick Asare</given-name><initials>P.A.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56648220600</author-url><authid>56648220600</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yadong</given-name><initials>Y.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56648220600</author-url><authid>56648220600</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yadong</given-name><initials>Y.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56648220600</author-url><authid>56648220600</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yadong</given-name><initials>Y.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56647149900</author-url><authid>56647149900</authid><authname>Shi Y.</authname><surname>Shi</surname><given-name>Yang</given-name><initials>Y.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56647149900</author-url><authid>56647149900</authid><authname>Shi Y.</authname><surname>Shi</surname><given-name>Yang</given-name><initials>Y.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56647149900</author-url><authid>56647149900</authid><authname>Shi Y.</authname><surname>Shi</surname><given-name>Yang</given-name><initials>Y.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55875423800</author-url><authid>55875423800</authid><authname>Agyemang K.</authname><surname>Agyemang</surname><given-name>Kojo</given-name><initials>K.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55875423800</author-url><authid>55875423800</authid><authname>Agyemang K.</authname><surname>Agyemang</surname><given-name>Kojo</given-name><initials>K.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55875423800</author-url><authid>55875423800</authid><authname>Agyemang K.</authname><surname>Agyemang</surname><given-name>Kojo</given-name><initials>K.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55120108900</author-url><authid>55120108900</authid><authname>Akinyi M.</authname><surname>Akinyi</surname><given-name>Mary</given-name><initials>M.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55120108900</author-url><authid>55120108900</authid><authname>Akinyi M.</authname><surname>Akinyi</surname><given-name>Mary</given-name><initials>M.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55120108900</author-url><authid>55120108900</authid><authname>Akinyi M.</authname><surname>Akinyi</surname><given-name>Mary</given-name><initials>M.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56647074500</author-url><authid>56647074500</authid><authname>Zhang Q.</authname><surname>Zhang</surname><given-name>Qiang</given-name><initials>Q.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56647074500</author-url><authid>56647074500</authid><authname>Zhang Q.</authname><surname>Zhang</surname><given-name>Qiang</given-name><initials>Q.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56647074500</author-url><authid>56647074500</authid><authname>Zhang Q.</authname><surname>Zhang</surname><given-name>Qiang</given-name><initials>Q.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35200869900</author-url><authid>35200869900</authid><authname>Fan G.</authname><surname>Fan</surname><given-name>Guanwei</given-name><initials>G.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35200869900</author-url><authid>35200869900</authid><authname>Fan G.</authname><surname>Fan</surname><given-name>Guanwei</given-name><initials>G.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35200869900</author-url><authid>35200869900</authid><authname>Fan G.</authname><surname>Fan</surname><given-name>Guanwei</given-name><initials>G.</initials><afid>60012594</afid><afid>60012594</afid><afid>60012594</afid></author><authkeywords>C-reactive protein | Complement activation | Endothelial dysfunction | Myocardial infarction</authkeywords><intid>1535964317</intid><article-number>69896</article-number><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928910534"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928910534?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928910534&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928910534&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014299915003258"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928910534</prism:url><dc:identifier>SCOPUS_ID:84928910534</dc:identifier><eid>2-s2.0-84928910534</eid><dc:title>Des-aspartate-angiotensin I, a novel angiotensin AT&lt;inf&gt;1&lt;/inf&gt; receptor drug</dc:title><dc:creator>Sim M.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>760</prism:volume><prism:pageRange>36-41</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>5 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.04.004</prism:doi><pii>S0014299915003258</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. The review describes DAA-I (des-aspartate-angiotensin-I) as a prototype of a novel class of drugs that acts as agonists on the angiotensin AT&lt;inf&gt;1&lt;/inf&gt; receptor or ARAs (angiotensin receptor agonists). DAA-I is a component of the renin angiotensin system. Earlier studies showed that it was rapidly metabolized to angiotensin III. However, when administered at doses below the Km of enzymes, DAA-I produces specific actions that antagonize the deleterious actions of angiotensin II. DAA-I exerts protective actions in animal models of eight human pathologies in which angiotensin II is implicated. The pathologies include cardiac hypertrophy, neointima growth and cardiovascular hypertrophy, myocardial-ischemia reperfusion injury, hyperglycemia and insulin resistance, chemical induced inflammation, and exercise-induced skeletal muscle inflammation. Binding of DAA-I to the angiotensin AT&lt;inf&gt;1&lt;/inf&gt; receptors releases prostaglandins, which could either function as autocrines/paracrines or second messengers and attenuate the deleterious actions of angiotensin II. It is possible that in in vivo DAA-I functions as a physiological antagonist to angiotensin II, and exogenous DAA-I is a novel class of angiotensin receptor drug that could rival the angiotensin receptor blockers.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026680</affiliation-url><afid>60026680</afid><affilname>Yong Loo Lin School of Medicine</affilname><name-variant>National University of</name-variant><affiliation-city>Singapore City</affiliation-city><affiliation-country>Singapore</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55664146400</author-url><authid>55664146400</authid><authname>Sim M.</authname><surname>Sim</surname><given-name>Meng Kwoon</given-name><initials>M.K.</initials><afid>60026680</afid></author><authkeywords>Angiotensin AT&lt;inf&gt;1&lt;/inf&gt; receptor | Des-aspartate-angiotensin I | Inflammation | Novel angiotensin receptor agonist</authkeywords><intid>1035857846</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929000220"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929000220?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929000220&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929000220&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S001429991500343X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929000220</prism:url><dc:identifier>SCOPUS_ID:84929000220</dc:identifier><eid>2-s2.0-84929000220</eid><dc:title>Basal activity of voltage-gated Ca&lt;sup&gt;2+&lt;/sup&gt; channels controls the IP&lt;inf&gt;3&lt;/inf&gt;-mediated contraction by α&lt;inf&gt;1&lt;/inf&gt;-adrenoceptor stimulation of mouse aorta segments</dc:title><dc:creator>Leloup A.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>760</prism:volume><prism:pageRange>163-171</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>5 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.04.011</prism:doi><pii>S001429991500343X</pii><dc:description>© 2015 Published by Elsevier B.V. α1-Adrenoceptor stimulation of mouse aorta causes intracellular Ca&lt;sup&gt;2+&lt;/sup&gt; release from sarcoplasmic reticulum Ca&lt;sup&gt;2+&lt;/sup&gt; stores via stimulation of inositoltriphosphate (IP3) receptors. It is hypothesized that this Ca&lt;sup&gt;2+&lt;/sup&gt; release from the contractile and IP3-sensitive Ca&lt;sup&gt;2+&lt;/sup&gt; store is under the continuous dynamic control of time-independent basal Ca&lt;sup&gt;2+&lt;/sup&gt; influx via L-type voltage-gated Ca&lt;sup&gt;2+&lt;/sup&gt; channels (LCC) residing in their window voltage range. Mouse aortic segments were α1-adrenoceptor stimulated with phenylephrine in the absence of external Ca&lt;sup&gt;2+&lt;/sup&gt; (0Ca) to measure phasic isometric contractions. They gradually decreased with time in 0Ca, were inhibited with 2-aminoethoxydiphenyl borate, and declined with previous membrane potential hyperpolarization (levcromakalim) or with previous inhibition of LCC (diltiazem). Former basal stimulation of LCC with depolarization (15 mM K&lt;sup&gt;+&lt;/sup&gt;) or with BAY K8644 increased the subsequent phasic contractions by phenylephrine in 0Ca. Although exogenous NO (diethylamine NONOate) reduced the phasic contractions by phenylephrine, stimulation of endothelial cells with acetylcholine in 0Ca failed to attenuate these phasic contractions. Finally, inhibition of the basal release of NO with N&lt;sup&gt;Ω&lt;/sup&gt;-nitro-L-arginine methyl ester also attenuated the phasic contractions by phenylephrine. Results indicated that α1-adrenoceptor stimulation with phenylephrine causes phasic contractions, which are controlled by basal LCC and endothelial NO synthase activity. Endothelial NO release by acetylcholine was absent in 0Ca. Given the growing interest in the active regulation of arterial compliance, the dependence of contractile SR Ca&lt;sup&gt;2+&lt;/sup&gt; store-refilling in basal conditions on the activity of LCC and basal eNOS may contribute to a more thorough understanding of physiological mechanisms leading to arterial stiffness.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012937</affiliation-url><afid>60012937</afid><affilname>Universiteit Antwerpen</affilname><name-variant>University of Antwerp</name-variant><affiliation-city>Antwerpen</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012937</affiliation-url><afid>60012937</afid><affilname>Universiteit Antwerpen</affilname><name-variant>University of Antwerp</name-variant><affiliation-city>Antwerpen</affiliation-city><affiliation-country>Belgium</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56124383800</author-url><authid>56124383800</authid><authname>Leloup A.</authname><surname>Leloup</surname><given-name>Arthur J.</given-name><initials>A.J.</initials><afid>60012937</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7003901599</author-url><authid>7003901599</authid><authname>Van Hove C.</authname><surname>Van Hove</surname><given-name>Cor E.</given-name><initials>C.E.</initials><afid>60012937</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7005384908</author-url><authid>7005384908</authid><authname>De Meyer G.</authname><surname>De Meyer</surname><given-name>Guido R Y</given-name><initials>G.R.Y.</initials><afid>60012937</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7006722630</author-url><authid>7006722630</authid><authname>Schrijvers D.</authname><surname>Schrijvers</surname><given-name>Dorien M.</given-name><initials>D.M.</initials><afid>60012937</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7003505260</author-url><authid>7003505260</authid><authname>Fransen P.</authname><surname>Fransen</surname><given-name>Paul</given-name><initials>P.</initials><afid>60012937</afid></author><authkeywords>Mouse aorta | Nitric oxide | Sarcoplasmic reticulum | Voltage-gated Ca&lt;sup&gt;2+&lt;/sup&gt; channel | α1-Adrenoceptor</authkeywords><intid>535885679</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928895808"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928895808?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928895808&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928895808&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014299915003246"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928895808</prism:url><dc:identifier>SCOPUS_ID:84928895808</dc:identifier><eid>2-s2.0-84928895808</eid><dc:title>Electrophysiological effect and the gating mechanism of astragaloside IV on l-type Ca&lt;sup&gt;2+&lt;/sup&gt; channels of guinea-pig ventricular myocytes</dc:title><dc:creator>Zhao M.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>760</prism:volume><prism:pageRange>27-35</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>5 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.03.082</prism:doi><pii>S0014299915003246</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Astragaloside IV (AS-IV) is one of the main active ingredients of Astragalus membranaceus. This study is aimed to investigate AS-IV's effects on Ca&lt;sup&gt;2+&lt;/sup&gt; channel activity of single cardiomyocytes and single Ca&lt;sup&gt;2+&lt;/sup&gt; channels. Whole-cell Ca&lt;sup&gt;2+&lt;/sup&gt; currents in freshly dissociated cardiomyocytes were measured using the whole-cell patch-clamp technique. Single Ca&lt;sup&gt;2+&lt;/sup&gt; channel currents were examined in cell-attached patches and inside-out patches. In the whole-cell recording, AS-IV reduced the amplitude of l-type Ca&lt;sup&gt;2+&lt;/sup&gt; currents (I&lt;inf&gt;CaL&lt;/inf&gt;) in a concentration-dependent manner. Although AS-IV did not alter the steady-state activation curves, the voltage dependence of the current inactivation curves was negatively shifted by AS-IV in a concentration dependent manner. Consistent with the results of the whole-cell recording, in the inside-out configuration the ensemble average of single Ba&lt;sup&gt;2+&lt;/sup&gt; current via l-type Ca&lt;sup&gt;2+&lt;/sup&gt; channel was dose-dependently reduced by AS-IV. The reduction of unitary Ba&lt;sup&gt;2+&lt;/sup&gt; current at 0.1 or 1 μM AS-IV was accounted for a decrease in the channel activity (NPo). In addition to the decrease in NPo, there was a reduction of Po without a change in channel number or an apparent change in single channel current. Furthermore, we found that the open-closed kinetics of the channel were affected by AS-IV. AS-IV induced the shift of l-type Ca&lt;sup&gt;2+&lt;/sup&gt; channels from either brief openings (mode 1) or long-lasting openings (mode 2) to no active opening (mode 0). Our results suggest that AS-IV blocks the currents through Ca&lt;sup&gt;2+&lt;/sup&gt; channels in guinea-pig ventricular myocytes by affecting the open-closed kinetics of l-type Ca&lt;sup&gt;2+&lt;/sup&gt; channels to inhibit the channel activities. This study could provide theoretical basis for the drug exploiting of the monomer of Astragalus membranaceus.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008872</affiliation-url><afid>60008872</afid><affilname>China Medical University Shenyang</affilname><name-variant>China Medical University</name-variant><affiliation-city>Shenyang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113760452</affiliation-url><afid>113760452</afid><affilname>Cardiovascular Institute of China Medical University</affilname><name-variant>Cardiovascular Institute of China Medical University</name-variant><affiliation-city/><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">12</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56591017900</author-url><authid>56591017900</authid><authname>Zhao M.</authname><surname>Zhao</surname><given-name>Meimi</given-name><initials>M.</initials><afid>60008872</afid><afid>113760452</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56591017900</author-url><authid>56591017900</authid><authname>Zhao M.</authname><surname>Zhao</surname><given-name>Meimi</given-name><initials>M.</initials><afid>60008872</afid><afid>113760452</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56622341400</author-url><authid>56622341400</authid><authname>Shao D.</authname><surname>Shao</surname><given-name>Dongxue</given-name><initials>D.</initials><afid>60008872</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56621683100</author-url><authid>56621683100</authid><authname>Yu L.</authname><surname>Yu</surname><given-name>Lifeng</given-name><initials>L.</initials><afid>60008872</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56601888300</author-url><authid>56601888300</authid><authname>Sun X.</authname><surname>Sun</surname><given-name>Xuefei</given-name><initials>X.</initials><afid>60008872</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55974886300</author-url><authid>55974886300</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yan</given-name><initials>Y.</initials><afid>60008872</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56621743600</author-url><authid>56621743600</authid><authname>Hu H.</authname><surname>Hu</surname><given-name>Huiyuan</given-name><initials>H.</initials><afid>60008872</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35589721500</author-url><authid>35589721500</authid><authname>Feng R.</authname><surname>Feng</surname><given-name>Rui</given-name><initials>R.</initials><afid>60008872</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56591257400</author-url><authid>56591257400</authid><authname>Gao Q.</authname><surname>Gao</surname><given-name>Qinghua</given-name><initials>Q.</initials><afid>60008872</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:55261568900</author-url><authid>55261568900</authid><authname>Guo F.</authname><surname>Guo</surname><given-name>Feng</given-name><initials>F.</initials><afid>60008872</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7202263036</author-url><authid>7202263036</authid><authname>Hao L.</authname><surname>Hao</surname><given-name>Liying</given-name><initials>L.</initials><afid>60008872</afid><afid>113760452</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7202263036</author-url><authid>7202263036</authid><authname>Hao L.</authname><surname>Hao</surname><given-name>Liying</given-name><initials>L.</initials><afid>60008872</afid><afid>113760452</afid></author><authkeywords>AS-IV | L-type Ca&lt;sup&gt;2+&lt;/sup&gt; channel | Patch-clamp</authkeywords><intid>535862211</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927728600"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927728600?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927728600&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927728600&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0048969715004544"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927728600</prism:url><dc:identifier>SCOPUS_ID:84927728600</dc:identifier><eid>2-s2.0-84927728600</eid><dc:title>Parental trophic exposure to three aromatic fractions of polycyclic aromatic hydrocarbons in the zebrafish: Consequences for the offspring</dc:title><dc:creator>Perrichon P.</dc:creator><prism:publicationName>Science of the Total Environment</prism:publicationName><prism:issn>00489697</prism:issn><prism:eIssn>18791026</prism:eIssn><prism:volume>524-525</prism:volume><prism:pageRange>52-62</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.scitotenv.2015.04.018</prism:doi><pii>S0048969715004544</pii><dc:description>© 2015 Elsevier B.V. In recent decades, PAH emissions due to extensive anthropogenic activities have risen sharply causing considerable pollution of aquatic ecosystems. This pollution represents a threat for organisms, among them are fish. Consequently, prenatal stress can have important repercussions, and may impact survival and population recruitment. To investigate this point, eggs were collected from zebrafish exposed during 6. months by trophic route to three aromatic fractions from two different origins, pyrolytic (PY) and petrogenic (light (BAL) and heavy (HFO) fractions) sources. Chronic dietary exposure of the parents was performed at environmentally relevant concentrations (0.3. ×, 1. × and 3. ×; 1. × represents an environmental concentration measured in French estuary). In order to explore the consequences of parental exposure for the next first generation, toxic responses were studied in both embryos and larvae using a multiscale approach. Toxic effects were assessed by looking at hatching success, developmental abnormalities, photomotor response and heartbeat. The level of PAH metabolites and EROD activity in fish larvae were measured to assess exposure to PAHs. Egg production of parents was significantly reduced compared to the Control; hence little information was available for BAL and HFO offspring. The size of larvae from PY parents was found to increase despite a reduced yolk sac compared to Control larvae. Furthermore, a high level of behavioral stress was observed in larvae originating from parents exposed to three-fold the environmental concentration. The cardiac activity was reduced in a concentration-dependent manner for the PY exposure group. No effect was however observed on biotransformation markers (cyp1a, EROD), nor on the level of DNA damage for all PY, BAL and HFO offspring. The absence of significant differences in metabolite levels may indicate a potential early depuration of transferred compounds or no PAH-transmission. The disruptions observed at the individual level in the next generation could impact on the longer-term, surviving population.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60017882</affiliation-url><afid>60017882</afid><affilname>IFREMER Centre de Nantes</affilname><name-variant>Ifremer</name-variant><affiliation-city>Nantes</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013717</affiliation-url><afid>60013717</afid><affilname>Universite de La Rochelle</affilname><name-variant>Université de La Rochelle</name-variant><affiliation-city>La Rochelle</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60102125</affiliation-url><afid>60102125</afid><affilname>Universite de Bordeaux</affilname><name-variant>Université de Bordeaux</name-variant><affiliation-city>Bordeaux</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021488</affiliation-url><afid>60021488</afid><affilname>INRA Centre de Rennes</affilname><name-variant>INRA</name-variant><affiliation-city>Le Rheu</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:47061879400</author-url><authid>47061879400</authid><authname>Perrichon P.</authname><surname>Perrichon</surname><given-name>Prescilla</given-name><initials>P.</initials><afid>60017882</afid><afid>60013717</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:47061879400</author-url><authid>47061879400</authid><authname>Perrichon P.</authname><surname>Perrichon</surname><given-name>Prescilla</given-name><initials>P.</initials><afid>60017882</afid><afid>60013717</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603206945</author-url><authid>6603206945</authid><authname>Akcha F.</authname><surname>Akcha</surname><given-name>Farida</given-name><initials>F.</initials><afid>60017882</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6507504802</author-url><authid>6507504802</authid><authname>Le Menach K.</authname><surname>Le Menach</surname><given-name>Karyn</given-name><initials>K.</initials><afid>60102125</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56507467900</author-url><authid>56507467900</authid><authname>Goubeau M.</authname><surname>Goubeau</surname><given-name>Manon</given-name><initials>M.</initials><afid>60017882</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55054479400</author-url><authid>55054479400</authid><authname>Budzinski H.</authname><surname>Budzinski</surname><given-name>Hélène</given-name><initials>H.</initials><afid>60102125</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603697199</author-url><authid>6603697199</authid><authname>Cousin X.</authname><surname>Cousin</surname><given-name>Xavier</given-name><initials>X.</initials><afid>60017882</afid><afid>60021488</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:6603697199</author-url><authid>6603697199</authid><authname>Cousin X.</authname><surname>Cousin</surname><given-name>Xavier</given-name><initials>X.</initials><afid>60017882</afid><afid>60021488</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7005942456</author-url><authid>7005942456</authid><authname>Bustamante P.</authname><surname>Bustamante</surname><given-name>Paco</given-name><initials>P.</initials><afid>60013717</afid></author><authkeywords>Cardiac performance | Fish early-life stages | Genotoxicity | PAH metabolites | Parental transmission | PhotoMotor response | Polycyclic aromatic hydrocarbons</authkeywords><intid>1035662214</intid><source-id>25349</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928150284"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928150284?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928150284&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928150284&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0048969715004714"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928150284</prism:url><dc:identifier>SCOPUS_ID:84928150284</dc:identifier><eid>2-s2.0-84928150284</eid><dc:title>Health impact and monetary cost of exposure to particulate matter emitted from biomass burning in large cities</dc:title><dc:creator>Sarigiannis D.</dc:creator><prism:publicationName>Science of the Total Environment</prism:publicationName><prism:issn>00489697</prism:issn><prism:eIssn>18791026</prism:eIssn><prism:volume>524-525</prism:volume><prism:pageRange>319-330</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.scitotenv.2015.02.108</prism:doi><pii>S0048969715004714</pii><dc:description>© 2015 Elsevier B.V. The study deals with the assessment of health impact and the respective economic cost attributed to particulate matter (PM) emitted into the atmosphere from biomass burning for space heating, focusing on the differences between the warm and cold seasons in 2011-2012 and 2012-2013 in Thessaloniki (Greece). Health impact was assessed based on estimated exposure levels and the use of established WHO concentration-response functions (CRFs) for all-cause mortality, infant mortality, new chronic bronchitis cases, respiratory and cardiac hospital admissions. Monetary cost was based on the valuation of the willingness-to-pay/accept (WTP/WTA), to avoid or compensate for the loss of welfare associated with illness.Results showed that long term mortality during the 2012-2013 winter increased by 200 excess deaths in a city of almost 900,000 inhabitants or 3540. years of life lost, corresponding to an economic cost of almost 200-250m€. New chronic bronchitis cases dominate morbidity estimates (490 additional new cases corresponding to a monetary cost of 30m€). Estimated health and monetary impacts are more severe during the cold season, despite its smaller duration (4. months). Considering that the increased ambient air concentrations (and the integral of outdoor/indoor exposure) are explained by shifting from oil to biomass for domestic heating purposes, several alternative scenarios were evaluated. Policy scenario analysis revealed that significant public health and monetary benefits (up to 2b€ in avoided mortality and 130m€ in avoided illness) might be obtained by limiting the biomass share in the domestic heat energy mix. Fiscal policy affecting fuels/technologies used for domestic heating needs to be reconsidered urgently, since the net tax loss from avoided oil taxation due to reduced consumption was further compounded by the public health cost of increased mid-term morbidity and mortality.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015331</affiliation-url><afid>60015331</afid><affilname>Aristoteleion Panepistimion Thessalonikis</affilname><name-variant>University of Thessaloniki</name-variant><affiliation-city>Thessaloniki</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026208</affiliation-url><afid>60026208</afid><affilname>Center For Research And Technology - Hellas</affilname><name-variant>Centre for Research and Technology Hellas</name-variant><affiliation-city>Thessaloniki</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701494091</author-url><authid>6701494091</authid><authname>Sarigiannis D.</authname><surname>Sarigiannis</surname><given-name>Dimosthenis A.</given-name><initials>D.A.</initials><afid>60015331</afid><afid>60026208</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701494091</author-url><authid>6701494091</authid><authname>Sarigiannis D.</authname><surname>Sarigiannis</surname><given-name>Dimosthenis A.</given-name><initials>D.A.</initials><afid>60015331</afid><afid>60026208</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506088529</author-url><authid>6506088529</authid><authname>Karakitsios S.</authname><surname>Karakitsios</surname><given-name>Spyros P.</given-name><initials>S.P.</initials><afid>60015331</afid><afid>60026208</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506088529</author-url><authid>6506088529</authid><authname>Karakitsios S.</authname><surname>Karakitsios</surname><given-name>Spyros P.</given-name><initials>S.P.</initials><afid>60015331</afid><afid>60026208</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55232386700</author-url><authid>55232386700</authid><authname>Kermenidou M.</authname><surname>Kermenidou</surname><given-name>Marianthi V.</given-name><initials>M.V.</initials><afid>60015331</afid></author><authkeywords>Biomass burning | Health impact | Monetary valuation | Morbidity | Mortality</authkeywords><intid>535733223</intid><source-id>25349</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928580559"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928580559?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928580559&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928580559&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014299915003295"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928580559</prism:url><dc:identifier>SCOPUS_ID:84928580559</dc:identifier><eid>2-s2.0-84928580559</eid><dc:title>Lipoxins and aspirin-triggered lipoxins in resolution of inflammation</dc:title><dc:creator>Romano M.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>760</prism:volume><prism:pageRange>49-63</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>5 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.03.083</prism:doi><pii>S0014299915003295</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. The resolution of the inflammatory response is highly regulated by the timely biosynthesis of a number of endogenous lipid mediators. Among these, lipoxins (LX) and their 15-epimers, aspirin triggered lipoxins (ATL) derived by the lipoxygenase (LO) route of arachidonic acid metabolism. In particular, they are formed and released by cells expressing 5-, 12- and 15-LO such as leukocytes, platelets, vascular endothelium and epithelium, alone or during transcellular interactions. ATL biosynthesis requires cyclooxygenase-2 acetylation by aspirin. LX and ATL exert potent bioactions on leukocytes, vascular and epithelial cells to stop inflammation and promote resolution. They have shown to be beneficial in a broad spectrum of preclinical models of disease as well as in some clinical trials. Counter-regulatory signaling by LXA&lt;inf&gt;4&lt;/inf&gt; and 15-epi-LXA&lt;inf&gt;4&lt;/inf&gt; follows the activation of a G protein-coupled receptor, termed ALX/FPR2, which is emerging as a key anti-inflammatory receptor.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004638</affiliation-url><afid>60004638</afid><affilname>University of G. d'Annunzio Chieti and Pescara</affilname><name-variant>University of Chieti</name-variant><affiliation-city>Chieti</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004638</affiliation-url><afid>60004638</afid><affilname>University of G. d'Annunzio Chieti and Pescara</affilname><name-variant>University of Chieti</name-variant><affiliation-city>Chieti</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004638</affiliation-url><afid>60004638</afid><affilname>University of G. d'Annunzio Chieti and Pescara</affilname><name-variant>University of Chieti</name-variant><affiliation-city>Chieti</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35115376400</author-url><authid>35115376400</authid><authname>Romano M.</authname><surname>Romano</surname><given-name>Mario</given-name><initials>M.</initials><afid>60004638</afid><afid>60004638</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35115376400</author-url><authid>35115376400</authid><authname>Romano M.</authname><surname>Romano</surname><given-name>Mario</given-name><initials>M.</initials><afid>60004638</afid><afid>60004638</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54894394300</author-url><authid>54894394300</authid><authname>Cianci E.</authname><surname>Cianci</surname><given-name>Eleonora</given-name><initials>E.</initials><afid>60004638</afid><afid>60004638</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:54894394300</author-url><authid>54894394300</authid><authname>Cianci E.</authname><surname>Cianci</surname><given-name>Eleonora</given-name><initials>E.</initials><afid>60004638</afid><afid>60004638</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55053611700</author-url><authid>55053611700</authid><authname>Simiele F.</authname><surname>Simiele</surname><given-name>Felice</given-name><initials>F.</initials><afid>60004638</afid><afid>60004638</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55053611700</author-url><authid>55053611700</authid><authname>Simiele F.</authname><surname>Simiele</surname><given-name>Felice</given-name><initials>F.</initials><afid>60004638</afid><afid>60004638</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16402976200</author-url><authid>16402976200</authid><authname>Recchiuti A.</authname><surname>Recchiuti</surname><given-name>Antonio</given-name><initials>A.</initials><afid>60004638</afid><afid>60004638</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16402976200</author-url><authid>16402976200</authid><authname>Recchiuti A.</authname><surname>Recchiuti</surname><given-name>Antonio</given-name><initials>A.</initials><afid>60004638</afid><afid>60004638</afid></author><authkeywords>Efferocytosis | Inflammation | Lipoxin | Lipoxygenase | microRNA | Polymorphysm | Promoter | Receptor | Resolution</authkeywords><intid>2035796683</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926436285"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926436285?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926436285&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926436285&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0956566315002183"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926436285</prism:url><dc:identifier>SCOPUS_ID:84926436285</dc:identifier><eid>2-s2.0-84926436285</eid><dc:title>Recent advancements in sensing techniques based on functional materials for organophosphate pesticides</dc:title><dc:creator>Kumar P.</dc:creator><prism:publicationName>Biosensors and Bioelectronics</prism:publicationName><prism:issn>09565663</prism:issn><prism:eIssn>18734235</prism:eIssn><prism:volume>70</prism:volume><prism:pageRange>469-481</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bios.2015.03.066</prism:doi><pii>S0956566315002183</pii><dc:description>© 2015 Elsevier B.V. The use of organophosphate pesticides (OPs) for pest control in agriculture has caused serious environmental problems throughout the world. OPs are highly toxic with the potential to cause neurological disorders in humans. As the application of OPs has greatly increased in various agriculture activities, it has become imperative to accurately monitor their concentration levels for the protection of ecological systems and food supplies. Although there are many conventional methods available for the detection of OPs, the development of portable sensors is necessary to facilitate routine analysis with more convenience. Some of these potent alternative techniques based on functional materials include fluorescence nanomaterials based sensors, molecular imprinted (MIP) sensors, electrochemical sensors, and biosensors. This review explores the basic features of these sensing approaches through evaluation of their performance. The discussion is extended further to describe the challenges and opportunities for these unique sensing techniques.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024872</affiliation-url><afid>60024872</afid><affilname>Hanyang University</affilname><name-variant>Hanyang University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069478</affiliation-url><afid>60069478</afid><affilname>Central Scientific Instruments Organization Chandigarh</affilname><name-variant>Central Scientific Instruments Organisation</name-variant><affiliation-city>Chandigarh</affiliation-city><affiliation-country>India</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56603331700</author-url><authid>56603331700</authid><authname>Kumar P.</authname><surname>Kumar</surname><given-name>Pawan</given-name><initials>P.</initials><afid>60024872</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55710568300</author-url><authid>55710568300</authid><authname>Kim K.</authname><surname>Kim</surname><given-name>Ki Hyun</given-name><initials>K.H.</initials><afid>60024872</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602909701</author-url><authid>6602909701</authid><authname>Deep A.</authname><surname>Deep</surname><given-name>Akash</given-name><initials>A.</initials><afid>60069478</afid></author><authkeywords>Health issues | Monitoring techniques | Organophosphate | Pesticides | Sensing</authkeywords><intid>2035448471</intid><source-id>15437</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930181376"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930181376?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930181376&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930181376&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0303720715001732"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930181376</prism:url><dc:identifier>SCOPUS_ID:84930181376</dc:identifier><eid>2-s2.0-84930181376</eid><dc:title>Interleukin-33/ST2 system attenuates aldosterone-induced adipogenesis and inflammation</dc:title><dc:creator>Martínez-Martínez E.</dc:creator><prism:publicationName>Molecular and Cellular Endocrinology</prism:publicationName><prism:issn>03037207</prism:issn><prism:eIssn>18728057</prism:eIssn><prism:volume>411</prism:volume><prism:pageRange>20-27</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.mce.2015.04.007</prism:doi><pii>S0303720715001732</pii><dc:description>© 2015 Elsevier Ireland Ltd. Interleukin-33 (IL-33) but not soluble ST2 (sST2) exerts anti-inflammatory and protective effects in several tissues. Aldosterone, a proinflammatory mediator which promotes adipogenesis, is elevated in obese patients. The aim of this study was to investigate the interactions between IL-33/ST2 system and Aldosterone in adipose tissue. Rats fed a high fat diet presented increased sST2 expression, diminished IL-33/sST2 ratio and enhanced levels of differentiation and inflammation in adipose tissue as compared to controls. A similar pattern was observed in adipose tissue from C57BL/6 Aldosterone-treated mice. In both animal models, Aldosterone was correlated with sST2. Treatment of 3T3-L1 adipocytes with IL-33 delayed adipocyte differentiation diminished lipid accumulation and decreased inflammation. Aldosterone decreased IL-33 and increased sST2 expressions in differentiated adipocytes. Aldosterone-induced adipocyte differentiation and inflammation were blocked by IL-33 treatment, but sST2 did not exert any effects. The crosstalk between IL-33/ST2 and Aldosterone could be relevant in the metabolic consequences of obesity.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112808477</affiliation-url><afid>112808477</afid><affilname>Navarra Biomed (Miguel Servet Foundation)</affilname><name-variant>Navarra Biomed (Miguel Servet Foundation)</name-variant><affiliation-city>Pamplona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027282</affiliation-url><afid>60027282</afid><affilname>Universidad Complutense de Madrid</affilname><name-variant>Universidad Complutense</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60104289</affiliation-url><afid>60104289</afid><affilname>Universite de Lorrain</affilname><name-variant>Université de Lorraine</name-variant><affiliation-city>Nancy</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020930</affiliation-url><afid>60020930</afid><affilname>Clinica Universitaria de Navarra</affilname><name-variant>Clinica Universitaria de Navarra</name-variant><affiliation-city>Pamplona</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026796</affiliation-url><afid>60026796</afid><affilname>Universidad Autonoma de Madrid</affilname><name-variant>Universidad Autónoma de Madrid</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026040</affiliation-url><afid>60026040</afid><affilname>Centre de Recherches BioMedicales des Cordeliers</affilname><name-variant>Centre de Recherche des Cordeliers</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">17</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55937314400</author-url><authid>55937314400</authid><authname>Martínez-Martínez E.</authname><surname>Martínez-Martínez</surname><given-name>Ernesto</given-name><initials>E.</initials><afid>112808477</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004845644</author-url><authid>7004845644</authid><authname>Cachofeiro V.</authname><surname>Cachofeiro</surname><given-name>Victoria</given-name><initials>V.</initials><afid>60027282</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56023709200</author-url><authid>56023709200</authid><authname>Rousseau E.</authname><surname>Rousseau</surname><given-name>Elodie</given-name><initials>E.</initials><afid>60104289</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56612920300</author-url><authid>56612920300</authid><authname>Álvarez V.</authname><surname>Álvarez</surname><given-name>Virginia</given-name><initials>V.</initials><afid>112808477</afid><afid>60020930</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56612920300</author-url><authid>56612920300</authid><authname>Álvarez V.</authname><surname>Álvarez</surname><given-name>Virginia</given-name><initials>V.</initials><afid>112808477</afid><afid>60020930</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55258751500</author-url><authid>55258751500</authid><authname>Calvier L.</authname><surname>Calvier</surname><given-name>Laurent</given-name><initials>L.</initials><afid>60104289</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56613445200</author-url><authid>56613445200</authid><authname>Fernández-Celis A.</authname><surname>Fernández-Celis</surname><given-name>Amaya</given-name><initials>A.</initials><afid>112808477</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56612890900</author-url><authid>56612890900</authid><authname>Leroy C.</authname><surname>Leroy</surname><given-name>Céline</given-name><initials>C.</initials><afid>60104289</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:8575277000</author-url><authid>8575277000</authid><authname>Miana M.</authname><surname>Miana</surname><given-name>María</given-name><initials>M.</initials><afid>60027282</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:52364056600</author-url><authid>52364056600</authid><authname>Jurado-López R.</authname><surname>Jurado-López</surname><given-name>Raquel</given-name><initials>R.</initials><afid>60027282</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7004606732</author-url><authid>7004606732</authid><authname>Briones A.</authname><surname>Briones</surname><given-name>Ana M.</given-name><initials>A.M.</initials><afid>60026796</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7003403773</author-url><authid>7003403773</authid><authname>Jaisser F.</authname><surname>Jaisser</surname><given-name>Frederic</given-name><initials>F.</initials><afid>60104289</afid><afid>60026040</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7003403773</author-url><authid>7003403773</authid><authname>Jaisser F.</authname><surname>Jaisser</surname><given-name>Frederic</given-name><initials>F.</initials><afid>60104289</afid><afid>60026040</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:7102111367</author-url><authid>7102111367</authid><authname>Zannad F.</authname><surname>Zannad</surname><given-name>Faiez</given-name><initials>F.</initials><afid>60104289</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7006015976</author-url><authid>7006015976</authid><authname>Rossignol P.</authname><surname>Rossignol</surname><given-name>Patrick</given-name><initials>P.</initials><afid>60104289</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:37100107500</author-url><authid>37100107500</authid><authname>López-Andrés N.</authname><surname>López-Andrés</surname><given-name>Natalia</given-name><initials>N.</initials><afid>112808477</afid><afid>60104289</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:37100107500</author-url><authid>37100107500</authid><authname>López-Andrés N.</authname><surname>López-Andrés</surname><given-name>Natalia</given-name><initials>N.</initials><afid>112808477</afid><afid>60104289</afid></author><authkeywords>Adipocyte differentiation | Adipose tissue | Aldosterone | IL-33/ST2 system</authkeywords><intid>536079954</intid><source-id>26206</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928667939"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928667939?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928667939&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928667939&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1569904815000919"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928667939</prism:url><dc:identifier>SCOPUS_ID:84928667939</dc:identifier><eid>2-s2.0-84928667939</eid><dc:title>Hypercapnic thresholds for embryonic acid-base metabolic compensation and hematological regulation during CO&lt;inf&gt;2&lt;/inf&gt; challenges in layer and broiler chicken strains</dc:title><dc:creator>Burggren W.</dc:creator><prism:publicationName>Respiratory Physiology and Neurobiology</prism:publicationName><prism:issn>15699048</prism:issn><prism:eIssn>18781519</prism:eIssn><prism:volume>215</prism:volume><prism:pageRange>1-12</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.resp.2015.04.008</prism:doi><pii>S1569904815000919</pii><dc:description>© 2015 Published by Elsevier B.V. Time specific acid-base metabolic compensation and responses of hematological respiratory variables were measured in day 15 layer (Hyline) and broiler (Cornish Rock) chicken embryos during acute hypercapnic challenges (3, 6, 10 and 20% CO&lt;inf&gt;2&lt;/inf&gt;). Control acid-base status and hematology differed between two strains. Broiler embryos were relatively respiratory acidotic and had higher hematocrit (Hct) and hemoglobin concentration. The partial metabolic compensation for respiratory acidosis produced by ≤10% CO&lt;inf&gt;2&lt;/inf&gt; exposures occurred in proportion to CO&lt;inf&gt;2&lt;/inf&gt; concentrations in both strains, but metabolic compensation for 20% CO&lt;inf&gt;2&lt;/inf&gt; respiratory acidosis was depressed at 2, 6 and 24h, particularly in broiler embryos. Exposure to ≤10% CO&lt;inf&gt;2&lt;/inf&gt; induced the same hematological responses across CO&lt;inf&gt;2&lt;/inf&gt; concentrations; i.e., Hct and mean corpuscular volume (MCV) increased while RBC concentration remained unchanged. In response to 20% CO&lt;inf&gt;2&lt;/inf&gt; exposure, Hct and MCV increased dramatically in both stains. Consequently, altered acid-base and hematology responses to 20% CO&lt;inf&gt;2&lt;/inf&gt; exposure compared to ≤10% CO&lt;inf&gt;2&lt;/inf&gt; suggest that the hypercapnic threshold to compensation for acidosis and regulation of hematology is &gt;10% CO&lt;inf&gt;2&lt;/inf&gt;.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024438</affiliation-url><afid>60024438</afid><affilname>University of North Texas</affilname><name-variant>University of North Texas</name-variant><affiliation-city>Denton</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031828</affiliation-url><afid>60031828</afid><affilname>McMaster University</affilname><name-variant>McMaster University</name-variant><affiliation-city>Hamilton</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7005365106</author-url><authid>7005365106</authid><authname>Burggren W.</authname><surname>Burggren</surname><given-name>Warren W.</given-name><initials>W.W.</initials><afid>60024438</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36716674600</author-url><authid>36716674600</authid><authname>Mueller C.</authname><surname>Mueller</surname><given-name>Casey A.</given-name><initials>C.A.</initials><afid>60031828</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56609914800</author-url><authid>56609914800</authid><authname>Tazawa H.</authname><surname>Tazawa</surname><given-name>Hiroshi</given-name><initials>H.</initials><afid>60024438</afid></author><authkeywords>Acid-base balance | Chicken embryo | Hematological respiratory variables | Hypercapnic threshold | Metabolic compensation | Respiratory acidosis</authkeywords><intid>35823739</intid><source-id>24030</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928314778"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928314778?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928314778&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928314778&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0048969715004210"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928314778</prism:url><dc:identifier>SCOPUS_ID:84928314778</dc:identifier><eid>2-s2.0-84928314778</eid><dc:title>Temperature modifies the association between particulate air pollution and mortality: A multi-city study in South Korea</dc:title><dc:creator>Kim S.</dc:creator><prism:publicationName>Science of the Total Environment</prism:publicationName><prism:issn>00489697</prism:issn><prism:eIssn>18791026</prism:eIssn><prism:volume>524-525</prism:volume><prism:pageRange>376-383</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.scitotenv.2015.03.137</prism:doi><pii>S0048969715004210</pii><dc:description>© 2015 Elsevier B.V. Substantial epidemiologic literature has demonstrated the effects of air pollution and temperature on mortality. However, there is inconsistent evidence regarding the temperature modification effect on acute mortality due to air pollution. Herein, we investigated the effects of temperature on the relationship between air pollution and mortality due to non-accidental, cardiovascular, and respiratory death in seven cities in South Korea. We applied stratified time-series models to the data sets in order to examine whether the effects of particulate matter &lt;10μm (PM&lt;inf&gt;10&lt;/inf&gt;) on mortality were modified by temperature. The effect of PM&lt;inf&gt;10&lt;/inf&gt; on daily mortality was first quantified within different ranges of temperatures at each location using a time-series model, and then the estimates were pooled through a random-effects meta-analysis using the maximum likelihood method. From all the data sets, 828,787 non-accidental deaths were registered from 2000-2009. The highest overall risk between PM&lt;inf&gt;10&lt;/inf&gt; and non-accidental or cardiovascular mortality was observed on extremely hot days (daily mean temperature: &gt;99th percentile) in individuals aged &lt;65years. In those aged ≥65years, the highest overall risk between PM&lt;inf&gt;10&lt;/inf&gt; and non-accidental or cardiovascular mortality was observed on very hot days and not on extremely hot days (daily mean temperature: 95-99th percentile). There were strong harmful effects from PM&lt;inf&gt;10&lt;/inf&gt; on non-accidental mortality with the highest temperature range (&gt;99th percentile) in men, with a very high temperature range (95-99th percentile) in women. Our findings showed that temperature can affect the relationship between the PM&lt;inf&gt;10&lt;/inf&gt; levels and cause-specific mortality. Moreover, the differences were apparent after considering the age and sex groups.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013682</affiliation-url><afid>60013682</afid><affilname>Seoul National University</affilname><name-variant>Seoul National University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013682</affiliation-url><afid>60013682</afid><affilname>Seoul National University</affilname><name-variant>Seoul National University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013682</affiliation-url><afid>60013682</afid><affilname>Seoul National University</affilname><name-variant>Seoul National University</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000656</affiliation-url><afid>60000656</afid><affilname>Seoul National University College of Medicine</affilname><name-variant>Seoul Natl. Univ. Coll. of Medicine</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56603397900</author-url><authid>56603397900</authid><authname>Kim S.</authname><surname>Kim</surname><given-name>Satbyul Estella</given-name><initials>S.E.</initials><afid>60013682</afid><afid>60013682</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56603397900</author-url><authid>56603397900</authid><authname>Kim S.</authname><surname>Kim</surname><given-name>Satbyul Estella</given-name><initials>S.E.</initials><afid>60013682</afid><afid>60013682</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56506136500</author-url><authid>56506136500</authid><authname>Lim Y.</authname><surname>Lim</surname><given-name>Youn Hee</given-name><initials>Y.H.</initials><afid>60013682</afid><afid>60000656</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56506136500</author-url><authid>56506136500</authid><authname>Lim Y.</authname><surname>Lim</surname><given-name>Youn Hee</given-name><initials>Y.H.</initials><afid>60013682</afid><afid>60000656</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55811901800</author-url><authid>55811901800</authid><authname>Kim H.</authname><surname>Kim</surname><given-name>Ho</given-name><initials>H.</initials><afid>60013682</afid><afid>60013682</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55811901800</author-url><authid>55811901800</authid><authname>Kim H.</authname><surname>Kim</surname><given-name>Ho</given-name><initials>H.</initials><afid>60013682</afid><afid>60013682</afid></author><authkeywords>Air pollution | Effect modification | Mortality | Particulate matter | Temperature | Time-series studies</authkeywords><intid>535767870</intid><source-id>25349</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928107080"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928107080?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928107080&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928107080&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021999115002454"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928107080</prism:url><dc:identifier>SCOPUS_ID:84928107080</dc:identifier><eid>2-s2.0-84928107080</eid><dc:title>Strongly coupled dynamics of fluids and rigid-body systems with the immersed boundary projection method</dc:title><dc:creator>Wang C.</dc:creator><prism:publicationName>Journal of Computational Physics</prism:publicationName><prism:issn>00219991</prism:issn><prism:eIssn>10902716</prism:eIssn><prism:volume>295</prism:volume><prism:pageRange>87-113</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jcp.2015.04.005</prism:doi><pii>S0021999115002454</pii><dc:description>© 2015 Elsevier Inc. A strong coupling algorithm is presented for simulating the dynamic interactions between incompressible viscous flows and rigid-body systems in both two- and three-dimensional problems. In this work, the Navier-Stokes equations for incompressible flow are solved on a uniform Cartesian grid by the vorticity-based immersed boundary projection method of Colonius and Taira. Dynamical equations for arbitrary rigid-body systems are also developed. The proposed coupling method attempts to unify the treatment of constraints in the fluid and structure-the incompressibility of the fluid, the linkages in the rigid-body system, and the conditions at the interface-through the use of Lagrange multipliers. The resulting partitioned system of equations is solved with a simple relaxation scheme, based on an identification of virtual inertia from the fluid. The scheme achieves convergence in only 2 to 5 iterations per time step for a wide variety of mass ratios. The formulation requires that only a subset of the discrete fluid equations be solved in each iteration. Several two- and three-dimensional numerical tests are conducted to validate and demonstrate the method, including a falling cylinder, flapping of flexible wings, self-excited oscillations of a system of many linked plates in a free stream, and passive pivoting of a finite aspect ratio plate under the influence of gravity in a free stream. The results from the current method are compared with previous experimental and numerical results and good agreement is achieved.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027550</affiliation-url><afid>60027550</afid><affilname>University of California, Los Angeles</affilname><name-variant>UCLA</name-variant><affiliation-city>Los Angeles</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36626799700</author-url><authid>36626799700</authid><authname>Wang C.</authname><surname>Wang</surname><given-name>Chengjie</given-name><initials>C.</initials><afid>60027550</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:15767239200</author-url><authid>15767239200</authid><authname>Eldredge J.</authname><surname>Eldredge</surname><given-name>Jeff D.</given-name><initials>J.D.</initials><afid>60027550</afid></author><authkeywords>Fluid-structure interaction | Immersed boundary method | Relaxation | Strong coupling</authkeywords><intid>535734352</intid><source-id>13191</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84924985783"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84924985783?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84924985783&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84924985783&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0956566315001542"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84924985783</prism:url><dc:identifier>SCOPUS_ID:84924985783</dc:identifier><eid>2-s2.0-84924985783</eid><dc:title>Giant magnetoresistive-based biosensing probe station system for multiplex protein assays</dc:title><dc:creator>Wang Y.</dc:creator><prism:publicationName>Biosensors and Bioelectronics</prism:publicationName><prism:issn>09565663</prism:issn><prism:eIssn>18734235</prism:eIssn><prism:volume>70</prism:volume><prism:pageRange>61-68</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bios.2015.03.011</prism:doi><pii>S0956566315001542</pii><dc:description>© 2015 Elsevier B.V. In this study, a sensitive immune-biosensing system capable of multiplexed, real-time electrical readout was developed based on giant magnetoresistive (GMR) sensor array to detect a panel of protein biomarkers simultaneously. PAPP-A, PCSK9, and ST2 have been regarded as promising candidate biomarkers for cardiovascular diseases. Early detection of multiple biomarkers for a disease could enable accurate prediction of a disease risk. 64 nano-size GMR sensors were assembled onto one 16. mm×16. mm chip with a reaction well, and they could work independently and be monitored simultaneously. A detect limit of 40. pg/mL for ST2 antigen had been achieved, and the dynamic ranges for the three proteins detection were up to four orders of magnitude. The GMR sensing platform was also selective enough to be directly used in serum samples. In addition, a lab-based probe station has been designed to implement quick lab-on-a-chip experiments instead of wire bonding. It has a potential application in clinical biomarkers identification and screening, and can be extended to fit other biosensing schemes.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005745</affiliation-url><afid>60005745</afid><affilname>University of Minnesota System</affilname><name-variant>University of Minnesota</name-variant><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56095806700</author-url><authid>56095806700</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yi</given-name><initials>Y.</initials><afid>60005745</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56121198400</author-url><authid>56121198400</authid><authname>Wang W.</authname><surname>Wang</surname><given-name>Wei</given-name><initials>W.</initials><afid>60005745</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55737420400</author-url><authid>55737420400</authid><authname>Yu L.</authname><surname>Yu</surname><given-name>Lina</given-name><initials>L.</initials><afid>60005745</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:42462708000</author-url><authid>42462708000</authid><authname>Tu L.</authname><surname>Tu</surname><given-name>Liang</given-name><initials>L.</initials><afid>60005745</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55428244800</author-url><authid>55428244800</authid><authname>Feng Y.</authname><surname>Feng</surname><given-name>Yinglong</given-name><initials>Y.</initials><afid>60005745</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56555939100</author-url><authid>56555939100</authid><authname>Klein T.</authname><surname>Klein</surname><given-name>Todd</given-name><initials>T.</initials><afid>60005745</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56512918500</author-url><authid>56512918500</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jian Ping</given-name><initials>J.P.</initials><afid>60005745</afid></author><authkeywords>Biomarker detection | Giant magnetoresistance | Magnetic biosensor | Multiplex | Point-of-care | Probe station</authkeywords><intid>2035227262</intid><source-id>15437</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929658645"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929658645?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929658645&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929658645&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014299915003520"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929658645</prism:url><dc:identifier>SCOPUS_ID:84929658645</dc:identifier><eid>2-s2.0-84929658645</eid><dc:title>Comparative effects of Aliskiren and Telmisartan in high fructose diet-induced metabolic syndrome in rats</dc:title><dc:creator>Rabie E.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>760</prism:volume><prism:pageRange>145-153</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>5 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.04.019</prism:doi><pii>S0014299915003520</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Fructose is a commonly used sweetener associated with diets that increase the prevalence of metabolic syndrome (MS). Inhibition of the renin-angiotensin system (RAS) has been consistently demonstrated to reduce MS. However, there has been no direct comparison among different pharmacological modes of inhibiting the RAS concerning their effects on MS. This study investigated the effect of aliskiren, a direct renin inhibitor, versus telmisartan, an angiotensin II-receptor blocker, in the treatment of fructose-induced MS in rats. MS was induced by high fructose (FRC) diet feeding for 12 weeks. Oral administrations of telmisartan (TEL, 5 mg/kg), aliskiren (ALS, 30 mg/kg) or vehicle were started in the last 4 weeks. Results showed that administration of either TEL or ALS with FRC diet equally ameliorated the metabolic parameters (glucose level, oral glucose tolerance test, insulin resistance and serum lipids profile), systolic blood pressure and oxidative stress markers (malondialdehyde, nitric oxide, reduced glutathione levels and catalase activity). Additionally, the effects of TEL and ALS were associated with a decrease in body composition index and attenuation of liver index, serum liver enzyme activities and hepatic expressions of inflammatory and fibrotic markers (tumor necrosis factor-α, nuclear factor kappa-B and transforming growth factor-β) with a significant increase in hepatic glucose transporter-2 and peroxisome proliferator-activated receptors-alpha and gamma expressions. The results suggested that, at indicated dosage, ALS has ameliorative effect equal to that of TEL against FRC-induced metabolic and hepatic disorders; implying that drugs which inhibit the RAS, by different mode of inhibition, profoundly affect fructose-induced MS in rats.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009750</affiliation-url><afid>60009750</afid><affilname>University of Minia</affilname><name-variant>Minia University</name-variant><affiliation-city>Menia</affiliation-city><affiliation-country>Egypt</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009750</affiliation-url><afid>60009750</afid><affilname>University of Minia</affilname><name-variant>Minia University</name-variant><affiliation-city>Menia</affiliation-city><affiliation-country>Egypt</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56652535300</author-url><authid>56652535300</authid><authname>Rabie E.</authname><surname>Rabie</surname><given-name>Esraa M.</given-name><initials>E.M.</initials><afid>60009750</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:23060107600</author-url><authid>23060107600</authid><authname>Heeba G.</authname><surname>Heeba</surname><given-name>Gehan H.</given-name><initials>G.H.</initials><afid>60009750</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6701530215</author-url><authid>6701530215</authid><authname>Abouzied M.</authname><surname>Abouzied</surname><given-name>Mekky M.</given-name><initials>M.M.</initials><afid>60009750</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7102313818</author-url><authid>7102313818</authid><authname>Khalifa M.</authname><surname>Khalifa</surname><given-name>Mohamed M A</given-name><initials>M.M.A.</initials><afid>60009750</afid></author><authkeywords>Aliskiren | Fructose | Insulin resistance | Metabolic syndrome | Telmisartan</authkeywords><intid>1535991506</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930178383"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930178383?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930178383&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930178383&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0303720715001975"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930178383</prism:url><dc:identifier>SCOPUS_ID:84930178383</dc:identifier><eid>2-s2.0-84930178383</eid><dc:title>Hypoxia inhibits semicarbazide-sensitive amine oxidase activity in adipocytes</dc:title><dc:creator>Repessé X.</dc:creator><prism:publicationName>Molecular and Cellular Endocrinology</prism:publicationName><prism:issn>03037207</prism:issn><prism:eIssn>18728057</prism:eIssn><prism:volume>411</prism:volume><prism:pageRange>58-66</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.mce.2015.04.011</prism:doi><pii>S0303720715001975</pii><dc:description>© 2015 Elsevier Ireland Ltd. Semicarbazide-sensitive amine oxidase (SSAO), an enzyme highly expressed on adipocyte plasma membranes, converts primary amines into aldehydes, ammonium and hydrogen peroxide, and is likely involved in endothelial damage during the course of diabetes and obesity. We investigated whether in vitro, adipocyte SSAO was modulated under hypoxic conditions that is present in adipose tissue from obese or intensive care unit. Physical or pharmacological hypoxia decreased SSAO activity in murine adipocytes and human adipose tissue explants, while enzyme expression was preserved. This effect was time-, dose-dependent and reversible. This down-regulation was confirmed in vivo in subcutaneous adipose tissue from a rat model of hypoxia. Hypoxia-induced suppression in SSAO activity was independent of the HIF-1-α pathway or of oxidative stress, but was partially antagonized by medium acidification. Hypoxia-induced down-regulation of SSAO activity could represent an adaptive mechanism to lower toxic molecules production, and may thus protect from tissue injury during these harmful conditions.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60018317</affiliation-url><afid>60018317</afid><affilname>Faculte de Medecine Paris-Sud</affilname><name-variant>Université Paris-Sud</name-variant><affiliation-city>Le Kremlin-Bicetre</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003335</affiliation-url><afid>60003335</afid><affilname>Hopital Ambroise Pare, Boulogne-Billancourt</affilname><name-variant>Hôpital Ambroise-Paré</name-variant><affiliation-city>Boulogne-Billancourt</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001422</affiliation-url><afid>60001422</afid><affilname>Universite Pierre et Marie Curie</affilname><name-variant>Université Pierre et Marie Curie</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113060697</affiliation-url><afid>113060697</afid><affilname>Institut Hospitalo-Universitaire ICAN</affilname><name-variant>Imagine Institut Hospital Universitaire Necker</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009907</affiliation-url><afid>60009907</afid><affilname>Hopital Saint-Antoine</affilname><name-variant>Hopital Saint-Antoine</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009647</affiliation-url><afid>60009647</afid><affilname>Universite Paris 13</affilname><name-variant>Université Paris 13</name-variant><affiliation-city>Villetaneuse</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60008800</affiliation-url><afid>60008800</afid><affilname>Hopital Avicenne</affilname><name-variant>Hopital Avicenne</name-variant><affiliation-city>Bobigny</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000905</affiliation-url><afid>60000905</afid><affilname>Inserm</affilname><name-variant>INSERM</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60104289</affiliation-url><afid>60104289</afid><affilname>Universite de Lorrain</affilname><name-variant>Université de Lorraine</name-variant><affiliation-city>Nancy</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013430</affiliation-url><afid>60013430</afid><affilname>Hopital de Bicetre</affilname><name-variant>Hôpital de Bicêtre</name-variant><affiliation-city>Le Kremlin-Bicetre</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:113145421</affiliation-url><afid>113145421</afid><affilname>Equipe Universitaire 3509</affilname><name-variant>Equipe Universitaire</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">27</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36626413200</author-url><authid>36626413200</authid><authname>Repessé X.</authname><surname>Repessé</surname><given-name>Xavier</given-name><initials>X.</initials><afid>60018317</afid><afid>60003335</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36626413200</author-url><authid>36626413200</authid><authname>Repessé X.</authname><surname>Repessé</surname><given-name>Xavier</given-name><initials>X.</initials><afid>60018317</afid><afid>60003335</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603599180</author-url><authid>6603599180</authid><authname>Moldes M.</authname><surname>Moldes</surname><given-name>Marthe</given-name><initials>M.</initials><afid>60001422</afid><afid>113060697</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6603599180</author-url><authid>6603599180</authid><authname>Moldes M.</authname><surname>Moldes</surname><given-name>Marthe</given-name><initials>M.</initials><afid>60001422</afid><afid>113060697</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37031592200</author-url><authid>37031592200</authid><authname>Muscat A.</authname><surname>Muscat</surname><given-name>Adeline</given-name><initials>A.</initials><afid>60018317</afid><afid>60001422</afid><afid>113060697</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37031592200</author-url><authid>37031592200</authid><authname>Muscat A.</authname><surname>Muscat</surname><given-name>Adeline</given-name><initials>A.</initials><afid>60018317</afid><afid>60001422</afid><afid>113060697</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:37031592200</author-url><authid>37031592200</authid><authname>Muscat A.</authname><surname>Muscat</surname><given-name>Adeline</given-name><initials>A.</initials><afid>60018317</afid><afid>60001422</afid><afid>113060697</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36946459400</author-url><authid>36946459400</authid><authname>Vatier C.</authname><surname>Vatier</surname><given-name>Camille</given-name><initials>C.</initials><afid>60001422</afid><afid>113060697</afid><afid>60009907</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36946459400</author-url><authid>36946459400</authid><authname>Vatier C.</authname><surname>Vatier</surname><given-name>Camille</given-name><initials>C.</initials><afid>60001422</afid><afid>113060697</afid><afid>60009907</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36946459400</author-url><authid>36946459400</authid><authname>Vatier C.</authname><surname>Vatier</surname><given-name>Camille</given-name><initials>C.</initials><afid>60001422</afid><afid>113060697</afid><afid>60009907</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701807656</author-url><authid>6701807656</authid><authname>Chetrite G.</authname><surname>Chetrite</surname><given-name>Gérard</given-name><initials>G.</initials><afid>60018317</afid><afid>60001422</afid><afid>113060697</afid><afid>60009907</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701807656</author-url><authid>6701807656</authid><authname>Chetrite G.</authname><surname>Chetrite</surname><given-name>Gérard</given-name><initials>G.</initials><afid>60018317</afid><afid>60001422</afid><afid>113060697</afid><afid>60009907</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701807656</author-url><authid>6701807656</authid><authname>Chetrite G.</authname><surname>Chetrite</surname><given-name>Gérard</given-name><initials>G.</initials><afid>60018317</afid><afid>60001422</afid><afid>113060697</afid><afid>60009907</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6701807656</author-url><authid>6701807656</authid><authname>Chetrite G.</authname><surname>Chetrite</surname><given-name>Gérard</given-name><initials>G.</initials><afid>60018317</afid><afid>60001422</afid><afid>113060697</afid><afid>60009907</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:12761799000</author-url><authid>12761799000</authid><authname>Gille T.</authname><surname>Gille</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60009647</afid><afid>60008800</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:12761799000</author-url><authid>12761799000</authid><authname>Gille T.</authname><surname>Gille</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60009647</afid><afid>60008800</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6603600829</author-url><authid>6603600829</authid><authname>Planes C.</authname><surname>Planes</surname><given-name>Carole</given-name><initials>C.</initials><afid>60009647</afid><afid>60008800</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:6603600829</author-url><authid>6603600829</authid><authname>Planes C.</authname><surname>Planes</surname><given-name>Carole</given-name><initials>C.</initials><afid>60009647</afid><afid>60008800</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56462379100</author-url><authid>56462379100</authid><authname>Filip A.</authname><surname>Filip</surname><given-name>Anna</given-name><initials>A.</initials><afid>60000905</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7006333958</author-url><authid>7006333958</authid><authname>Mercier N.</authname><surname>Mercier</surname><given-name>Nathalie</given-name><initials>N.</initials><afid>60000905</afid><afid>60104289</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7006333958</author-url><authid>7006333958</authid><authname>Mercier N.</authname><surname>Mercier</surname><given-name>Nathalie</given-name><initials>N.</initials><afid>60000905</afid><afid>60104289</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55314670800</author-url><authid>55314670800</authid><authname>Duranteau J.</authname><surname>Duranteau</surname><given-name>Jacques</given-name><initials>J.</initials><afid>60013430</afid><afid>113145421</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55314670800</author-url><authid>55314670800</authid><authname>Duranteau J.</authname><surname>Duranteau</surname><given-name>Jacques</given-name><initials>J.</initials><afid>60013430</afid><afid>113145421</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7004222238</author-url><authid>7004222238</authid><authname>Fève B.</authname><surname>Fève</surname><given-name>Bruno</given-name><initials>B.</initials><afid>60018317</afid><afid>60001422</afid><afid>113060697</afid><afid>60009907</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7004222238</author-url><authid>7004222238</authid><authname>Fève B.</authname><surname>Fève</surname><given-name>Bruno</given-name><initials>B.</initials><afid>60018317</afid><afid>60001422</afid><afid>113060697</afid><afid>60009907</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7004222238</author-url><authid>7004222238</authid><authname>Fève B.</authname><surname>Fève</surname><given-name>Bruno</given-name><initials>B.</initials><afid>60018317</afid><afid>60001422</afid><afid>113060697</afid><afid>60009907</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:7004222238</author-url><authid>7004222238</authid><authname>Fève B.</authname><surname>Fève</surname><given-name>Bruno</given-name><initials>B.</initials><afid>60018317</afid><afid>60001422</afid><afid>113060697</afid><afid>60009907</afid></author><authkeywords>Adipocyte | Diabetes | Hypoxia | Obesity | SSAO</authkeywords><intid>2036074527</intid><source-id>26206</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929317152"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929317152?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929317152&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929317152&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1569904815000956"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929317152</prism:url><dc:identifier>SCOPUS_ID:84929317152</dc:identifier><eid>2-s2.0-84929317152</eid><dc:title>Hydrogen sulfide and hypoxia-induced changes in TASK (K&lt;inf&gt;2P&lt;/inf&gt;3/9) activity and intracellular Ca&lt;sup&gt;2+&lt;/sup&gt; concentration in rat carotid body glomus cells</dc:title><dc:creator>Kim D.</dc:creator><prism:publicationName>Respiratory Physiology and Neurobiology</prism:publicationName><prism:issn>15699048</prism:issn><prism:eIssn>18781519</prism:eIssn><prism:volume>215</prism:volume><prism:pageRange>30-38</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.resp.2015.04.012</prism:doi><pii>S1569904815000956</pii><dc:description>© 2015 Elsevier B.V. Acute hypoxia depolarizes carotid body chemoreceptor (glomus) cells and elevates intracellular Ca&lt;sup&gt;2+&lt;/sup&gt; concentration ([Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;i&lt;/inf&gt;). Recent studies suggest that hydrogen sulfide (H&lt;inf&gt;2&lt;/inf&gt;S) may serve as an oxygen sensor/signal in the carotid body during acute hypoxia. To further test such a role for H&lt;inf&gt;2&lt;/inf&gt;S, we studied the effects of H&lt;inf&gt;2&lt;/inf&gt;S on the activity of TASK channel and [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;i&lt;/inf&gt;, which are considered important for mediating the glomus cell response to hypoxia. Like hypoxia, NaHS (a H&lt;inf&gt;2&lt;/inf&gt;S donor) inhibited TASK activity and elevated [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;i&lt;/inf&gt;. To inhibit the production of H&lt;inf&gt;2&lt;/inf&gt;S, glomus cells were incubated (3h) with inhibitors of cystathionine-β-synthase and cystathionine-γ-lyase (dl-propargylglycine, aminooxyacetic acid, β-cyano-l-alanine; 0.3mM). SF7 fluorescence was used to assess the level of H&lt;inf&gt;2&lt;/inf&gt;S production. The inhibitors blocked L-cysteine- and hypoxia-induced elevation of SF7 fluorescence intensity. In cells treated with the inhibitors, hypoxia produced an inhibition of TASK activity and a rise in [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;i&lt;/inf&gt;, similar in magnitude to those observed in control cells. L-cysteine produced no effect on TASK activity or [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;i&lt;/inf&gt; and did not affect hypoxia-induced inhibition of TASK and elevation of [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;i&lt;/inf&gt;. These findings suggest that under normal conditions, H&lt;inf&gt;2&lt;/inf&gt;S is not a major signal in hypoxia-induced modulation of TASK channels and [Ca&lt;sup&gt;2+&lt;/sup&gt;]&lt;inf&gt;i&lt;/inf&gt; in isolated glomus cells.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023655</affiliation-url><afid>60023655</afid><affilname>Chicago Medical School</affilname><name-variant>Chicago Medical School</name-variant><affiliation-city>Chicago</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024885</affiliation-url><afid>60024885</afid><affilname>University of Arkansas for Medical Sciences</affilname><name-variant>Univ. of Arkansas for Med. Sciences</name-variant><affiliation-city>Little Rock</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55742855200</author-url><authid>55742855200</authid><authname>Kim D.</authname><surname>Kim</surname><given-name>Donghee</given-name><initials>D.</initials><afid>60023655</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55712966800</author-url><authid>55712966800</authid><authname>Kim I.</authname><surname>Kim</surname><given-name>Insook</given-name><initials>I.</initials><afid>60024885</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56079160700</author-url><authid>56079160700</authid><authname>Wang J.</authname><surname>Wang</surname><given-name>Jiaju</given-name><initials>J.</initials><afid>60023655</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55619320724</author-url><authid>55619320724</authid><authname>White C.</authname><surname>White</surname><given-name>Carl</given-name><initials>C.</initials><afid>60023655</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35571479400</author-url><authid>35571479400</authid><authname>Carroll J.</authname><surname>Carroll</surname><given-name>John L.</given-name><initials>J.L.</initials><afid>60024885</afid></author><authkeywords>Carotid body | Chemoreceptors | Hydrogen sulfide | Hypoxia | L-Cysteine</authkeywords><intid>1535943351</intid><source-id>24030</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926181955"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926181955?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926181955&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926181955&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1386142515003832"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926181955</prism:url><dc:identifier>SCOPUS_ID:84926181955</dc:identifier><eid>2-s2.0-84926181955</eid><dc:title>Complementary analysis of tissue homogenates composition obtained by Vis and NIR laser excitations and Raman spectroscopy</dc:title><dc:creator>Staniszewska-Slezak E.</dc:creator><prism:publicationName>Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy</prism:publicationName><prism:issn>13861425</prism:issn><prism:volume>147</prism:volume><prism:pageRange>245-256</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>5 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.saa.2015.03.086</prism:doi><pii>S1386142515003832</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Raman spectroscopy and four excitation lines in the visible (Vis: 488, 532, 633 nm) and near infrared (NIR: 785 nm) were used for biochemical analysis of rat tissue homogenates, i.e. myocardium, brain, liver, lung, intestine, and kidney. The Vis Raman spectra are very similar for some organs (brain/intestines and kidney/liver) and dominated by heme signals when tissues of lung and myocardium were investigated (especially with 532 nm excitation). On the other hand, the NIR Raman spectra are specific for each tissue and more informative than the corresponding ones collected with the Vis excitations. The spectra analyzed without any special pre-processing clearly illustrate different chemical composition of each tissue and give information about main components e.g. lipids or proteins, but also about the content of some specific compounds such as amino acid residues, nucleotides and nucleobases. However, in order to obtain the whole spectral information about tissues complex composition the spectra of Vis and NIR excitations should be collected and analyzed together. A good agreement of data gathered from Raman spectra of the homogenates and those obtained previously from Raman imaging of the tissue cross-sections indicates that the presented here approach can be a method of choice for an investigation of biochemical variation in animal tissues. Moreover, the Raman spectral profile of tissue homogenates is specific enough to be used for an investigation of potential pathological changes the organism undergoes, in particular when supported by the complementary FTIR spectroscopy.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021361</affiliation-url><afid>60021361</afid><affilname>Uniwersytet Jagiellonski w Krakowie</affilname><name-variant>Jagiellonian University</name-variant><affiliation-city>Krakow</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60021361</affiliation-url><afid>60021361</afid><affilname>Uniwersytet Jagiellonski w Krakowie</affilname><name-variant>Jagiellonian University</name-variant><affiliation-city>Krakow</affiliation-city><affiliation-country>Poland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56565591900</author-url><authid>56565591900</authid><authname>Staniszewska-Slezak E.</authname><surname>Staniszewska-Slezak</surname><given-name>Emilia</given-name><initials>E.</initials><afid>60021361</afid><afid>60021361</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56565591900</author-url><authid>56565591900</authid><authname>Staniszewska-Slezak E.</authname><surname>Staniszewska-Slezak</surname><given-name>Emilia</given-name><initials>E.</initials><afid>60021361</afid><afid>60021361</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004666071</author-url><authid>7004666071</authid><authname>Malek K.</authname><surname>Malek</surname><given-name>Kamilla</given-name><initials>K.</initials><afid>60021361</afid><afid>60021361</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004666071</author-url><authid>7004666071</authid><authname>Malek K.</authname><surname>Malek</surname><given-name>Kamilla</given-name><initials>K.</initials><afid>60021361</afid><afid>60021361</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603933941</author-url><authid>6603933941</authid><authname>Baranska M.</authname><surname>Baranska</surname><given-name>Malgorzata</given-name><initials>M.</initials><afid>60021361</afid><afid>60021361</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6603933941</author-url><authid>6603933941</authid><authname>Baranska M.</authname><surname>Baranska</surname><given-name>Malgorzata</given-name><initials>M.</initials><afid>60021361</afid><afid>60021361</afid></author><authkeywords>Comparative analysis | Excitation laser lines | Raman spectroscopy | Tissue homogenates</authkeywords><intid>35428131</intid><source-id>24530</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928887972"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928887972?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928887972&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928887972&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021999115002971"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928887972</prism:url><dc:identifier>SCOPUS_ID:84928887972</dc:identifier><eid>2-s2.0-84928887972</eid><dc:title>A non-iterative direct forcing immersed boundary method for strongly-coupled fluid-solid interactions</dc:title><dc:creator>Yang J.</dc:creator><prism:publicationName>Journal of Computational Physics</prism:publicationName><prism:issn>00219991</prism:issn><prism:eIssn>10902716</prism:eIssn><prism:volume>295</prism:volume><prism:pageRange>779-804</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jcp.2015.04.040</prism:doi><pii>S0021999115002971</pii><dc:description>© 2015 Elsevier Inc. A non-iterative direct forcing immersed boundary method is presented for the strongly-coupled simulations of fluid-solid interactions. While it retains many advantages of the immersed boundary framework by Yang and Stern (2012) [30], especially the simplified field extension strategy for moving boundary treatment and the pointwise integration of hydrodynamic force using the momentum forcing term, the present approach improves upon the previous method in several aspects including optimized computational cost for a strong coupling scheme, reduced algorithm complexity for a straightforward implementation, and enhanced numerical stability for low density ratio problems. Central to these improvements is a simple intermediate step in which the velocity fields around solid bodies are predicted on temporary non-inertial reference frames attached to moving solid bodies in a one-to-one manner. This step enables the explicit inverse of the implicit equations for rigid body dynamics, thus rendering unnecessary the previous predictor-corrector scheme for iteratively adjusting the displacements and velocities of the immersed bodies until reaching a convergence. In addition, a simple, generalized procedure is developed to obtain the interpolation coefficients in a local reconstruction stencil explicitly from the geometric relationship. For verification and validation, the vortex-induced vibration of a circular cylinder and the rotational galloping of a rectangular body are considered first; then several particulate flow problems, including settling and buoyant particles of low density ratios, a settling particle in a small container, and the kissing-drafting-tumbling problem of two settling particles, are studied. The agreement between the present results and the reference data in the literature is excellent. An overall second-order accuracy of the algorithm is verified in two systematic grid convergence tests. The present idea can be easily applied to similar methods for achieving a strong coupling scheme on top of a weak one with a nominal increase in the computational cost. Details of the algorithm are provided to facilitate its implementation in other solvers using non-boundary-conforming grids.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:</affiliation-url><afid/><affilname>University of Iowa</affilname><name-variant>IIHR - Hydroscience and Engineering</name-variant><affiliation-city>Iowa City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:36647084400</author-url><authid>36647084400</authid><authname>Yang J.</authname><surname>Yang</surname><given-name>Jianming</given-name><initials>J.</initials><afid/></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7005001633</author-url><authid>7005001633</authid><authname>Stern F.</authname><surname>Stern</surname><given-name>Frederick</given-name><initials>F.</initials><afid/></author><authkeywords>Cartesian grid | Direct forcing | Fluid-solid interaction | Fluid-structure interaction | Galloping | Immersed boundary method | Non-inertial reference frame | Non-iterative scheme | Particulate flow | Reconstruction stencil | Strong coupling | Vortex-induced vibration</authkeywords><intid>35862899</intid><source-id>13191</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927762367"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927762367?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927762367&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927762367&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0048969715004209"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927762367</prism:url><dc:identifier>SCOPUS_ID:84927762367</dc:identifier><eid>2-s2.0-84927762367</eid><dc:title>Metabolomic responses in caged clams, Ruditapes decussatus, exposed to agricultural and urban inputs in a Mediterranean coastal lagoon (Mar Menor, SE Spain)</dc:title><dc:creator>Campillo J.</dc:creator><prism:publicationName>Science of the Total Environment</prism:publicationName><prism:issn>00489697</prism:issn><prism:eIssn>18791026</prism:eIssn><prism:volume>524-525</prism:volume><prism:pageRange>136-147</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.scitotenv.2015.03.136</prism:doi><pii>S0048969715004209</pii><dc:description>© 2015 Elsevier B.V. The Mar Menor is a coastal lagoon affected by the growth of intensive agriculture and urban development in the surrounding area. Large amounts of chemical pollutants from these areas are discharged into El Albujón, a permanent water-course flowing into the lagoon. Biomarkers such as the activity of acetylcholinesterase or antioxidant enzymes have been previously tested in this lagoon demonstrating the presence of neurotoxicity and oxidative stress in clams transplanted in sites affected by the dispersion of the effluent from El Albujón. To complete this traditional toxicology work, a metabolomic profiling of these transplanted organisms has been carried out for the detection of metabolic biomarkers induced by agricultural/urban pollutants. More than 70 metabolites have been quantified using a targeting metabolomics platform based on HPLC-MS. The intracellular metabolic pattern was analyzed by PCA from the digestive gland of clams after 7 and 22. days of transplantation. Results showed a different profile of metabolite between organisms collected from control and exposed sites. At the shorter exposure time, there was an increase in several metabolites in the latter when compared with those from control sites, whereas metabolic profiling at 22. days showed that those metabolites were drastically diminished, with even lower levels than at control sites. These metabolites included: (i) 12 amino acids from the 21 proteogenic and HomoSer, (ii) osmotic protectants such as γ-butyrobetaine and taurine and (iii) nucleotides such as ITP. Regarding sulfur-containing molecules, taurine could be highlighted as a potential biomarker since its concentration was reduced by more than 30 times after 22. days of exposure, whereas the antioxidant glutathione remained constant in the organisms from both control and exposed sites. Although targeted metabolomics has been shown as an early technique of pollutant effect detection, the two-phase pattern could highlight a more complicated metabolite response to pollutants than classical biomarkers.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000950</affiliation-url><afid>60000950</afid><affilname>Instituto Espanol de Oceanografia</affilname><name-variant>Southampton Oceanography Centre</name-variant><affiliation-city>Madrid</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006288</affiliation-url><afid>60006288</afid><affilname>Delft University of Technology</affilname><name-variant>Delft University of Technology</name-variant><affiliation-city>Delft</affiliation-city><affiliation-country>Netherlands</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000130</affiliation-url><afid>60000130</afid><affilname>Universidad de Murcia</affilname><name-variant>University of Murcia</name-variant><affiliation-city>Murcia</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000130</affiliation-url><afid>60000130</afid><affilname>Universidad de Murcia</affilname><name-variant>University of Murcia</name-variant><affiliation-city>Murcia</affiliation-city><affiliation-country>Spain</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23995170400</author-url><authid>23995170400</authid><authname>Campillo J.</authname><surname>Campillo</surname><given-name>Juan A.</given-name><initials>J.A.</initials><afid>60000950</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55425740000</author-url><authid>55425740000</authid><authname>Sevilla A.</authname><surname>Sevilla</surname><given-name>Angel</given-name><initials>A.</initials><afid>60006288</afid><afid>60000130</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55425740000</author-url><authid>55425740000</authid><authname>Sevilla A.</authname><surname>Sevilla</surname><given-name>Angel</given-name><initials>A.</initials><afid>60006288</afid><afid>60000130</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6701572482</author-url><authid>6701572482</authid><authname>Albentosa M.</authname><surname>Albentosa</surname><given-name>Marina</given-name><initials>M.</initials><afid>60000950</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55331391300</author-url><authid>55331391300</authid><authname>Bernal C.</authname><surname>Bernal</surname><given-name>Cristina</given-name><initials>C.</initials><afid>60000130</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55485222900</author-url><authid>55485222900</authid><authname>Lozano A.</authname><surname>Lozano</surname><given-name>Ana B.</given-name><initials>A.B.</initials><afid>60000130</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56240036800</author-url><authid>56240036800</authid><authname>Cánovas M.</authname><surname>Cánovas</surname><given-name>Manuel</given-name><initials>M.</initials><afid>60000130</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7004598871</author-url><authid>7004598871</authid><authname>León V.</authname><surname>León</surname><given-name>Víctor M.</given-name><initials>V.M.</initials><afid>60000950</afid></author><authkeywords>Biomarkers | Metabolomics | Pollution | Toxicity</authkeywords><intid>35665844</intid><source-id>25349</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930181093"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930181093?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930181093&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930181093&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0303720715001720"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930181093</prism:url><dc:identifier>SCOPUS_ID:84930181093</dc:identifier><eid>2-s2.0-84930181093</eid><dc:title>MicroRNA-765 influences arterial stiffness through modulating apelin expression</dc:title><dc:creator>Liao Y.</dc:creator><prism:publicationName>Molecular and Cellular Endocrinology</prism:publicationName><prism:issn>03037207</prism:issn><prism:eIssn>18728057</prism:eIssn><prism:volume>411</prism:volume><prism:pageRange>11-19</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.mce.2015.04.006</prism:doi><pii>S0303720715001720</pii><dc:description>© 2015 Elsevier Ireland Ltd. The present study aims to discover single nucleotide polymorphisms (SNPs) at the apelin gene (. APLN) in relation to arterial stiffness, and to explore its molecular mechanisms. A two-step genetic association study was conducted using 799 and 937 subjects in the screening and validation data, respectively. Four tagging SNPs of APLN were tested. SNP rs3115757 was significantly associated with stiffness parameters (β, Ep and PWV) in women, but not in men. The function of rs3115757 was tagged by rs3115758 which is located in miR-765 binding site in the 3' untranslated region of APLN. The reporter assay confirmed that different alleles of rs3115758 interfered with miR-765 binding and then modified APLN expression. Over-expression of miR-765 in endothelial cells decreased mRNA and protein levels of A. PLN, which further inhibited the phosphorylation of eNOS and ERK/Akt/AMPK signaling. Collectively, our data showed that rs3115758 accounts for the susceptibility of arterial stiffening through miR-765-induced APLN repression.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013314</affiliation-url><afid>60013314</afid><affilname>Veterans General Hospital-Taipei</affilname><name-variant>Taipei Veterans General Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003525</affiliation-url><afid>60003525</afid><affilname>National Yang-Ming University, School of Medicine</affilname><name-variant>Natl. Yang-Ming Univ. Sch. of Med.</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005429</affiliation-url><afid>60005429</afid><affilname>National Taiwan University</affilname><name-variant>National Taiwan University</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012256</affiliation-url><afid>60012256</afid><affilname>Kaohsiung Medical University</affilname><name-variant>Kaohsiung Medical University</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073387</affiliation-url><afid>60073387</afid><affilname>Kaohsiung Medical University Chung-Ho Memorial Hospital</affilname><name-variant>Kaohsiung Medical University Hospital</name-variant><affiliation-city>Kaohsiung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006121</affiliation-url><afid>60006121</afid><affilname>Veterans General Hospital-Taichung Taiwan</affilname><name-variant>Taichung Veterans General Hospital</name-variant><affiliation-city>Taichung</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">9</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23051389700</author-url><authid>23051389700</authid><authname>Liao Y.</authname><surname>Liao</surname><given-name>Yi Chu</given-name><initials>Y.C.</initials><afid>60013314</afid><afid>60003525</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:23051389700</author-url><authid>23051389700</authid><authname>Liao Y.</authname><surname>Liao</surname><given-name>Yi Chu</given-name><initials>Y.C.</initials><afid>60013314</afid><afid>60003525</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36509387300</author-url><authid>36509387300</authid><authname>Wang Y.</authname><surname>Wang</surname><given-name>Yung Song</given-name><initials>Y.S.</initials><afid>60005429</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:15053395800</author-url><authid>15053395800</authid><authname>Hsi E.</authname><surname>Hsi</surname><given-name>Edward</given-name><initials>E.</initials><afid>60012256</afid><afid>60073387</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:15053395800</author-url><authid>15053395800</authid><authname>Hsi E.</authname><surname>Hsi</surname><given-name>Edward</given-name><initials>E.</initials><afid>60012256</afid><afid>60073387</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56097302500</author-url><authid>56097302500</authid><authname>Chang M.</authname><surname>Chang</surname><given-name>Ming Hung</given-name><initials>M.H.</initials><afid>60006121</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56604623900</author-url><authid>56604623900</authid><authname>You Y.</authname><surname>You</surname><given-name>Yun Zhen</given-name><initials>Y.Z.</initials><afid>60006121</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003867375</author-url><authid>7003867375</authid><authname>Juo S.</authname><surname>Juo</surname><given-name>Suh Hang Hank</given-name><initials>S.H.H.</initials><afid>60012256</afid><afid>60073387</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003867375</author-url><authid>7003867375</authid><authname>Juo S.</authname><surname>Juo</surname><given-name>Suh Hang Hank</given-name><initials>S.H.H.</initials><afid>60012256</afid><afid>60073387</afid></author><authkeywords>Arterial stiffness | Endothelial nitric oxide synthase | MicroRNAs | Single nucleotide polymorphism</authkeywords><intid>1036074645</intid><source-id>26206</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930227259"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930227259?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930227259&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930227259&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0378427415001769"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930227259</prism:url><dc:identifier>SCOPUS_ID:84930227259</dc:identifier><eid>2-s2.0-84930227259</eid><dc:title>Natural products-friends or foes?</dc:title><dc:creator>Margină D.</dc:creator><prism:publicationName>Toxicology Letters</prism:publicationName><prism:issn>03784274</prism:issn><prism:eIssn>18793169</prism:eIssn><prism:volume>236</prism:volume><prism:issueIdentifier>3</prism:issueIdentifier><prism:pageRange>154-167</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.toxlet.2015.05.009</prism:doi><pii>S0378427415001769</pii><dc:description>© 2015 . A trend in the general population has been observed in recent years regarding the orientation toward preventive measures in health; in this context the increased interest from the users and researchers concerning the active effect of food supplements on the health state and on longevity, is noticeable. All over the world, the consumption of natural foods and of vegetal supplements has increased spectacularly over the last 5-10 years. The decreased prevalence of cardio-vascular diseases associated with Mediterranean diet, as well as the French paradox convinced researchers to scientifically document the beneficial outcomes pointed out by traditional use of plants, and to try to develop supplements that would have the same positive effects as these noticed for diet components.The intense research dedicated to this topic revealed the fact that food supplements are linked to some problematic aspects, such as toxicological side effects when associated with classical synthetic drugs. The food supplement-drug interactions are submitted to complex issues regarding pharmacokinetic interactions leading to changes in absorption, distribution, metabolism and excretion processes with direct impact on effect and toxicological potential.The present review based on recent literature aims at discussing the food-drug interactions with direct impact on efficacy and toxicity of drugs.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60033150</affiliation-url><afid>60033150</afid><affilname>Universitatea de Medicina si Farmacie Carol Davila din Bucuresti</affilname><name-variant>Carol Davila University of Medicine and Pharmacy</name-variant><affiliation-city>Bucuresti</affiliation-city><affiliation-country>Romania</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001524</affiliation-url><afid>60001524</afid><affilname>Panepistimio Kritis</affilname><name-variant>University of Crete</name-variant><affiliation-city>Rethymnon</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025812</affiliation-url><afid>60025812</afid><affilname>Panepistimio Thesalias</affilname><name-variant>University of Thessaly</name-variant><affiliation-city>Volos</affiliation-city><affiliation-country>Greece</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">6</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8612023800</author-url><authid>8612023800</authid><authname>Margină D.</authname><surname>Margină</surname><given-name>Denisa</given-name><initials>D.</initials><afid>60033150</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7004423355</author-url><authid>7004423355</authid><authname>Ilie M.</authname><surname>Ilie</surname><given-name>Mihaela</given-name><initials>M.</initials><afid>60033150</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602180181</author-url><authid>6602180181</authid><authname>Grădinaru D.</authname><surname>Grădinaru</surname><given-name>Daniela</given-name><initials>D.</initials><afid>60033150</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:23979379600</author-url><authid>23979379600</authid><authname>Androutsopoulos V.</authname><surname>Androutsopoulos</surname><given-name>Vasilis P.</given-name><initials>V.P.</initials><afid>60001524</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004229191</author-url><authid>7004229191</authid><authname>Kouretas D.</authname><surname>Kouretas</surname><given-name>Demetrios</given-name><initials>D.</initials><afid>60025812</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35596169100</author-url><authid>35596169100</authid><authname>Tsatsakis A.</authname><surname>Tsatsakis</surname><given-name>Aristidis M.</given-name><initials>A.M.</initials><afid>60001524</afid></author><authkeywords>Diet components | Food supplements | Food-drug interactions | Toxic outcomes</authkeywords><intid>2036081377</intid><source-id>25240</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929177848"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929177848?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929177848&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929177848&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1569904815000944"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929177848</prism:url><dc:identifier>SCOPUS_ID:84929177848</dc:identifier><eid>2-s2.0-84929177848</eid><dc:title>Fentanyl effects on breath generation in C57BL/6J and A/J mouse strains</dc:title><dc:creator>Fechtner L.</dc:creator><prism:publicationName>Respiratory Physiology and Neurobiology</prism:publicationName><prism:issn>15699048</prism:issn><prism:eIssn>18781519</prism:eIssn><prism:volume>215</prism:volume><prism:pageRange>20-29</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.resp.2015.04.011</prism:doi><pii>S1569904815000944</pii><dc:description>© 2015. We examined the effect of fentanyl on chemoresponsiveness in mouse strains divergent in the expression of spontaneous and post-hypoxic pauses. Frequency and tidal volume were recorded with plethysmography in A/J and C57BL/6J (B6) male mice. Mice selected at random received an intraperitoneal (IP) injection of either saline, low dose fentanyl (LDF=0.04mg/kg), or high dose fentanyl (HDF=0.4mg/kg) under hypoxia (8% O&lt;inf&gt;2&lt;/inf&gt;) or hyperoxia (100%O&lt;inf&gt;2&lt;/inf&gt;). LDF produced a decrease in frequency during hypoxia in B6, but not A/J, mice. HDF significantly decreased frequency and tidal volume in both strains under hypoxia and hyperoxia (p&lt;0.01); naloxone, an opioid antagonist, reversed this response. The acute administration of fentanyl at any dose did not promote apneas in strains of mice exhibiting regular or irregular respiratory patterns. However, higher doses depressed respiratory frequency in both strains. The B6 mice responded with a depressive response to hypoxia that did not recover with reoxygenation, but did recover with time or naloxone.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006404</affiliation-url><afid>60006404</afid><affilname>CASE School of Medicine</affilname><name-variant>Case Western Reserve University School of Medicine</name-variant><affiliation-city>Cleveland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60014232</affiliation-url><afid>60014232</afid><affilname>VA Medical Center</affilname><affiliation-city/><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000305</affiliation-url><afid>60000305</afid><affilname>Case Western Reserve University</affilname><name-variant>Case Western Reserve University</name-variant><affiliation-city>Cleveland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56641804300</author-url><authid>56641804300</authid><authname>Fechtner L.</authname><surname>Fechtner</surname><given-name>Linnea</given-name><initials>L.</initials><afid>60006404</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640314500</author-url><authid>56640314500</authid><authname>Ali M.</authname><surname>Ali</surname><given-name>Mazen El</given-name><initials>M.E.</initials><afid>60014232</afid><afid>60000305</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640314500</author-url><authid>56640314500</authid><authname>Ali M.</authname><surname>Ali</surname><given-name>Mazen El</given-name><initials>M.E.</initials><afid>60014232</afid><afid>60000305</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640869200</author-url><authid>56640869200</authid><authname>Sattar A.</authname><surname>Sattar</surname><given-name>Abdus</given-name><initials>A.</initials><afid>60006404</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:54780281600</author-url><authid>54780281600</authid><authname>Moore M.</authname><surname>Moore</surname><given-name>Michael</given-name><initials>M.</initials><afid>60014232</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004903850</author-url><authid>7004903850</authid><authname>Strohl K.</authname><surname>Strohl</surname><given-name>Kingman P.</given-name><initials>K.P.</initials><afid>60014232</afid><afid>60000305</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004903850</author-url><authid>7004903850</authid><authname>Strohl K.</authname><surname>Strohl</surname><given-name>Kingman P.</given-name><initials>K.P.</initials><afid>60014232</afid><afid>60000305</afid></author><authkeywords>Apnea | Genetic background | Hypoxia | Ventilatory control</authkeywords><intid>1035911394</intid><source-id>24030</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928531174"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928531174?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928531174&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928531174&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021999115002636"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928531174</prism:url><dc:identifier>SCOPUS_ID:84928531174</dc:identifier><eid>2-s2.0-84928531174</eid><dc:title>Grad's approximation for moving and stationary walls in entropic lattice Boltzmann simulations</dc:title><dc:creator>Dorschner B.</dc:creator><prism:publicationName>Journal of Computational Physics</prism:publicationName><prism:issn>00219991</prism:issn><prism:eIssn>10902716</prism:eIssn><prism:volume>295</prism:volume><prism:pageRange>340-354</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jcp.2015.04.017</prism:doi><pii>S0021999115002636</pii><dc:description>© 2015 Elsevier Inc. We introduce a new generalized wall boundary condition for the entropic lattice Boltzmann method (ELBM) that is capable of handling complex flow geometries including moving walls. The Grad's ten moments approximation is employed to approximate the missing populations at the boundary nodes. The new boundary condition significantly improves accuracy, stability and sub-grid features of LBM and in particular of its entropic variant, ELBM. The proposed boundary condition is tested for a range of flows in two dimensions, including planar channel flow, Couette flow, flow past a circular cylinder and sedimenting circular particles. Further simulations involving complex geometries such as flapping wing and transversely oscillating cylinder demonstrate superior stability and accuracy of the new wall boundary condition.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025858</affiliation-url><afid>60025858</afid><affilname>Eidgenossische Technische Hochschule Zurich</affilname><name-variant>ETH Zurich</name-variant><affiliation-city>Zurich</affiliation-city><affiliation-country>Switzerland</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56607286300</author-url><authid>56607286300</authid><authname>Dorschner B.</authname><surname>Dorschner</surname><given-name>B.</given-name><initials>B.</initials><afid>60025858</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6504588772</author-url><authid>6504588772</authid><authname>Chikatamarla S.</authname><surname>Chikatamarla</surname><given-name>S. S.</given-name><initials>S.S.</initials><afid>60025858</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56207792200</author-url><authid>56207792200</authid><authname>Bösch F.</authname><surname>Bösch</surname><given-name>F.</given-name><initials>F.</initials><afid>60025858</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:7005694242</author-url><authid>7005694242</authid><authname>Karlin I.</authname><surname>Karlin</surname><given-name>I. V.</given-name><initials>I.V.</initials><afid>60025858</afid></author><authkeywords>Complex boundaries | Entropic lattice Boltzmann method (ELBM) | Moving boundaries</authkeywords><intid>1535801497</intid><source-id>13191</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929179542"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929179542?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929179542&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929179542&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0169743915001136"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929179542</prism:url><dc:identifier>SCOPUS_ID:84929179542</dc:identifier><eid>2-s2.0-84929179542</eid><dc:title>A gross error detection method based on 3MAD-GRW-MMMD</dc:title><dc:creator>Xiao D.</dc:creator><prism:publicationName>Chemometrics and Intelligent Laboratory Systems</prism:publicationName><prism:issn>01697439</prism:issn><prism:eIssn>18733239</prism:eIssn><prism:volume>146</prism:volume><prism:pageRange>24-33</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.chemolab.2015.04.021</prism:doi><pii>S0169743915001136</pii><dc:description>© 2015 Elsevier B.V. Due to various reasons, there are inevitably gross errors in the data collected in the field. Gross errors need to be detected for modeling data to keep soft-sensing model accurate. Because different variables have different degrees of influence on modeling, gross error detection method is proposed, which is based on 3MAD-GRW-MMMD weighted clustering analysis. Combined with 3MAD method, this new method avoids the affect of large errors which are in a single variable before detecting gross errors of multivariate data. Meanwhile, based on the classic clustering algorithm-MMMD method, the new method adds the appropriate weights to the calculation of variables using gray relational analysis (GRA). Then the gross errors of the dominant variables in the multivariate data sets are detected. In addition, this new method is used to process the data sets of relevant parameters in penicillin fermentation and the smelting of LF refining furnace. Experiments and simulation results show that gross error detection method based on 3MAD-GRW-MMMD weighted clustering analysis is real-time, accurate, economical and reliable.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031863</affiliation-url><afid>60031863</afid><affilname>Northeastern University China</affilname><name-variant>Northeastern University</name-variant><affiliation-city>Shenyang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:49362391900</author-url><authid>49362391900</authid><authname>Xiao D.</authname><surname>Xiao</surname><given-name>Dong</given-name><initials>D.</initials><afid>60031863</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640509400</author-url><authid>56640509400</authid><authname>Bao J.</authname><surname>Bao</surname><given-name>Jingjing</given-name><initials>J.</initials><afid>60031863</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640012400</author-url><authid>56640012400</authid><authname>Zhang B.</authname><surname>Zhang</surname><given-name>Bi</given-name><initials>B.</initials><afid>60031863</afid></author><authkeywords>3MAD (3 median deviation) | Cluster analysis | Gross errors | GRW (gray relational weighted) | MMMD (modified median minimum distance)</authkeywords><intid>1535915629</intid><source-id>24595</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84925388537"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84925388537?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84925388537&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84925388537&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0956566315001906"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84925388537</prism:url><dc:identifier>SCOPUS_ID:84925388537</dc:identifier><eid>2-s2.0-84925388537</eid><dc:title>Rapid and sensitive detection of multiple microRNAs in cell lysate by low-fouling surface plasmon resonance biosensor</dc:title><dc:creator>Vaisocherová H.</dc:creator><prism:publicationName>Biosensors and Bioelectronics</prism:publicationName><prism:issn>09565663</prism:issn><prism:eIssn>18734235</prism:eIssn><prism:volume>70</prism:volume><prism:pageRange>226-231</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bios.2015.03.038</prism:doi><pii>S0956566315001906</pii><dc:description>© 2015 Elsevier B.V. We report an ultra-low fouling surface plasmon resonance imaging (SPRi) biosensor for the rapid simultaneous detection of multiple miRNAs in erythrocyte lysate (EL) at subpicomolar levels without need of RNA extraction. The SPRi chips were coated with ultra-low fouling functionalizable poly(carboxybetaine acrylamide) (pCBAA) brushes having optimized thicknesses and directly functionalized with amino-modified oligonucleotide probes. We have characterized the effect of the brush thickness on the probe loading capacity: a loading capacity of ~9.8×1012probes/cm2 was achieved for pCBAA having a thickness of ~40nm. The probe-functionalized sensor also exhibited a high resistance to fouling from ~90% EL samples (&lt;2ng/cm2). A two-step detection assay was employed for multiplexed miRNA detection in EL. Specifically, the assay consisted of (i) a sandwich-type hybridization of the probe-functionalized pCBAA with target miRNA in EL (bound to biotinylated oligonucleotides) and (ii) the capture of streptavidin-functionalized gold nanoparticles to the aforementioned biotinylated probes. We have demonstrated that this approach enables the detection of miRNAs in EL at concentrations as low as 0.5pM. Finally, we have confirmed the detection of four endogenous miRNAs representing a set of potential miRNA biomarkers of myelodysplastic syndrome (MDS) in clinical EL samples (miR-16, miR-181, miR-34a, and miR-125b). The results revealed significantly higher levels of miR-16 in all the clinical EL samples compared to the other measured miRNAs.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60060658</affiliation-url><afid>60060658</afid><affilname>Institute of Photonics and Electronics of the Academy of Sciences of the Czech Republic</affilname><name-variant>Academy of Sciences of the Czech Republic</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000796</affiliation-url><afid>60000796</afid><affilname>Institute of Hematology and Blood Transfusion</affilname><name-variant>Institute of Haematology and Blood Transfusion</name-variant><affiliation-city>Prague</affiliation-city><affiliation-country>Czech Republic</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">15</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:8954651600</author-url><authid>8954651600</authid><authname>Vaisocherová H.</authname><surname>Vaisocherová</surname><given-name>Hana</given-name><initials>H.</initials><afid>60060658</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:25641829000</author-url><authid>25641829000</authid><authname>Šípová H.</authname><surname>Šípová</surname><given-name>Hana</given-name><initials>H.</initials><afid>60060658</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56568463200</author-url><authid>56568463200</authid><authname>Víšová I.</authname><surname>Víšová</surname><given-name>Ivana</given-name><initials>I.</initials><afid>60060658</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35168765900</author-url><authid>35168765900</authid><authname>Bocková M.</authname><surname>Bocková</surname><given-name>Markéta</given-name><initials>M.</initials><afid>60060658</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:25641913800</author-url><authid>25641913800</authid><authname>Špringer T.</authname><surname>Špringer</surname><given-name>Tomáš</given-name><initials>T.</initials><afid>60060658</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56568397200</author-url><authid>56568397200</authid><authname>Laura Ermini M.</authname><surname>Laura Ermini</surname><given-name>Maria</given-name><initials>M.</initials><afid>60060658</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56567029000</author-url><authid>56567029000</authid><authname>Song X.</authname><surname>Song</surname><given-name>Xue</given-name><initials>X.</initials><afid>60060658</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:6506611679</author-url><authid>6506611679</authid><authname>Krejčík Z.</authname><surname>Krejčík</surname><given-name>Zdeněk</given-name><initials>Z.</initials><afid>60000796</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:54894851500</author-url><authid>54894851500</authid><authname>Chrastinová L.</authname><surname>Chrastinová</surname><given-name>Leona</given-name><initials>L.</initials><afid>60000796</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56281929900</author-url><authid>56281929900</authid><authname>Pastva O.</authname><surname>Pastva</surname><given-name>Ondřej</given-name><initials>O.</initials><afid>60000796</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:54917432300</author-url><authid>54917432300</authid><authname>Pimková K.</authname><surname>Pimková</surname><given-name>Kristýna</given-name><initials>K.</initials><afid>60060658</afid><afid>60000796</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:54917432300</author-url><authid>54917432300</authid><authname>Pimková K.</authname><surname>Pimková</surname><given-name>Kristýna</given-name><initials>K.</initials><afid>60060658</afid><afid>60000796</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:36659048900</author-url><authid>36659048900</authid><authname>Dostálová Merkerová M.</authname><surname>Dostálová Merkerová</surname><given-name>Michaela</given-name><initials>M.</initials><afid>60000796</afid></author><author seq="13"><author-url>http://api.elsevier.com/content/author/author_id:7003357434</author-url><authid>7003357434</authid><authname>Dyr J.</authname><surname>Dyr</surname><given-name>Jan E.</given-name><initials>J.E.</initials><afid>60000796</afid></author><author seq="14"><author-url>http://api.elsevier.com/content/author/author_id:7007017469</author-url><authid>7007017469</authid><authname>Homola J.</authname><surname>Homola</surname><given-name>Jiří</given-name><initials>J.</initials><afid>60060658</afid></author><authkeywords>DNA array | Erythrocyte lysate | Low-fouling surface chemistry | MicroRNA | Polymer brushes | Surface plasmon resonance imaging</authkeywords><intid>2035290738</intid><source-id>15437</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930181000"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930181000?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930181000&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930181000&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0303720715002373"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930181000</prism:url><dc:identifier>SCOPUS_ID:84930181000</dc:identifier><eid>2-s2.0-84930181000</eid><dc:title>Fatty Acid-Binding Protein 4 mediates apoptosis via endoplasmic reticulum stress in mesangial cells of diabetic nephropathy</dc:title><dc:creator>Yao F.</dc:creator><prism:publicationName>Molecular and Cellular Endocrinology</prism:publicationName><prism:issn>03037207</prism:issn><prism:eIssn>18728057</prism:eIssn><prism:volume>411</prism:volume><prism:pageRange>232-242</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.mce.2015.05.003</prism:doi><pii>S0303720715002373</pii><dc:description>© 2015 Elsevier Ireland Ltd. Type 2 diabetes is characterized by hyperglycemia and deregulated lipid metabolism with increased plasma non-esterified fatty acids (NEFA). Apoptosis of glomerular cells is a hallmark in diabetic glomerulosclerosis. Fatty acid-binding protein 4 (FABP4), a carrier protein for fatty acids, has been linked to diabetes and diabetic nephropathy (DN). Here we aimed to investigate the link between FABP4 and apoptosis in diabetic glomerulosclerosis. We first evaluated the presence of FABP4 and ER stress markers as well as apoptosis-related proteins in renal biopsies of patients with DN. Then we used FABP4 inhibitor BMS309403 or siRNA to further investigate the role of FABP4 in ER stress and apoptosis induced by NEFA or high glucose in cultured human mesangial cells (HMCs).We found FABP4 was expressed mainly in glomerular mesangial cells of the human renal biopsies and the glomerular FABP4 was increased in renal biopsies of DN. The up-regulation of FABP4 was accompanied with increased glucose-regulated protein 78 (GRP78) and Caspase-12 as well as down-regulated B-cell CLL/lymphoma 2 (Bcl-2) in glomeruli. Along with the induction of FABP4 and apoptosis, GRP78 and its three sensors as well as C/EBP homologous protein (CHOP) and Caspase-12 were induced in HMCs treated with NEFA or high glucose and these responses were attenuated or even abrogated by treating with FABP4 inhibitor or FABP4 siRNA. Ultrastructure observation confirmed the lipotoxicity of oleic acid by showing the morphological damage in HMCs. Our data suggest that FABP4 in glomerular mesangial cells is up-regulated in DN and FABP4 mediates apoptosis via the ER stress in HMCs.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009884</affiliation-url><afid>60009884</afid><affilname>Hebei Medical University</affilname><name-variant>Hebei Medical University</name-variant><affiliation-city>Shijiazhuang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:112723207</affiliation-url><afid>112723207</afid><affilname>Key Laboratory of Forensic Medicine of Hebei Province</affilname><name-variant>Key Laboratory of Kidney Diseases of Hebei Province</name-variant><affiliation-city>Shijiazhuang</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114031649</affiliation-url><afid>114031649</afid><affilname>First Hospital of Changsha City</affilname><name-variant>First Hospital of Changsha City</name-variant><affiliation-city>Changsha</affiliation-city><affiliation-country>China</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114899550</affiliation-url><afid>114899550</afid><affilname>Matsumoto University</affilname><name-variant>Matsumoto University</name-variant><affiliation-city>Matsumoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">16</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26436266400</author-url><authid>26436266400</authid><authname>Yao F.</authname><surname>Yao</surname><given-name>Fang</given-name><initials>F.</initials><afid>60009884</afid><afid>112723207</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:26436266400</author-url><authid>26436266400</authid><authname>Yao F.</authname><surname>Yao</surname><given-name>Fang</given-name><initials>F.</initials><afid>60009884</afid><afid>112723207</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640753400</author-url><authid>56640753400</authid><authname>Li Z.</authname><surname>Li</surname><given-name>Zhen</given-name><initials>Z.</initials><afid>60009884</afid><afid>114031649</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56640753400</author-url><authid>56640753400</authid><authname>Li Z.</authname><surname>Li</surname><given-name>Zhen</given-name><initials>Z.</initials><afid>60009884</afid><afid>114031649</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56640974500</author-url><authid>56640974500</authid><authname>Ehara T.</authname><surname>Ehara</surname><given-name>Takashi</given-name><initials>T.</initials><afid>114899550</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56640071000</author-url><authid>56640071000</authid><authname>Yang L.</authname><surname>Yang</surname><given-name>Lin</given-name><initials>L.</initials><afid>112723207</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56640111400</author-url><authid>56640111400</authid><authname>Wang D.</authname><surname>Wang</surname><given-name>Dandan</given-name><initials>D.</initials><afid>60009884</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55974531900</author-url><authid>55974531900</authid><authname>Feng L.</authname><surname>Feng</surname><given-name>Lulu</given-name><initials>L.</initials><afid>60009884</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55974920400</author-url><authid>55974920400</authid><authname>Zhang Y.</authname><surname>Zhang</surname><given-name>Yiming</given-name><initials>Y.</initials><afid>60009884</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56640131000</author-url><authid>56640131000</authid><authname>Wang K.</authname><surname>Wang</surname><given-name>Kun</given-name><initials>K.</initials><afid>60009884</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56482443600</author-url><authid>56482443600</authid><authname>Shi Y.</authname><surname>Shi</surname><given-name>Yonghong</given-name><initials>Y.</initials><afid>60009884</afid><afid>112723207</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56482443600</author-url><authid>56482443600</authid><authname>Shi Y.</authname><surname>Shi</surname><given-name>Yonghong</given-name><initials>Y.</initials><afid>60009884</afid><afid>112723207</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55600721300</author-url><authid>55600721300</authid><authname>Duan H.</authname><surname>Duan</surname><given-name>Huijun</given-name><initials>H.</initials><afid>60009884</afid><afid>112723207</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:55600721300</author-url><authid>55600721300</authid><authname>Duan H.</authname><surname>Duan</surname><given-name>Huijun</given-name><initials>H.</initials><afid>60009884</afid><afid>112723207</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:55974905600</author-url><authid>55974905600</authid><authname>Zhang L.</authname><surname>Zhang</surname><given-name>Lianshan</given-name><initials>L.</initials><afid>60009884</afid><afid>112723207</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:55974905600</author-url><authid>55974905600</authid><authname>Zhang L.</authname><surname>Zhang</surname><given-name>Lianshan</given-name><initials>L.</initials><afid>60009884</afid><afid>112723207</afid></author><authkeywords>Apoptosis | Diabetic nephropathy | Endoplasmic reticulum stress | Fatty acid-binding protein 4 | Mesangial cell</authkeywords><intid>536079763</intid><source-id>26206</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929470393"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929470393?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929470393&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929470393&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0012821X15002940"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929470393</prism:url><dc:identifier>SCOPUS_ID:84929470393</dc:identifier><eid>2-s2.0-84929470393</eid><dc:title>Syn-volcanic cannibalisation of juvenile felsic crust: Superimposed giant &lt;sup&gt;18&lt;/sup&gt;O-depleted rhyolite systems in the hot and thinned crust of Mesoproterozoic central Australia</dc:title><dc:creator>Smithies R.</dc:creator><prism:publicationName>Earth and Planetary Science Letters</prism:publicationName><prism:issn>0012821X</prism:issn><prism:volume>424</prism:volume><prism:pageRange>15-25</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.epsl.2015.05.005</prism:doi><pii>S0012821X15002940</pii><dc:description>© 2015 Published by Elsevier B.V. Eruptions of voluminous &lt;sup&gt;18&lt;/sup&gt;O-depleted rhyolite provide the best evidence that the extreme conditions required to produce and accumulate huge volumes of felsic magma can occur in the upper 10 km of the crust. Mesoproterozoic bimodal volcanic sequences from the Talbot Sub-basin in central Australia contain possibly the world's most voluminous accumulation of &lt;sup&gt;18&lt;/sup&gt;O-depleted rhyolite. This volcanic system differs from the better known, but geochemically similar, Miocene Snake River Plain - Yellowstone Plateau of North America. Both systems witnessed 'super' sized eruptions from shallow crustal chambers, and produced &lt;sup&gt;18&lt;/sup&gt;O-depleted rhyolite. The Talbot system, however, accumulated over a much longer period (&gt;30 Ma), at a single depositional centre, and from a magma with mantle-like isotopic compositions that contrast strongly with the isotopically evolved basement and country-rock compositions. Nevertheless, although the Talbot rhyolites are exclusively &lt;sup&gt;18&lt;/sup&gt;O-depleted, the unavoidable inference of an &lt;sup&gt;18&lt;/sup&gt;O-undepleted precursor requires high-temperature rejuvenation of crust in an upper-crustal chamber, and in this respect the evolution of the Talbot rhyolites and &lt;sup&gt;18&lt;/sup&gt;O-depleted rhyolites of the Snake River Plain - Yellowstone Plateau is very similar. However, instead of older crustal material, the primary upper-crustal source recycled into Talbot rhyolites was comagmatic (or nearly so) felsic rock itself derived from a contemporaneous juvenile basement hot-zone. Whereas giant low δ&lt;sup&gt;18&lt;/sup&gt;O volcanic systems show that voluminous melting of upper crust can occur, our studies indicate that felsic magmas generated at lower crustal depths can also contribute significantly to the thermal and material budget of these systems. The requirement that very high-temperatures be achieved and sustained in the upper crust means that voluminous low δ&lt;sup&gt;18&lt;/sup&gt;O magmatism is rare, primarily restricted to bimodal tholeiitic, high-K rhyolite (A-type) magmatic associations in highly attenuated lithosphere. In the case of the Talbot system, at least, our data suggest that an unusually hot pre-history might also be required to thermally prime the crust.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000385</affiliation-url><afid>60000385</afid><affilname>Geological Survey of Western Australia</affilname><name-variant>Geological Survey of Western Australia</name-variant><affiliation-city>Perth</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031806</affiliation-url><afid>60031806</afid><affilname>University of Western Australia</affilname><name-variant>University of Western Australia</name-variant><affiliation-city>Perth</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031226</affiliation-url><afid>60031226</afid><affilname>Curtin University</affilname><name-variant>Curtin University of Technology</name-variant><affiliation-city>Perth</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031226</affiliation-url><afid>60031226</afid><affilname>Curtin University</affilname><name-variant>Curtin University of Technology</name-variant><affiliation-city>Perth</affiliation-city><affiliation-country>Australia</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60023471</affiliation-url><afid>60023471</afid><affilname>Pacific Northwest National Laboratory</affilname><name-variant>Pacific Northwest National Laboratory</name-variant><affiliation-city>Richland</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:6701726721</author-url><authid>6701726721</authid><authname>Smithies R.</authname><surname>Smithies</surname><given-name>R. H.</given-name><initials>R.H.</initials><afid>60000385</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14622849000</author-url><authid>14622849000</authid><authname>Kirkland C.</authname><surname>Kirkland</surname><given-name>C. L.</given-name><initials>C.L.</initials><afid>60000385</afid><afid>60031226</afid><afid>60031226</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14622849000</author-url><authid>14622849000</authid><authname>Kirkland C.</authname><surname>Kirkland</surname><given-name>C. L.</given-name><initials>C.L.</initials><afid>60000385</afid><afid>60031226</afid><afid>60031226</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:14622849000</author-url><authid>14622849000</authid><authname>Kirkland C.</authname><surname>Kirkland</surname><given-name>C. L.</given-name><initials>C.L.</initials><afid>60000385</afid><afid>60031226</afid><afid>60031226</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003925019</author-url><authid>7003925019</authid><authname>Cliff J.</authname><surname>Cliff</surname><given-name>J. B.</given-name><initials>J.B.</initials><afid>60031806</afid><afid>60023471</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003925019</author-url><authid>7003925019</authid><authname>Cliff J.</authname><surname>Cliff</surname><given-name>J. B.</given-name><initials>J.B.</initials><afid>60031806</afid><afid>60023471</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8247192400</author-url><authid>8247192400</authid><authname>Howard H.</authname><surname>Howard</surname><given-name>H. M.</given-name><initials>H.M.</initials><afid>60000385</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55368696200</author-url><authid>55368696200</authid><authname>Quentin de Gromard R.</authname><surname>Quentin de Gromard</surname><given-name>R.</given-name><initials>R.</initials><afid>60000385</afid></author><authkeywords>&lt;sup&gt;18&lt;/sup&gt;O-depleted rhyolite | Central Australia | Juvenile crustal addition | Mesoproterozoic | Musgrave Province | Supervolcano</authkeywords><intid>535965276</intid><source-id>22566</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928720778"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928720778?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928720778&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928720778&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021999115002697"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928720778</prism:url><dc:identifier>SCOPUS_ID:84928720778</dc:identifier><eid>2-s2.0-84928720778</eid><dc:title>A locally stabilized immersed boundary method for the compressible Navier-Stokes equations</dc:title><dc:creator>Brehm C.</dc:creator><prism:publicationName>Journal of Computational Physics</prism:publicationName><prism:issn>00219991</prism:issn><prism:eIssn>10902716</prism:eIssn><prism:volume>295</prism:volume><prism:pageRange>475-504</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jcp.2015.04.023</prism:doi><pii>S0021999115002697</pii><dc:description>© 2015 . A higher-order immersed boundary method for solving the compressible Navier-Stokes equations is presented. The distinguishing feature of this new immersed boundary method is that the coefficients of the irregular finite-difference stencils in the vicinity of the immersed boundary are optimized to obtain improved numerical stability. This basic idea was introduced in a previous publication by the authors for the advection step in the projection method used to solve the incompressible Navier-Stokes equations. This paper extends the original approach to the compressible Navier-Stokes equations considering flux vector splitting schemes and viscous wall boundary conditions at the immersed geometry. In addition to the stencil optimization procedure for the convective terms, this paper discusses other key aspects of the method, such as imposing flux boundary conditions at the immersed boundary and the discretization of the viscous flux in the vicinity of the boundary. Extensive linear stability investigations of the immersed scheme confirm that a linearly stable method is obtained. The method of manufactured solutions is used to validate the expected higher-order accuracy and to study the error convergence properties of this new method. Steady and unsteady, 2D and 3D canonical test cases are used for validation of the immersed boundary approach. Finally, the method is employed to simulate the laminar to turbulent transition process of a hypersonic Mach 6 boundary layer flow over a porous wall and subsonic boundary layer flow over a three-dimensional spherical roughness element.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60004179</affiliation-url><afid>60004179</afid><affilname>NASA Ames Research Center</affilname><name-variant>NASA Ames Research Center</name-variant><affiliation-city>Moffett Field</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60010065</affiliation-url><afid>60010065</afid><affilname>University of Arizona</affilname><name-variant>University of Arizona</name-variant><affiliation-city>Tucson</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15123994400</author-url><authid>15123994400</authid><authname>Brehm C.</authname><surname>Brehm</surname><given-name>C.</given-name><initials>C.</initials><afid>60004179</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55596805900</author-url><authid>55596805900</authid><authname>Hader C.</authname><surname>Hader</surname><given-name>C.</given-name><initials>C.</initials><afid>60010065</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7003517969</author-url><authid>7003517969</authid><authname>Fasel H.</authname><surname>Fasel</surname><given-name>H. F.</given-name><initials>H.F.</initials><afid>60010065</afid></author><authkeywords>Compressible flows | Higher-order finite-difference | Immersed boundary | Numerical stability analysis</authkeywords><intid>1785839646</intid><source-id>13191</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84927772678"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84927772678?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84927772678&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84927772678&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014299915002885"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84927772678</prism:url><dc:identifier>SCOPUS_ID:84927772678</dc:identifier><eid>2-s2.0-84927772678</eid><dc:title>Effects of Icariin on insulin resistance via the activation of AMPK pathway in C2C12 mouse muscle cells</dc:title><dc:creator>Han Y.</dc:creator><prism:publicationName>European Journal of Pharmacology</prism:publicationName><prism:issn>00142999</prism:issn><prism:eIssn>18790712</prism:eIssn><prism:volume>758</prism:volume><prism:pageRange>60-63</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>5 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ejphar.2015.03.059</prism:doi><pii>S0014299915002885</pii><dc:description>© 2015 Elsevier B.V. All rights reserved. Insulin resistance in skeletal muscle is a major risk factor for the development of type 2 diabetes (T2D). In this study, we investigated the effect of icariin on insulin resistance in C2C12 mouse skeletal muscle cells. C2C12 myoblasts were differentiated into myotubes for five days, then treated with icariin (50 and 100 μM) or metformin (1 mM) in the presence of 100 nM insulin for 24 h. Adiponectin production was measured in culture media by ELISA, and AMP-activated protein kinase (AMPK)/insulin signaling pathway activation was assessed by the western blot analysis. Icariin significantly increased adiponectin production in C2C12 myotubes. Moreover, icariin markedly promoted the phosphorylation of AMPK and acetyl-CoA carboxylase (ACC). Icariin up-regulated the expression of phosphatidylinositol 3-kinase (PI3K) and the phosphorylation of insulin receptor substrate-1 (IRS-1) in C2C12 myotubes. These results suggest that icariin has therapeutic potential for the treatment of T2D via the regulation of insulin resistance in skeletal muscle.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009387</affiliation-url><afid>60009387</afid><affilname>Dongguk University, Seoul</affilname><name-variant>Dongguk University-Seoul</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009387</affiliation-url><afid>60009387</afid><affilname>Dongguk University, Seoul</affilname><name-variant>Dongguk University-Seoul</name-variant><affiliation-city>Seoul</affiliation-city><affiliation-country>South Korea</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:35169341200</author-url><authid>35169341200</authid><authname>Han Y.</authname><surname>Han</surname><given-name>Yunkyung</given-name><initials>Y.</initials><afid>60009387</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7403030124</author-url><authid>7403030124</authid><authname>Jung H.</authname><surname>Jung</surname><given-name>Hyo Won</given-name><initials>H.W.</initials><afid>60009387</afid><afid>60009387</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7403030124</author-url><authid>7403030124</authid><authname>Jung H.</authname><surname>Jung</surname><given-name>Hyo Won</given-name><initials>H.W.</initials><afid>60009387</afid><afid>60009387</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55697630900</author-url><authid>55697630900</authid><authname>Park Y.</authname><surname>Park</surname><given-name>Yong Ki</given-name><initials>Y.K.</initials><afid>60009387</afid><afid>60009387</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55697630900</author-url><authid>55697630900</authid><authname>Park Y.</authname><surname>Park</surname><given-name>Yong Ki</given-name><initials>Y.K.</initials><afid>60009387</afid><afid>60009387</afid></author><authkeywords>AMPK pathway | C2C12 cells | Icariin | Insulin resistance | Skeletal muscle | Type 2 diabetes</authkeywords><intid>1035660906</intid><source-id>21333</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929379075"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929379075?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929379075&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929379075&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1569904815000920"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929379075</prism:url><dc:identifier>SCOPUS_ID:84929379075</dc:identifier><eid>2-s2.0-84929379075</eid><dc:title>Persistent reduced oxygen requirement following blood transfusion during recovery from hemorrhagic shock</dc:title><dc:creator>Haouzi P.</dc:creator><prism:publicationName>Respiratory Physiology and Neurobiology</prism:publicationName><prism:issn>15699048</prism:issn><prism:eIssn>18781519</prism:eIssn><prism:volume>215</prism:volume><prism:pageRange>39-46</prism:pageRange><prism:coverDate>2015-08-05</prism:coverDate><prism:coverDisplayDate>August 05, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.resp.2015.04.009</prism:doi><pii>S1569904815000920</pii><dc:description>© 2015 Elsevier B.V. Our study intended to determine the effects on oxygen uptake (V ˙O2) of restoring a normal rate of O&lt;inf&gt;2&lt;/inf&gt; delivery following blood transfusion (BT) after a severe hemorrhage (H). Spontaneously breathing urethane anesthetized rats were bled by removing 20ml/kg of blood over 30min. Rats were then infused with their own shed blood 15min after the end of H. At mid-perfusion, half of the rats received a unique infusion of the decoupling agent 2,4-dinitrophenol (DNP, 6mg/kg). V ˙O2 and arterial blood pressure (ABP) were continuously measured throughout the study, along with serial determination of blood lactate concentration [La]. Animals were euthanized 45min after the end of reperfusion; liver and lungs were further analyzed for early expression of oxidative stress gene using RT-PCR. Our bleeding protocol induced a significant decrease in ABP and increase in [La], while V ˙O2 dropped by half. The O&lt;inf&gt;2&lt;/inf&gt; deficit progressively accumulated during the period of bleeding reached -114±53ml/kg, just before blood transfusion. Despite the transfusion of blood, a significant O&lt;inf&gt;2&lt;/inf&gt; deficit persisted (-82±59ml/kg) 45min after reperfusion. This slow recovery of V ˙O2 was sped up by DNP injection, leading to a fast recovery of O&lt;inf&gt;2&lt;/inf&gt; deficit after reperfusion, becoming positive (+460±132ml/kg) by the end of the protocol, supporting the view that O&lt;inf&gt;2&lt;/inf&gt; supply is not the main controller of V ˙O2 dynamics after BT. Of note is that DNP also enhanced oxidative stress gene expression (up-regulation of NADPH oxidase 4 in the lung for instance). The mechanism of slow recovery of O&lt;inf&gt;2&lt;/inf&gt; requirement/demand following BT and the resulting effects on tissues exposed to relatively high O&lt;inf&gt;2&lt;/inf&gt; partial pressure are discussed.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013671</affiliation-url><afid>60013671</afid><affilname>Milton S. Hershey Medical Center</affilname><name-variant>Penn State Milton S. Hershey Medical Center</name-variant><affiliation-city>Hershey</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004139922</author-url><authid>7004139922</authid><authname>Haouzi P.</authname><surname>Haouzi</surname><given-name>Philippe</given-name><initials>P.</initials><afid>60013671</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56124219700</author-url><authid>56124219700</authid><authname>Van de Louw A.</authname><surname>Van de Louw</surname><given-name>Andry</given-name><initials>A.</initials><afid>60013671</afid></author><authkeywords>Hemorrhagic shock | Mitochondria | Mitochondrial uncoupling | Oxygen consumption | Oxygen delivery</authkeywords><intid>2035939004</intid><source-id>24030</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84918816665"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84918816665?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84918816665&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84918816665&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0378437114009868"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84918816665</prism:url><dc:identifier>SCOPUS_ID:84918816665</dc:identifier><eid>2-s2.0-84918816665</eid><dc:title>Self-organized criticality attributed to a central limit-like convergence effect</dc:title><dc:creator>Kendal W.</dc:creator><prism:publicationName>Physica A: Statistical Mechanics and its Applications</prism:publicationName><prism:issn>03784371</prism:issn><prism:volume>421</prism:volume><prism:pageRange>141-150</prism:pageRange><prism:coverDate>2015-08-03</prism:coverDate><prism:coverDisplayDate>3 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.physa.2014.11.035</prism:doi><pii>S0378437114009868</pii><dc:description>© 2014 Elsevier B.V. Self-organized criticality is a hypothesis used to explain the origin of 1/f noise and other scaling behaviors. Despite being proposed nearly 30 years ago, no consensus exists as to its exact definition or mathematical mechanism(s). Recently, a model for 1/f noise was proposed based on a family of statistical distributions known as the Tweedie exponential dispersion models. These distributions are characterized by an inherent scale invariance that manifests as a variance to mean power law, called fluctuation scaling; they also serve as foci of convergence in a limit theorem on independent and identically distributed distributions. Fluctuation scaling can be modeled by self-similar stochastic processes that relate the variance to mean power law to 1/f noise through their correlation structure. A hypothesis is proposed whereby the effects of self-organized criticality are mathematically modeled by the Tweedie distributions and their convergence behavior as applied to self-similar stochastic processes. Sandpile model fluctuations are shown to manifest 1/f noise, fluctuation scaling, and to conform to the Tweedie compound Poisson distribution. The Tweedie models and their convergence theorem allow for a mechanistic explanation of 1/f noise and fluctuation scaling in phenomena conventionally attributed to self-organized criticality, thus providing a paradigm shift in our understanding of these phenomena.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028897</affiliation-url><afid>60028897</afid><affilname>University of Ottawa, Canada</affilname><name-variant>University of Ottawa</name-variant><affiliation-city>Ottawa</affiliation-city><affiliation-country>Canada</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">1</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7004551979</author-url><authid>7004551979</authid><authname>Kendal W.</authname><surname>Kendal</surname><given-name>Wayne S.</given-name><initials>W.S.</initials><afid>60028897</afid></author><authkeywords>1 / f noise | Fluctuation scaling | Multifractality | Sandpile model | Taylor's power law | Tweedie exponential dispersion models</authkeywords><intid>1534202940</intid><source-id>29115</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930209881"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930209881?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930209881&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930209881&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S1874391915300191"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930209881</prism:url><dc:identifier>SCOPUS_ID:84930209881</dc:identifier><eid>2-s2.0-84930209881</eid><dc:title>Quantitative and integrated proteome and microRNA analysis of endothelial replicative senescence</dc:title><dc:creator>Yentrapalli R.</dc:creator><prism:publicationName>Journal of Proteomics</prism:publicationName><prism:issn>18743919</prism:issn><prism:eIssn>18767737</prism:eIssn><prism:volume>126</prism:volume><prism:pageRange>12-23</prism:pageRange><prism:coverDate>2015-08-03</prism:coverDate><prism:coverDisplayDate>August 03, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.jprot.2015.05.023</prism:doi><pii>S1874391915300191</pii><dc:description>© 2015 Elsevier B.V.. Age-related changes in vascular functioning are a harbinger of cardiovascular disease but the biological mechanisms during the progression of endothelial senescence have not been studied. We investigated alterations in the proteome and miRNA profiles in the course of replicative senescence using primary human umbilical vein endothelial cells as an in vitro vascular model. Quantitative proteomic profiling from early growth stage to senescence was performed by isotope-coded protein label coupled to LC-ESI-MS/MS analysis. Some proteins consistently changed their expression during the senescence whereas others appeared as deregulated only during the late senescence. The latter was accompanied by alterations in morphology of senescent endothelial cells. MicroRNA expression profiling revealed transient changes in the level of miR-16-5p, miR-28-3p and miR-886-5p in the early senescence, decrease in the level of miR-106b-3p at the late stage, and continuous changes in the expression of miR-181a-5p and miR-376a-3p during the whole senescence process. Integrating data on proteomic and microRNA changes indicated potential crosstalk between specific proteins and non-coding RNAs in the regulation of metabolism, cell cycle progression and cytoskeletal organization in the endothelial senescence. The knowledge of molecular targets that change during the senescence can ultimately contribute to a better understanding and prevention of age-related vascular diseases.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024007</affiliation-url><afid>60024007</afid><affilname>Helmholtz Center Munich German Research Center for Environmental Health</affilname><affiliation-city>Neuherberg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60019722</affiliation-url><afid>60019722</afid><affilname>Technische Universitat Munchen</affilname><name-variant>Technische Universität München</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60024007</affiliation-url><afid>60024007</afid><affilname>Helmholtz Center Munich German Research Center for Environmental Health</affilname><affiliation-city>Neuherberg</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015035</affiliation-url><afid>60015035</afid><affilname>Klinikum rechts der Isar</affilname><name-variant>Technische Universität München</name-variant><affiliation-city>Munich</affiliation-city><affiliation-country>Germany</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55070735600</author-url><authid>55070735600</authid><authname>Yentrapalli R.</authname><surname>Yentrapalli</surname><given-name>Ramesh</given-name><initials>R.</initials><afid>60024007</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:36143709200</author-url><authid>36143709200</authid><authname>Azimzadeh O.</authname><surname>Azimzadeh</surname><given-name>Omid</given-name><initials>O.</initials><afid>60024007</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:40661406500</author-url><authid>40661406500</authid><authname>Kraemer A.</authname><surname>Kraemer</surname><given-name>Anne</given-name><initials>A.</initials><afid>60024007</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:23991009700</author-url><authid>23991009700</authid><authname>Malinowsky K.</authname><surname>Malinowsky</surname><given-name>Katharina</given-name><initials>K.</initials><afid>60019722</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7801452001</author-url><authid>7801452001</authid><authname>Sarioglu H.</authname><surname>Sarioglu</surname><given-name>Hakan</given-name><initials>H.</initials><afid>60024007</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:35591585400</author-url><authid>35591585400</authid><authname>Becker K.</authname><surname>Becker</surname><given-name>Karl Friedrich</given-name><initials>K.F.</initials><afid>60019722</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7202246780</author-url><authid>7202246780</authid><authname>Atkinson M.</authname><surname>Atkinson</surname><given-name>Michael J.</given-name><initials>M.J.</initials><afid>60024007</afid><afid>60015035</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7202246780</author-url><authid>7202246780</authid><authname>Atkinson M.</authname><surname>Atkinson</surname><given-name>Michael J.</given-name><initials>M.J.</initials><afid>60024007</afid><afid>60015035</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:24465261600</author-url><authid>24465261600</authid><authname>Moertl S.</authname><surname>Moertl</surname><given-name>Simone</given-name><initials>S.</initials><afid>60024007</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6603056637</author-url><authid>6603056637</authid><authname>Tapio S.</authname><surname>Tapio</surname><given-name>Soile</given-name><initials>S.</initials><afid>60024007</afid></author><authkeywords>Cellular senescence | Endothelial cell | MiRNA | Proteomics</authkeywords><intid>1786087835</intid><source-id>11700154304</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928337337"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928337337?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928337337&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928337337&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0168160515002056"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928337337</prism:url><dc:identifier>SCOPUS_ID:84928337337</dc:identifier><eid>2-s2.0-84928337337</eid><dc:title>Use of power ultrasound to enhance the thermal inactivation of Clostridium perfringens spores in beef slurry</dc:title><dc:creator>Evelyn </dc:creator><prism:publicationName>International Journal of Food Microbiology</prism:publicationName><prism:issn>01681605</prism:issn><prism:eIssn>18793460</prism:eIssn><prism:volume>206</prism:volume><prism:pageRange>17-23</prism:pageRange><prism:coverDate>2015-08-03</prism:coverDate><prism:coverDisplayDate>August 03, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijfoodmicro.2015.04.013</prism:doi><pii>S0168160515002056</pii><dc:description>© 2015 Elsevier B.V. Clostridium perfringens is a pathogen of concern in pasteurised foods. The main objective of this study was to use power ultrasound to enhance the thermal inactivation of C. perfringens spores in beef slurry. The effect of simultaneous ultrasound and heat (TS, thermosonication) on the spore inactivation in beef slurry was first investigated. At 75°C, a 60min TS process (24kHz, 0.33W/g) resulted in a less than 1.5 log reduction for both C. perfringens NZRM 898 and NZRM 2621 spores. Then, the thermal inactivation first order kinetic parameters of C. perfringens spores in beef slurry were estimated for the two strains. The D&lt;inf&gt;105°C&lt;/inf&gt;- and z-values were 2.5min and 10.6°C for NZRM 898 and 1.8min and 10.9°C for NZRM 2621. After, the effect of a spore heat shock followed by ultrasound on its thermal inactivation in beef slurry was investigated. This heat shock+ultrasound pretreatment was able to double the spore thermal inactivation rate in beef slurry. For example at 95°C D-value of 20.2min decreased to 9.8min, demonstrating that spore exposure to heat shock followed by ultrasonication enhanced its thermal inactivation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60005686</affiliation-url><afid>60005686</afid><affilname>University of Auckland</affilname><name-variant>University of Auckland</name-variant><affiliation-city>Auckland</affiliation-city><affiliation-country>New Zealand</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60069417</affiliation-url><afid>60069417</afid><affilname>Universitas Riau</affilname><name-variant>Universitas Riau</name-variant><affiliation-city>Pekanbaru</affiliation-city><affiliation-country>Indonesia</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55902544300</author-url><authid>55902544300</authid><authname>Evelyn </authname><surname>Evelyn</surname><given-name/><initials/><afid>60005686</afid><afid>60069417</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55902544300</author-url><authid>55902544300</authid><authname>Evelyn </authname><surname>Evelyn</surname><given-name/><initials/><afid>60005686</afid><afid>60069417</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:22942414000</author-url><authid>22942414000</authid><authname>Silva F.</authname><surname>Silva</surname><given-name>Filipa V M</given-name><initials>F.V.M.</initials><afid>60005686</afid></author><authkeywords>Heat shock | Kinetics | Modelling | Spore pretreatment | Thermosonication | Ultrasonication</authkeywords><intid>1535766146</intid><source-id>19760</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84918821841"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84918821841?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84918821841&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84918821841&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S030384671400451X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84918821841</prism:url><dc:identifier>SCOPUS_ID:84918821841</dc:identifier><eid>2-s2.0-84918821841</eid><dc:title>Neoplastic cerebral aneurysm from metastatic tumor: A systematic review of clinical and treatment characteristics</dc:title><dc:creator>Zheng J.</dc:creator><prism:publicationName>Clinical Neurology and Neurosurgery</prism:publicationName><prism:issn>03038467</prism:issn><prism:eIssn>18726968</prism:eIssn><prism:volume>128</prism:volume><prism:pageRange>107-111</prism:pageRange><prism:coverDate>2015-08-02</prism:coverDate><prism:coverDisplayDate>2 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.clineuro.2014.11.010</prism:doi><pii>S030384671400451X</pii><dc:description>© 2014 Elsevier B.V. All rights reserved. Objective Neoplastic cerebral aneurysm (NCA) is a very rare event. The authors aimed to characterize the clinical and treatment details of this poorly defined entity. Materials and methods A computerized systematic literature search was performed in PubMed, Medline, Web of Science, Cochrane Library, Embase, Google Scholar, Science Direct and Scopus. Keywords used were as follows: "aneurysm"; "myxoma"; "choriocarcinoma"; "oncotic aneurysm"; "neoplastic aneurysm". Only reports with cerebral aneurysm resulting from metastatic tumor and contained adequate clinical information pertinent to the analysis were included. Clinical and treatment characteristics were analyzed. Results Ninety-two studies reporting 96 cases of neoplastic cerebral aneurysm were identified. NCA from cardiac myxoma accounted for 60.4%, while NCA from choriocarcinoma and other tumors accounted for 26.1% and 13.5%, respectively. The rates of intracranial hemorrhages were 19.6% in NCA from myxoma, 100% in NCA from choriocarcinoma, and 84.6% in NCA from other tumors. 75.9% of NCA from myxoma were managed conservatively, 92% of NCA from choriocarcinoma were treated by surgery and/or chemotherapy, and 69.2% of NCA from other tumors were treated by surgery with or without chemotherapy. The mortality rates were 11.4% in NCA from myxoma, 60.9% in NCA from choriocarcinoma, and 92.3% in NCA from other tumors. According to a multiple logistic regression model, "pathology (P = 0.002)" is significantly correlated with outcome. Conclusions Neoplastic cerebral aneurysms are usually complicated with cardiac myxoma, choriocarcinoma and lung carcinoma. NCA from cardiac myxoma were probably multiple and rarely associated with intracranial hemorrhage, while the majority of NCA from choriocarcinoma and other tumors were single and presented with intracranial hemorrhage. The prognosis is quite good in NCA from cardiac myxoma, while NCA from malignant tumors were associated with poor outcome.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003970</affiliation-url><afid>60003970</afid><affilname>Zhejiang University</affilname><name-variant>Zhejiang University</name-variant><affiliation-city>Hangzhou</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">2</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56449751800</author-url><authid>56449751800</authid><authname>Zheng J.</authname><surname>Zheng</surname><given-name>Jian</given-name><initials>J.</initials><afid>60003970</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56451229400</author-url><authid>56451229400</authid><authname>Zhang J.</authname><surname>Zhang</surname><given-name>Jianmin</given-name><initials>J.</initials><afid>60003970</afid></author><authkeywords>Cardiac myxoma | Choriocarcinoma | Metastatic tumor | Neoplastic cerebral aneurysm | Treatment</authkeywords><intid>34205784</intid><source-id>14895</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929008805"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929008805?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929008805&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929008805&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0925443915001222"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929008805</prism:url><dc:identifier>SCOPUS_ID:84929008805</dc:identifier><eid>2-s2.0-84929008805</eid><dc:title>ScaRNAs regulate splicing and vertebrate heart development</dc:title><dc:creator>Patil P.</dc:creator><prism:publicationName>Biochimica et Biophysica Acta - Molecular Basis of Disease</prism:publicationName><prism:issn>09254439</prism:issn><prism:eIssn>1879260X</prism:eIssn><prism:volume>1852</prism:volume><prism:issueIdentifier>8</prism:issueIdentifier><prism:pageRange>1619-1629</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.bbadis.2015.04.016</prism:doi><pii>S0925443915001222</pii><dc:description>© 2015 . Alternative splicing (AS) plays an important role in regulating mammalian heart development, but a link between misregulated splicing and congenital heart defects (CHDs) has not been shown. We reported that more than 50% of genes associated with heart development were alternatively spliced in the right ventricle (RV) of infants with tetralogy of Fallot (TOF). Moreover, there was a significant decrease in the level of 12 small cajal body-specific RNAs (scaRNAs) that direct the biochemical modification of specific nucleotides in spliceosomal RNAs. We sought to determine if scaRNA levels influence patterns of AS and heart development. We used primary cells derived from the RV of infants with TOF to show a direct link between scaRNA levels and splice isoforms of several genes that regulate heart development (e.g., GATA4, NOTCH2, DAAM1, DICER1, MBNL1 and MBNL2). In addition, we used antisense morpholinos to knock down the expression of two scaRNAs (scarna1 and snord94) in zebrafish and saw a corresponding disruption of heart development with an accompanying alteration in splice isoforms of cardiac regulatory genes. Based on these combined results, we hypothesize that scaRNA modification of spliceosomal RNAs assists in fine tuning the spliceosome for dynamic selection of mRNA splice isoforms. Our results are consistent with disruption of splicing patterns during early embryonic development leading to insufficient communication between the first and second heart fields, resulting in conotruncal misalignment and TOF. Our findings represent a new paradigm for determining the mechanisms underlying congenital cardiac malformations.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60001580</affiliation-url><afid>60001580</afid><affilname>University of Miyazaki</affilname><name-variant>Miyazaki University</name-variant><affiliation-city>Miyazaki</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020359</affiliation-url><afid>60020359</afid><affilname>UMKC School of Medicine</affilname><name-variant>University of Missouri-Kansas City School of Medicine</name-variant><affiliation-city>Kansas City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020359</affiliation-url><afid>60020359</afid><affilname>UMKC School of Medicine</affilname><name-variant>University of Missouri-Kansas City School of Medicine</name-variant><affiliation-city>Kansas City</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">8</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7201725196</author-url><authid>7201725196</authid><authname>Patil P.</authname><surname>Patil</surname><given-name>Prakash</given-name><initials>P.</initials><afid>60001580</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6507764657</author-url><authid>6507764657</authid><authname>Kibiryeva N.</authname><surname>Kibiryeva</surname><given-name>Nataliya</given-name><initials>N.</initials><afid>60020359</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6602266109</author-url><authid>6602266109</authid><authname>Uechi T.</authname><surname>Uechi</surname><given-name>Tamayo</given-name><initials>T.</initials><afid>60001580</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55605774141</author-url><authid>55605774141</authid><authname>Marshall J.</authname><surname>Marshall</surname><given-name>Jennifer</given-name><initials>J.</initials><afid>60020359</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:35475283200</author-url><authid>35475283200</authid><authname>O'Brien J.</authname><surname>O'Brien</surname><given-name>James E.</given-name><initials>J.E.</initials><afid>60020359</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:55628588428</author-url><authid>55628588428</authid><authname>Artman M.</authname><surname>Artman</surname><given-name>Michael</given-name><initials>M.</initials><afid>60020359</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:7003976520</author-url><authid>7003976520</authid><authname>Kenmochi N.</authname><surname>Kenmochi</surname><given-name>Naoya</given-name><initials>N.</initials><afid>60001580</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:13608114500</author-url><authid>13608114500</authid><authname>Bittel D.</authname><surname>Bittel</surname><given-name>Douglas C.</given-name><initials>D.C.</initials><afid>60020359</afid></author><authkeywords>Congenital heart defect | ScaRNA | Spliceosome | Splicing | Tetralogy of Fallot | Zebrafish</authkeywords><intid>35883479</intid><source-id>21722</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84928340741"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84928340741?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84928340741&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84928340741&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S016363831420035X"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84928340741</prism:url><dc:identifier>SCOPUS_ID:84928340741</dc:identifier><eid>2-s2.0-84928340741</eid><dc:title>Infants with complex congenital heart diseases show poor short-term memory in the mobile paradigm at 3 months of age</dc:title><dc:creator>Chen C.</dc:creator><prism:publicationName>Infant Behavior and Development</prism:publicationName><prism:issn>01636383</prism:issn><prism:eIssn>19348800</prism:eIssn><prism:volume>40</prism:volume><prism:pageRange>12-19</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.infbeh.2015.02.007</prism:doi><pii>S016363831420035X</pii><dc:description>© 2015 Elsevier Inc. The purpose of this study was to examine learning, short-term memory and general development including cognitive, motor, and language domains in infants with Complex Congenital Heart Defects (CCDH). Ten infants with CCHD (4 males, 6 females) and 14 infants with typical development (TD) were examined at 3 months of age. The mobile paradigm, where an infant's leg is tethered to an overhead mobile, was used to evaluate learning and short-term memory. The Bayley Scales of Infant Development 3rd edition (Bayley-III) was used to evaluate general development in cognitive, motor, and language domains. Infants with CCHD and infants with TD both showed learning with significant increase in kicking rate (. p&lt;. 0.001) across periods of the mobile paradigm, but only infants with TD demonstrated short-term memory (. p=. 0.017) in the mobile paradigm. There were no differences on cognitive, motor, and language development between infants with CCHD and infants with TD on the Bayley-III. Early assessment is necessary to guide targeted treatment in infants with CCHD. One-time assessment may fail to detect potential cognitive impairments during early infancy in infants with CCHD. Supportive intervention programs for infants with CCHD that focuses on enhancing short-term memory are recommended.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003500</affiliation-url><afid>60003500</afid><affilname>Ohio State University</affilname><name-variant>The Ohio State University</name-variant><affiliation-city>Columbus</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60000515</affiliation-url><afid>60000515</afid><affilname>Nationwide</affilname><name-variant>Nationwide Children's Hospital</name-variant><affiliation-city>Columbus</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60003500</affiliation-url><afid>60003500</afid><affilname>Ohio State University</affilname><name-variant>The Ohio State University</name-variant><affiliation-city>Columbus</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55546544800</author-url><authid>55546544800</authid><authname>Chen C.</authname><surname>Chen</surname><given-name>Chao Ying</given-name><initials>C.Y.</initials><afid>60003500</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56648323900</author-url><authid>56648323900</authid><authname>Harrison T.</authname><surname>Harrison</surname><given-name>Tondi</given-name><initials>T.</initials><afid>60000515</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56648321000</author-url><authid>56648321000</authid><authname>Heathcock J.</authname><surname>Heathcock</surname><given-name>Jill</given-name><initials>J.</initials><afid>60003500</afid></author><authkeywords>Complex congenital heart defects | Development | Learning | Motor | Short-term memory</authkeywords><intid>2035762248</intid><source-id>14830</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929301279"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929301279?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929301279&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929301279&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315003939"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929301279</prism:url><dc:identifier>SCOPUS_ID:84929301279</dc:identifier><eid>2-s2.0-84929301279</eid><dc:title>Prognostic scores in heart failure - Critical appraisal and practical use</dc:title><dc:creator>Ferrero P.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>1-9</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.154</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Survival in patients with heart failure in the last two decades has significantly improved, owing to availability of new drugs, devices, and technologies. However, these new therapeutic tools are often costly and not without attendant risks. Thus, accurate and reproducible risk stratification is required to assess appropriateness of therapy. Although a growing body of evidence has characterized various predictors of poor outcomes, the application of comprehensive prognostic models in clinical practice remains limited. Herein, we critically evaluate the utility of prognostic scores in heart failure, discussing the strategies to select the most efficient and appropriate risk estimator in the individual patient.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114014514</affiliation-url><afid>114014514</afid><affilname>Azienda Ospedaliera Papa Giovanni XXIII</affilname><name-variant>Azienda Ospedaliera Papa Giovanni XXIII</name-variant><affiliation-city>Bergamo</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60029929</affiliation-url><afid>60029929</afid><affilname>Massachusetts General Hospital</affilname><name-variant>Massachusetts General Hospital</name-variant><affiliation-city>Boston</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:114014514</affiliation-url><afid>114014514</afid><affilname>Azienda Ospedaliera Papa Giovanni XXIII</affilname><name-variant>Azienda Ospedaliera Papa Giovanni XXIII</name-variant><affiliation-city>Bergamo</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60015197</affiliation-url><afid>60015197</afid><affilname>Universita degli Studi di Pavia</affilname><name-variant>Università di Pavia</name-variant><affiliation-city>Pavia</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:15768672300</author-url><authid>15768672300</authid><authname>Ferrero P.</authname><surname>Ferrero</surname><given-name>Paolo</given-name><initials>P.</initials><afid>114014514</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6507851606</author-url><authid>6507851606</authid><authname>Iacovoni A.</authname><surname>Iacovoni</surname><given-name>Attilio</given-name><initials>A.</initials><afid>114014514</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:40660899000</author-url><authid>40660899000</authid><authname>D'Elia E.</authname><surname>D'Elia</surname><given-name>Emilia</given-name><initials>E.</initials><afid>114014514</afid><afid>60015197</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:40660899000</author-url><authid>40660899000</authid><authname>D'Elia E.</authname><surname>D'Elia</surname><given-name>Emilia</given-name><initials>E.</initials><afid>114014514</afid><afid>60015197</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:16417973600</author-url><authid>16417973600</authid><authname>Vaduganathan M.</authname><surname>Vaduganathan</surname><given-name>Muthiah</given-name><initials>M.</initials><afid>60029929</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7005467815</author-url><authid>7005467815</authid><authname>Gavazzi A.</authname><surname>Gavazzi</surname><given-name>Antonello</given-name><initials>A.</initials><afid>114014514</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7003359867</author-url><authid>7003359867</authid><authname>Senni M.</authname><surname>Senni</surname><given-name>Michele</given-name><initials>M.</initials><afid>114014514</afid></author><authkeywords>Heart failure | Outcomes | Prognosis</authkeywords><intid>1535945218</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929300489"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929300489?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929300489&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929300489&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007172"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929300489</prism:url><dc:identifier>SCOPUS_ID:84929300489</dc:identifier><eid>2-s2.0-84929300489</eid><dc:title>Echocardiography screening to detect rheumatic heart disease: A cohort study of schoolchildren in French Pacific Islands</dc:title><dc:creator>Mirabel M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>89-95</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.007</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Objective: The objective of this study is to assess the outcomes of rheumatic heart disease (RHD) diagnosed by means of echocardiography-based screening. Methods: A cohort of children with and with no RHD was driven from a systematic echocardiography-based nationwide surveillance among 4th grade (age 9-10 years) schoolchildren in South-Pacific New Caledonia (2008-2011). The specific follow-up programme used clinical and standardised echocardiography (2012 World Heart Federation criteria) predefined endpoints. Results: Out of the 17,633 children screened, 157 were detected with findings of RHD. Among them, 114 consented children (76.5%) were enrolled (RHD-group), and were compared to 227 randomly selected healthy classmates (non-RHD group). After a median follow-up period of 2.58 years [1.31-3.63], incidence of acute rheumatic fever was similar in RHD and non-RHD groups (p = 0.23): 10.28/1000/year and 3.31/1000/year, respectively. By echocardiography, 90 children in the RHD group (78.9%) still presented with RHD at follow-up, compared to 31 (13.7%) in the non-RHD group (p &lt; 0.0001). Only 12 children (10.5%) experienced progression of RHD over time, mild single valve disease lesions remaining unchanged in the majority of cases (61 out of 73, 83.6%). Overcrowded living conditions were independently associated with persistent RHD on echocardiography (OR 8.27 95% CI (1.67-41.08), p &lt; 0.01). Benzathine penicillin G was given in 88.6% of children in the RHD-group. Conclusions: Children screened positive for RHD by echocardiography have mostly mild but irreversible heart valve disease under secondary prophylaxis. Our findings also suggest that a single screening point in childhood may prove insufficient in high-risk populations.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030857</affiliation-url><afid>60030857</afid><affilname>Hopital Europeen Georges-Pompidou</affilname><name-variant>Hôpital Européen Georges Pompidou</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60028950</affiliation-url><afid>60028950</afid><affilname>Universite Paris Descartes</affilname><name-variant>Université Paris Descartes</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030857</affiliation-url><afid>60030857</afid><affilname>Hopital Europeen Georges-Pompidou</affilname><name-variant>Hôpital Européen Georges Pompidou</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115140632</affiliation-url><afid>115140632</afid><affilname>Cardiology and Development</affilname><name-variant>Cardiology and Development</name-variant><affiliation-city>Paris</affiliation-city><affiliation-country>France</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:115241817</affiliation-url><afid>115241817</afid><affilname>Agence Sanitaire et Sociale de Nouvelle Calédonie</affilname><name-variant>Agence Sanitaire et Sociale de Nouvelle Calédonie</name-variant><affiliation-city>Noumea</affiliation-city><affiliation-country>France</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">19</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:19337718800</author-url><authid>19337718800</authid><authname>Mirabel M.</authname><surname>Mirabel</surname><given-name>Mariana</given-name><initials>M.</initials><afid>60030857</afid><afid>60028950</afid><afid>60030857</afid><afid>115140632</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:19337718800</author-url><authid>19337718800</authid><authname>Mirabel M.</authname><surname>Mirabel</surname><given-name>Mariana</given-name><initials>M.</initials><afid>60030857</afid><afid>60028950</afid><afid>60030857</afid><afid>115140632</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:19337718800</author-url><authid>19337718800</authid><authname>Mirabel M.</authname><surname>Mirabel</surname><given-name>Mariana</given-name><initials>M.</initials><afid>60030857</afid><afid>60028950</afid><afid>60030857</afid><afid>115140632</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:19337718800</author-url><authid>19337718800</authid><authname>Mirabel M.</authname><surname>Mirabel</surname><given-name>Mariana</given-name><initials>M.</initials><afid>60030857</afid><afid>60028950</afid><afid>60030857</afid><afid>115140632</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56578816700</author-url><authid>56578816700</authid><authname>Fauchier T.</authname><surname>Fauchier</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60030857</afid><afid>115241817</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56578816700</author-url><authid>56578816700</authid><authname>Fauchier T.</authname><surname>Fauchier</surname><given-name>Thomas</given-name><initials>T.</initials><afid>60030857</afid><afid>115241817</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56598031400</author-url><authid>56598031400</authid><authname>Bacquelin R.</authname><surname>Bacquelin</surname><given-name>Raoul</given-name><initials>R.</initials><afid>60030857</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:35263255200</author-url><authid>35263255200</authid><authname>Tafflet M.</authname><surname>Tafflet</surname><given-name>Muriel</given-name><initials>M.</initials><afid>60030857</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:55567866100</author-url><authid>55567866100</authid><authname>Germain A.</authname><surname>Germain</surname><given-name>Agnès</given-name><initials>A.</initials><afid>115241817</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56597949900</author-url><authid>56597949900</authid><authname>Robillard C.</authname><surname>Robillard</surname><given-name>Corinne</given-name><initials>C.</initials><afid>115241817</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:35799010200</author-url><authid>35799010200</authid><authname>Rouchon B.</authname><surname>Rouchon</surname><given-name>Bernard</given-name><initials>B.</initials><afid>115241817</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:12143483700</author-url><authid>12143483700</authid><authname>Marijon E.</authname><surname>Marijon</surname><given-name>Eloi</given-name><initials>E.</initials><afid>60030857</afid><afid>60028950</afid><afid>60030857</afid><afid>115140632</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:12143483700</author-url><authid>12143483700</authid><authname>Marijon E.</authname><surname>Marijon</surname><given-name>Eloi</given-name><initials>E.</initials><afid>60030857</afid><afid>60028950</afid><afid>60030857</afid><afid>115140632</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:12143483700</author-url><authid>12143483700</authid><authname>Marijon E.</authname><surname>Marijon</surname><given-name>Eloi</given-name><initials>E.</initials><afid>60030857</afid><afid>60028950</afid><afid>60030857</afid><afid>115140632</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:12143483700</author-url><authid>12143483700</authid><authname>Marijon E.</authname><surname>Marijon</surname><given-name>Eloi</given-name><initials>E.</initials><afid>60030857</afid><afid>60028950</afid><afid>60030857</afid><afid>115140632</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003891080</author-url><authid>7003891080</authid><authname>Jouven X.</authname><surname>Jouven</surname><given-name>Xavier</given-name><initials>X.</initials><afid>60030857</afid><afid>60028950</afid><afid>60030857</afid><afid>115140632</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003891080</author-url><authid>7003891080</authid><authname>Jouven X.</authname><surname>Jouven</surname><given-name>Xavier</given-name><initials>X.</initials><afid>60030857</afid><afid>60028950</afid><afid>60030857</afid><afid>115140632</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003891080</author-url><authid>7003891080</authid><authname>Jouven X.</authname><surname>Jouven</surname><given-name>Xavier</given-name><initials>X.</initials><afid>60030857</afid><afid>60028950</afid><afid>60030857</afid><afid>115140632</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7003891080</author-url><authid>7003891080</authid><authname>Jouven X.</authname><surname>Jouven</surname><given-name>Xavier</given-name><initials>X.</initials><afid>60030857</afid><afid>60028950</afid><afid>60030857</afid><afid>115140632</afid></author><authkeywords>Acute rheumatic fever | Global health | Heart valve disease | Rheumatic heart disease | Ultrasounds</authkeywords><intid>2035941033</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926651838"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926651838?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926651838&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926651838&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0958166915000609"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926651838</prism:url><dc:identifier>SCOPUS_ID:84926651838</dc:identifier><eid>2-s2.0-84926651838</eid><dc:title>Developing injectable nanomaterials to repair the heart</dc:title><dc:creator>Nguyen M.</dc:creator><prism:publicationName>Current Opinion in Biotechnology</prism:publicationName><prism:issn>09581669</prism:issn><prism:eIssn>18790429</prism:eIssn><prism:volume>34</prism:volume><prism:pageRange>225-231</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.copbio.2015.03.016</prism:doi><pii>S0958166915000609</pii><dc:description>© 2015 Elsevier Ltd. Injectable nanomaterials have been designed for the treatment of myocardial infarction, particularly during the acute stages of inflammation and injury. Among these strategies, injectable nanofibrous hydrogel networks or nanoparticle complexes may be delivered alone or with a therapeutic to improve heart function. Intramyocardial delivery of these materials localizes treatments to the site of injury. As an alternative, nanoparticles may be delivered intravenously, which provides the ultimate minimally invasive approach. These systems take advantage of the leaky vasculature after myocardial infarction, and may be designed to specifically target the injured region. The translational applicability of both intramyocardial and intravenous applications may provide safe and effective solutions upon optimizing the timing of the treatments and biodistribution.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030612</affiliation-url><afid>60030612</afid><affilname>University of California, San Diego</affilname><name-variant>University of California San Diego</name-variant><affiliation-city>San Diego</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030612</affiliation-url><afid>60030612</afid><affilname>University of California, San Diego</affilname><name-variant>University of California San Diego</name-variant><affiliation-city>San Diego</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>re</subtype><subtypeDescription>Review</subtypeDescription><author-count limit="100">3</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56585267100</author-url><authid>56585267100</authid><authname>Nguyen M.</authname><surname>Nguyen</surname><given-name>Mary M.</given-name><initials>M.M.</initials><afid>60030612</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:6506786781</author-url><authid>6506786781</authid><authname>Gianneschi N.</authname><surname>Gianneschi</surname><given-name>Nathan C.</given-name><initials>N.C.</initials><afid>60030612</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55879147600</author-url><authid>55879147600</authid><authname>Christman K.</authname><surname>Christman</surname><given-name>Karen L.</given-name><initials>K.L.</initials><afid>60030612</afid></author><intid>1535483952</intid><source-id>15579</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84926332767"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84926332767?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84926332767&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84926332767&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0048969715004453"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84926332767</prism:url><dc:identifier>SCOPUS_ID:84926332767</dc:identifier><eid>2-s2.0-84926332767</eid><dc:title>Framingham risk score modifies the effect of PM&lt;inf&gt;10&lt;/inf&gt; on heart rate variability</dc:title><dc:creator>Feng Y.</dc:creator><prism:publicationName>Science of the Total Environment</prism:publicationName><prism:issn>00489697</prism:issn><prism:eIssn>18791026</prism:eIssn><prism:volume>523</prism:volume><prism:pageRange>146-151</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.scitotenv.2015.04.009</prism:doi><pii>S0048969715004453</pii><dc:description>© 2015 Elsevier B.V. Health conditions may greatly modify the association between particulate matter (PM) and heart rate variability (HRV), but whether the modification of PM effect by coronary artery disease (CAD) risk status depends on the PM levels remains unknown. We investigated the associations between personal exposures to PM with aerodynamic diameter of ≤10μm (PM&lt;inf&gt;10&lt;/inf&gt;) and ≤2.5μm (PM&lt;inf&gt;2.5&lt;/inf&gt;) and concurrent HRV, and whether the effect of PM on HRV was modified by Framingham risk score (FRS) in healthy subjects with different PM exposure levels. Personal exposures to PM&lt;inf&gt;10&lt;/inf&gt; and PM&lt;inf&gt;2.5&lt;/inf&gt; were measured for 24h in 152 volunteers of community residents who were free of cardiovascular disease in two cities (Zhuhai and Wuhan) that differ in air quality. Simultaneously, 24h HRV indices were obtained from 3-channel Holter monitor. FRS was calculated based on age, sex, lipid profiles, blood pressure, diabetes, and smoking status. Linear regression models were constructed after adjusting for potential confounders. We found significant decrease in total power (TP) and low power (LF) with increased PM&lt;inf&gt;10&lt;/inf&gt; concentrations (P for trend&lt;0.05) in the high PM levels city (Wuhan) and total population, but not in the low PM levels city (Zhuhai). We also observed significant modification of FRS on PM&lt;inf&gt;10&lt;/inf&gt; effect in Wuhan. Interestingly, elevated PM&lt;inf&gt;10&lt;/inf&gt; was associated in a greater decreased HRV in the low FRS subgroup, but not in the high FRS subgroup. However, we did not find any significant main effects of PM&lt;inf&gt;2.5&lt;/inf&gt; or PM&lt;inf&gt;2.5&lt;/inf&gt;-FRS interactions on HRV in city-specified or city-combined analyses. Overall, the findings indicate that individual coronary risk profiles may modulate the association between particulate air pollution and HRV in high PM exposure levels.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025761</affiliation-url><afid>60025761</afid><affilname>Huazhong University of Science and Technology</affilname><name-variant>Huazhong Univ. of Sci. and Technol.</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">11</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55361241200</author-url><authid>55361241200</authid><authname>Feng Y.</authname><surname>Feng</surname><given-name>Yingying</given-name><initials>Y.</initials><afid>60025761</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55822462100</author-url><authid>55822462100</authid><authname>Huang X.</authname><surname>Huang</surname><given-name>Xiji</given-name><initials>X.</initials><afid>60025761</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56062413900</author-url><authid>56062413900</authid><authname>Sun H.</authname><surname>Sun</surname><given-name>Huizhen</given-name><initials>H.</initials><afid>60025761</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56088358300</author-url><authid>56088358300</authid><authname>Liu C.</authname><surname>Liu</surname><given-name>Chuanyao</given-name><initials>C.</initials><afid>60025761</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56580654000</author-url><authid>56580654000</authid><authname>Zhang B.</authname><surname>Zhang</surname><given-name>Bing</given-name><initials>B.</initials><afid>60025761</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:56429989800</author-url><authid>56429989800</authid><authname>Zhang Z.</authname><surname>Zhang</surname><given-name>Zhihong</given-name><initials>Z.</initials><afid>60025761</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:56582206700</author-url><authid>56582206700</authid><authname>Sharma Tengur V.</authname><surname>Sharma Tengur</surname><given-name>Vashish</given-name><initials>V.</initials><afid>60025761</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56150102700</author-url><authid>56150102700</authid><authname>Chen W.</authname><surname>Chen</surname><given-name>Weihong</given-name><initials>W.</initials><afid>60025761</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:7404815278</author-url><authid>7404815278</authid><authname>Wu T.</authname><surname>Wu</surname><given-name>Tangchun</given-name><initials>T.</initials><afid>60025761</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:9639419000</author-url><authid>9639419000</authid><authname>Yuan J.</authname><surname>Yuan</surname><given-name>Jing</given-name><initials>J.</initials><afid>60025761</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:55872349200</author-url><authid>55872349200</authid><authname>Zhang X.</authname><surname>Zhang</surname><given-name>Xiaomin</given-name><initials>X.</initials><afid>60025761</afid></author><authkeywords>Framingham risk score | Heart rate variability | Particulate matter</authkeywords><intid>1535430095</intid><source-id>25349</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929376621"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929376621?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929376621&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929376621&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315008001"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929376621</prism:url><dc:identifier>SCOPUS_ID:84929376621</dc:identifier><eid>2-s2.0-84929376621</eid><dc:title>High readmission rate after heart valve surgery: A nationwide cohort study</dc:title><dc:creator>Sibilitz K.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>189</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>96-104</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.078</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: After heart valve surgery, knowledge on long-term self-reported health status and readmission is lacking. Thus, the optimal strategy for out-patient management after surgery remains unclear. Methods: Using a nationwide survey with linkage to Danish registers with one year follow-up, we included all adults 6-12 months after heart valve surgery irrespective of valve procedure, during Jan-June 2011 (n = 867). Participants completed a questionnaire regarding health-status (n = 742), and answers were compared with age- and sex-matched healthy controls. Readmission rates and mortality were investigated. Results: After valve surgery, the self-reported health was lower (Short Form-36 (SF-36) Physical Component Scale (PCS): 44.5 vs. 50.6 and Mental Component Scale (MCS): 51.9 vs. 55.0, p &lt; 0.0001) and more were physically sedentary compared with healthy controls (11.1% vs. 15.2%). Clinical signs of anxiety and depression were present in 13.6% and 13.8%, respectively (Hospital Anxiety and Depression Scale score ≥ 8). Twelve months following discharge, 483 persons (56%) were readmitted. Readmission was associated with lower self-reported health (SF-36 PCS: 46.5 vs. 43.9, and MCS 52.2 vs. 50.7). Higher age (hazard ratio (95% CI): 1.3 (1.0-1.6)), male sex (1.2 (1.0-1.5)), mitral valve surgery (1.3 (1.0-1.6)), and infective endocarditis after surgery (1.8 (1.1-3.0), p: 0.01) predicted readmission, whereas higher age (2.3 (1.0-5.4)), higher comorbidity score (3.2 (1.8-6.0)), and infective endocarditis after surgery (3.2 (1.2-8.9)) predicted mortality. Conclusions: 6-12 months after heart valve surgery the readmission rate is high and the self-reported health status is low. Readmission is associated with low self-reported health. Therefore, targeted follow-up strategies post-surgery are needed.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60006564</affiliation-url><afid>60006564</afid><affilname>Rigshospitalet</affilname><name-variant>Copenhagen University Hospital</name-variant><affiliation-city>Copenhagen</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60020191</affiliation-url><afid>60020191</afid><affilname>Statens Institut for Folkesundhed</affilname><name-variant>University of Southern Denmark</name-variant><affiliation-city>Copenhagen</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60030762</affiliation-url><afid>60030762</afid><affilname>Roskilde Sygehus</affilname><name-variant>Roskilde Hospital</name-variant><affiliation-city>Roskilde</affiliation-city><affiliation-country>Denmark</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:55576091600</author-url><authid>55576091600</authid><authname>Sibilitz K.</authname><surname>Sibilitz</surname><given-name>K. L.</given-name><initials>K.L.</initials><afid>60006564</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55665331800</author-url><authid>55665331800</authid><authname>Berg S.</authname><surname>Berg</surname><given-name>S. K.</given-name><initials>S.K.</initials><afid>60006564</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6701410573</author-url><authid>6701410573</authid><authname>Thygesen L.</authname><surname>Thygesen</surname><given-name>L. C.</given-name><initials>L.C.</initials><afid>60020191</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:55861108500</author-url><authid>55861108500</authid><authname>Hansen T.</authname><surname>Hansen</surname><given-name>T. B.</given-name><initials>T.B.</initials><afid>60030762</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:17534387200</author-url><authid>17534387200</authid><authname>Køber L.</authname><surname>Køber</surname><given-name>L.</given-name><initials>L.</initials><afid>60006564</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7005846737</author-url><authid>7005846737</authid><authname>Hassager C.</authname><surname>Hassager</surname><given-name>C.</given-name><initials>C.</initials><afid>60006564</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:9248288900</author-url><authid>9248288900</authid><authname>Zwisler A.</authname><surname>Zwisler</surname><given-name>A. D.</given-name><initials>A.D.</initials><afid>60006564</afid></author><authkeywords>Disease management | Health status | Heart valve surgery | Quality of life | Readmission</authkeywords><intid>1535945498</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929376996"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929376996?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929376996&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929376996&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007007"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929376996</prism:url><dc:identifier>SCOPUS_ID:84929376996</dc:identifier><eid>2-s2.0-84929376996</eid><dc:title>Does the target dose of neurohormonal blockade matter for outcome in systolic heart failure in octogenarians?</dc:title><dc:creator>Barywani S.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>187</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>666-672</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.03.428</prism:doi><dc:description>© 2015 Elsevier Ireland Ltd. All rights reserved. Background: In elderly patients with chronic heart failure (CHF), a gap exists between widespread use of lower doses of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin-receptor blockers (ARBs) and β-blockers (BBs) and guideline recommendations. Therefore, the aim of the present study was to investigate whether patients receiving ≥50% target dose outperform those receiving &lt;50% target dose, despite maximum up-titration, and whether the target dose outperforms all other doses. Methods and Results: Patients (n = 185) aged ≥80 years with CHF and left ventricular ejection fraction ≤40% referred (between January 2000 and January 2008) to two CHF outpatient clinics at two university hospitals, were included and retrospectively studied. Of the study population, 53% received the target dose of ACEIs/ARBs, whereas 26% received &lt;50% of the target dose. Half received b50% of the target dose of BBs and 21% received the target dose. After ≥5 years of follow-up, all-cause mortality was 76.8%. Patients who received the target dose of ACEIs/ARBs had higher survival rates from all-cause mortality than those receiving &lt;50% of target dose (HR = 0.6, 95%CI 0.4-0.9, P = 0.033), but those receiving ≥50% of target dose did not statistically differ from those who achieved target dose. This dose-survival relationship was not the case for BBs. Conclusions: Target dose of ACEIs/ARBs is associated with reduced all-cause five-year mortality in very old patients with systolic heart failure, despite that this was achievable in only about half of the patients. However, the clinical outcome of BB therapy is independent of BB dose when the target heart rate is achieved.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031699</affiliation-url><afid>60031699</afid><affilname>Sahlgrenska Universitetssjukhuset</affilname><name-variant>Sahlgrenska University Hospital</name-variant><affiliation-city>Molndal</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60027675</affiliation-url><afid>60027675</afid><affilname>Sahlgrenska Academy</affilname><name-variant>Göteborg University</name-variant><affiliation-city>Gothenburg</affiliation-city><affiliation-country>Sweden</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">5</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56190025600</author-url><authid>56190025600</authid><authname>Barywani S.</authname><surname>Barywani</surname><given-name>Salim Bary</given-name><initials>S.B.</initials><afid>60031699</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644789700</author-url><authid>56644789700</authid><authname>Ergatoudes C.</authname><surname>Ergatoudes</surname><given-name>Constantinos</given-name><initials>C.</initials><afid>60031699</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:55887737100</author-url><authid>55887737100</authid><authname>Schaufelberger M.</authname><surname>Schaufelberger</surname><given-name>Maria</given-name><initials>M.</initials><afid>60031699</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56519479800</author-url><authid>56519479800</authid><authname>Petzold M.</authname><surname>Petzold</surname><given-name>Max</given-name><initials>M.</initials><afid>60027675</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7202031118</author-url><authid>7202031118</authid><authname>Fu M.</authname><surname>Fu</surname><given-name>Michael L X</given-name><initials>M.L.X.</initials><afid>60031699</afid></author><authkeywords>ACEIs/ARBs | Beta-blockers | Mortality | Octogenarians | Systolic heart failure | Target dose</authkeywords><intid>535947354</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929575332"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929575332?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929575332&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929575332&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0022282815001534"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929575332</prism:url><dc:identifier>SCOPUS_ID:84929575332</dc:identifier><eid>2-s2.0-84929575332</eid><dc:title>Tbx5 and Osr1 interact to regulate posterior second heart field cell cycle progression for cardiac septation</dc:title><dc:creator>Zhou L.</dc:creator><prism:publicationName>Journal of Molecular and Cellular Cardiology</prism:publicationName><prism:issn>00222828</prism:issn><prism:eIssn>10958584</prism:eIssn><prism:volume>85</prism:volume><prism:pageRange>1-12</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yjmcc.2015.05.005</prism:doi><pii>S0022282815001534</pii><dc:description>© 2015 Elsevier Ltd. Rationale: Mutations of TBX5 cause Holt-Oram syndrome (HOS) in humans, a disease characterized by atrial or occasionally ventricular septal defects in the heart and skeletal abnormalities of the upper extremity. Previous studies have demonstrated that Tbx5 regulates Osr1 expression in the second heart field (SHF) of E9.5 mouse embryos. However, it is unknown whether and how Tbx5 and Osr1 interact in atrial septation. Objective: To determine if and how Tbx5 and Osr1 interact in the posterior SHF for cardiac septation. Methods and Results: In the present study, genetic inducible fate mapping showed that Osr1-expressing cells contribute to atrial septum progenitors between E8.0 and E11.0. Osr1 expression in the pSHF was dependent on the level of Tbx5 at E8.5 and E9.5 but not E10.5, suggesting that the embryo stage before E10.5 is critical for Tbx5 interacting with Osr1 in atrial septation. Significantly more atrioventricular septal defects (AVSDs) were observed in embryos with compound haploinsufficiency for Tbx5 and Osr1. Conditional compound haploinsufficiency for Tbx5 and Osr1 resulted in a significant cell proliferation defect in the SHF, which was associated with fewer cells in the G2 and M phases and a decreased level of Cdk6 expression. Remarkably, genetically targeted disruption of Pten expression in atrial septum progenitors rescued AVSDs caused by Tbx5 and Osr1 compound haploinsufficiency. There was a significant decrease in Smo expression, which is a Hedgehog (Hh) signaling pathway modulator, in the pSHF of Osr1 knockout embryos at E9.5, implying a role for Osr1 in regulating Hh signaling. Conclusions: Tbx5 and Osr1 interact to regulate posterior SHF cell cycle progression for cardiac septation.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026161</affiliation-url><afid>60026161</afid><affilname>University of North Dakota</affilname><name-variant>University of North Dakota</name-variant><affiliation-city>Grand Forks</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026161</affiliation-url><afid>60026161</afid><affilname>University of North Dakota</affilname><name-variant>University of North Dakota</name-variant><affiliation-city>Grand Forks</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60026161</affiliation-url><afid>60026161</afid><affilname>University of North Dakota</affilname><name-variant>University of North Dakota</name-variant><affiliation-city>Grand Forks</affiliation-city><affiliation-country>United States</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60025761</affiliation-url><afid>60025761</afid><affilname>Huazhong University of Science and Technology</affilname><name-variant>Huazhong Univ. of Sci. and Technol.</name-variant><affiliation-city>Wuhan</affiliation-city><affiliation-country>China</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">7</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56355408700</author-url><authid>56355408700</authid><authname>Zhou L.</authname><surname>Zhou</surname><given-name>Lun</given-name><initials>L.</initials><afid>60026161</afid><afid>60025761</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56355408700</author-url><authid>56355408700</authid><authname>Zhou L.</authname><surname>Zhou</surname><given-name>Lun</given-name><initials>L.</initials><afid>60026161</afid><afid>60025761</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56650653200</author-url><authid>56650653200</authid><authname>Liu J.</authname><surname>Liu</surname><given-name>Jielin</given-name><initials>J.</initials><afid>60026161</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56650674000</author-url><authid>56650674000</authid><authname>Olson P.</authname><surname>Olson</surname><given-name>Patrick</given-name><initials>P.</initials><afid>60026161</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56650363800</author-url><authid>56650363800</authid><authname>Zhang K.</authname><surname>Zhang</surname><given-name>Ke</given-name><initials>K.</initials><afid>60026161</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:56650691100</author-url><authid>56650691100</authid><authname>Wynne J.</authname><surname>Wynne</surname><given-name>Joshua</given-name><initials>J.</initials><afid>60026161</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:13402994500</author-url><authid>13402994500</authid><authname>Xie L.</authname><surname>Xie</surname><given-name>Linglin</given-name><initials>L.</initials><afid>60026161</afid></author><authkeywords>Atrioventricular septal defects (AVSDs) | Cell cycle | Osr1 | Pten | Second heart field | Tbx5</authkeywords><intid>2035976126</intid><source-id>23882</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84930209978"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84930209978?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84930209978&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84930209978&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0014480015001161"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84930209978</prism:url><dc:identifier>SCOPUS_ID:84930209978</dc:identifier><eid>2-s2.0-84930209978</eid><dc:title>Mitochondrial apoptotic pathway activation in the atria of heart failure patients due to mitral and tricuspid regurgitation</dc:title><dc:creator>Chang J.</dc:creator><prism:publicationName>Experimental and Molecular Pathology</prism:publicationName><prism:issn>00144800</prism:issn><prism:eIssn>10960945</prism:eIssn><prism:volume>99</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>65-73</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.yexmp.2015.05.007</prism:doi><pii>S0014480015001161</pii><dc:description>© 2015. Apoptosis occurs in atrial cardiomyocytes in mitral and tricuspid valve disease. The purpose of this study was to examine the respective roles of the mitochondrial and tumor necrosis factor-α receptor associated death domain (TRADD)-mediated death receptor pathways for apoptosis in the atrial cardiomyocytes of heart failure patients due to severe mitral and moderate-to-severe tricuspid regurgitation. This study comprised eighteen patients (7 patients with persistent atrial fibrillation and 11 in sinus rhythm). Atrial appendage tissues were obtained during surgery. Three purchased normal human left atrial tissues served as normal controls. Moderately-to-severely myolytic cardiomyocytes comprised 59.7. ±. 22.1% of the cardiomyocytes in the right atria and 52.4. ±. 12.9% of the cardiomyocytes in the left atria of mitral and tricuspid regurgitation patients with atrial fibrillation group and comprised 58.4. ±. 24.8% of the cardiomyocytes in the right atria of mitral and tricuspid regurgitation patients with sinus rhythm. In contrast, no myolysis was observed in the normal human adult left atrial tissue samples. Immunohistochemical analysis showed expression of cleaved caspase-9, an effector of the mitochondrial pathways, in the majority of right atrial cardiomyocytes (87.3. ±. 10.0%) of mitral and tricuspid regurgitation patients with sinus rhythm, and right atrial cardiomyocytes (90.6. ±. 31.4%) and left atrial cardiomyocytes (70.7. ±. 22.0%) of mitral and tricuspid regurgitation patients with atrial fibrillation. In contrast, only 5.7% of cardiomyocytes of the normal left atrial tissues showed strongly positive expression of cleaved caspase-9. Of note, none of the atrial cardiomyocytes in right atrial tissue in sinus rhythm and in the fibrillating right and left atria of mitral and tricuspid regurgitation patients, and in the normal human adult left atrial tissue samples showed cleaved caspase-8 expression, which is a downstream effector of TRADD of the death receptor pathway. Immunoblotting of atrial extracts showed that there was enhanced expression of cytosolic cytochrome c, an effector of the mitochondrial pathways, but no expression of membrane TRADD and cytosolic caspase-8 in the right atrial tissue of mitral and tricuspid regurgitation patients with sinus rhythm, and right atrial and left atrial tissues of mitral and tricuspid regurgitation patients with atrial fibrillation. Taken together, this study showed that mitochondrial pathway for apoptosis was activated in the right atria in sinus rhythm and in the left and right atria in atrial fibrillation of heart failure patients due to mitral and tricuspid regurgitation, and this mitochondrial pathway activation may contribute to atrial contractile dysfunction and enlargement in this clinical setting.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073391</affiliation-url><afid>60073391</afid><affilname>Chang Gung University College of Medicine</affilname><name-variant>Chang Gung University College of Medicine</name-variant><affiliation-city>Taoyuan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60073391</affiliation-url><afid>60073391</afid><affilname>Chang Gung University College of Medicine</affilname><name-variant>Chang Gung University College of Medicine</name-variant><affiliation-city>Taoyuan</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031913</affiliation-url><afid>60031913</afid><affilname>Chang Gung Memorial Hospital</affilname><name-variant>Chang Gung Memorial Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60031913</affiliation-url><afid>60031913</afid><affilname>Chang Gung Memorial Hospital</affilname><name-variant>Chang Gung Memorial Hospital</name-variant><affiliation-city>Taipei</affiliation-city><affiliation-country>Taiwan</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7601551837</author-url><authid>7601551837</authid><authname>Chang J.</authname><surname>Chang</surname><given-name>Jen Ping</given-name><initials>J.P.</initials><afid>60073391</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:9434387700</author-url><authid>9434387700</authid><authname>Chen M.</authname><surname>Chen</surname><given-name>Mien Cheng</given-name><initials>M.C.</initials><afid>60073391</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:7407342389</author-url><authid>7407342389</authid><authname>Liu W.</authname><surname>Liu</surname><given-name>Wen Hao</given-name><initials>W.H.</initials><afid>60073391</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56277886100</author-url><authid>56277886100</authid><authname>Lin Y.</authname><surname>Lin</surname><given-name>Yu Sheng</given-name><initials>Y.S.</initials><afid>60031913</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:25623030900</author-url><authid>25623030900</authid><authname>Huang Y.</authname><surname>Huang</surname><given-name>Yao Kuang</given-name><initials>Y.K.</initials><afid>60031913</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:23668566900</author-url><authid>23668566900</authid><authname>Pan K.</authname><surname>Pan</surname><given-name>Kuo Li</given-name><initials>K.L.</initials><afid>60031913</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:36135678500</author-url><authid>36135678500</authid><authname>Ho W.</authname><surname>Ho</surname><given-name>Wan Chun</given-name><initials>W.C.</initials><afid>60073391</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56637567800</author-url><authid>56637567800</authid><authname>Fang C.</authname><surname>Fang</surname><given-name>Chih Yuan</given-name><initials>C.Y.</initials><afid>60073391</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56608649100</author-url><authid>56608649100</authid><authname>Chen C.</authname><surname>Chen</surname><given-name>Chien Jen</given-name><initials>C.J.</initials><afid>60073391</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:36658950800</author-url><authid>36658950800</authid><authname>Chen H.</authname><surname>Chen</surname><given-name>Huang Chung</given-name><initials>H.C.</initials><afid>60073391</afid></author><authkeywords>Apoptosis | Atrium | Mitral insufficiency | Myocytes | Tricuspid insufficiency</authkeywords><intid>1036082213</intid><source-id>13247</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84921473820"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84921473820?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84921473820&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84921473820&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0021915014011861"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84921473820</prism:url><dc:identifier>SCOPUS_ID:84921473820</dc:identifier><eid>2-s2.0-84921473820</eid><dc:title>Accumulation of oxidative stress-related gene polymorphisms and the risk of coronary heart disease events in patients with type 2 diabetes - An 8-year prospective study</dc:title><dc:creator>Katakami N.</dc:creator><prism:publicationName>Atherosclerosis</prism:publicationName><prism:issn>00219150</prism:issn><prism:eIssn>18791484</prism:eIssn><prism:volume>235</prism:volume><prism:issueIdentifier>2</prism:issueIdentifier><prism:pageRange>408-414</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>August 01, 2015</prism:coverDisplayDate><prism:doi>10.1016/j.atherosclerosis.2014.05.936</prism:doi><pii>S0021915014011861</pii><dc:description>© 2014 Elsevier Ireland Ltd. Objective: Oxidative stress, which is provoked in patients with diabetes, plays critical roles in the pathogenesis of coronary heart disease (CHD). We simultaneously determined 5 relatively common genetic variants related to oxidative stress and evaluated the combined effect on CHD. Methods: We enrolled 1977 Japanese type 2 diabetic subjects without history of CVD (males 66.1%, 59.5±10.0 years old), determined their genotypes regarding glutamate-cysteine ligase modifier subunit (GCLM) C-588T, manganese superoxide dismutase (SOD2) Val16Ala, endothelial nitric oxide synthase (NOS3) G894T, NAD(P)H oxidase p22phox (CYBA) C242T, and myeloperoxidase (MPO) G-463A polymorphisms, and prospectively evaluated the association between these polymorphisms and CHD events. Results: The median follow-up period was 7.5 years and there were 85 new CHD events. The single association analysis revealed that there were no statistically significant associations between each polymorphism and the prevalence of CHD. Interestingly, the risk of CHD event was higher with the increase of the total number of 10 concomitant unfavorable "pro-oxidant alleles" in each subject (p for trend=0.018, log-rank test). Especially, the carriers of &lt;8 pro-oxidant alleles had a significantly increased risk as compared to the carriers of &lt;8 pro-oxidant alleles, whether the other clinical variables were adjusted (HR 2.92 with 95%CI 1.50-5.67, p=0.002) or not (HR 2.89 with 95%CI 1.49-5.59, p=0.002). Conclusions: Accumulation of gene polymorphisms related to oxidative stress is likely associated with the development of CHD in patients with type 2 diabetes, suggesting that the combined information about these variants is useful to assess the risk of CHD.</dc:description><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013829</affiliation-url><afid>60013829</afid><affilname>Osaka University Faculty of Medicine</affilname><name-variant>Osaka University Medical School</name-variant><affiliation-city>Suita</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013829</affiliation-url><afid>60013829</afid><affilname>Osaka University Faculty of Medicine</affilname><name-variant>Osaka University Medical School</name-variant><affiliation-city>Suita</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:106686091</affiliation-url><afid>106686091</afid><affilname>Naka Memorial Clinic</affilname><name-variant>Naka Memorial Clinic</name-variant><affiliation-city>Naka City, Ibaraki</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100555715</affiliation-url><afid>100555715</afid><affilname>Kawai Clinic</affilname><name-variant>Kawai Skin Clinic</name-variant><affiliation-city>Kyoto</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60091862</affiliation-url><afid>60091862</afid><affilname>Ishibashi Clinic</affilname><name-variant>Ishibashi Clinic</name-variant><affiliation-city>Hatsukaichi</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60007524</affiliation-url><afid>60007524</afid><affilname>Shiga University of Medical Science</affilname><name-variant>Shiga University of Medical Science</name-variant><affiliation-city>Otsu</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60009740</affiliation-url><afid>60009740</afid><affilname>Juntendo University School of Medicine</affilname><name-variant>Juntendo University School of Medicine</name-variant><affiliation-city>Tokyo</affiliation-city><affiliation-country>Japan</affiliation-country></affiliation><pubmed-id>24933031</pubmed-id><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">13</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56495643700</author-url><authid>56495643700</authid><authname>Katakami N.</authname><surname>Katakami</surname><given-name>Naoto</given-name><initials>N.</initials><afid>60013829</afid><afid>60013829</afid></author><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56495643700</author-url><authid>56495643700</authid><authname>Katakami N.</authname><surname>Katakami</surname><given-name>Naoto</given-name><initials>N.</initials><afid>60013829</afid><afid>60013829</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:7006829280</author-url><authid>7006829280</authid><authname>Kaneto H.</authname><surname>Kaneto</surname><given-name>Hideaki</given-name><initials>H.</initials><afid>60013829</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:56429848600</author-url><authid>56429848600</authid><authname>Matsuoka T.</authname><surname>Matsuoka</surname><given-name>Taka aki</given-name><initials>T.a.</initials><afid>60013829</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:56401621900</author-url><authid>56401621900</authid><authname>Takahara M.</authname><surname>Takahara</surname><given-name>Mitsuyoshi</given-name><initials>M.</initials><afid>60013829</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:6603634457</author-url><authid>6603634457</authid><authname>Osonoi T.</authname><surname>Osonoi</surname><given-name>Takeshi</given-name><initials>T.</initials><afid>106686091</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:36461668300</author-url><authid>36461668300</authid><authname>Saitou M.</authname><surname>Saitou</surname><given-name>Miyoko</given-name><initials>M.</initials><afid>106686091</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:55496448300</author-url><authid>55496448300</authid><authname>Kawai K.</authname><surname>Kawai</surname><given-name>Koichi</given-name><initials>K.</initials><afid>100555715</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:56490255900</author-url><authid>56490255900</authid><authname>Ishibashi F.</authname><surname>Ishibashi</surname><given-name>Fukashi</given-name><initials>F.</initials><afid>60091862</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:56490016900</author-url><authid>56490016900</authid><authname>Kashiwagi A.</authname><surname>Kashiwagi</surname><given-name>Atsunori</given-name><initials>A.</initials><afid>60007524</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:56490060800</author-url><authid>56490060800</authid><authname>Kawamori R.</authname><surname>Kawamori</surname><given-name>Ryuzo</given-name><initials>R.</initials><afid>60009740</afid></author><author seq="11"><author-url>http://api.elsevier.com/content/author/author_id:56429872400</author-url><authid>56429872400</authid><authname>Shimomura I.</authname><surname>Shimomura</surname><given-name>Iichiro</given-name><initials>I.</initials><afid>60013829</afid></author><author seq="12"><author-url>http://api.elsevier.com/content/author/author_id:56489753900</author-url><authid>56489753900</authid><authname>Yamasaki Y.</authname><surname>Yamasaki</surname><given-name>Yoshimitsu</given-name><initials>Y.</initials><afid>60013829</afid></author><authkeywords>Atherosclerosis | Coronary heart disease | Diabetes | Oxidative stress | Polymorphism</authkeywords><intid>1034650854</intid><source-id>22483</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929312608"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929312608?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929312608&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929312608&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007627"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929312608</prism:url><dc:identifier>SCOPUS_ID:84929312608</dc:identifier><eid>2-s2.0-84929312608</eid><dc:title>Lymphocyte count and prognosis in patients with heart failure</dc:title><dc:creator>Marçula M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>60-62</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.043</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60013877</affiliation-url><afid>60013877</afid><affilname>Hospital das Clinicas da FMUSP</affilname><name-variant>Universidade de São Paulo</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:100526378</affiliation-url><afid>100526378</afid><affilname>Institute of Mathematics and Statistics</affilname><name-variant>Institute of Mathematics and Statistics</name-variant><affiliation-city>Sao Paulo</affiliation-city><affiliation-country>Brazil</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">10</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:56644945200</author-url><authid>56644945200</authid><authname>Marçula M.</authname><surname>Marçula</surname><given-name>Magaly</given-name><initials>M.</initials><afid>60013877</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:56644937900</author-url><authid>56644937900</authid><authname>De Souza Buto M.</authname><surname>De Souza Buto</surname><given-name>Marcelo Felipe</given-name><initials>M.F.</initials><afid>60013877</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:35748825800</author-url><authid>35748825800</authid><authname>Madaloso B.</authname><surname>Madaloso</surname><given-name>Bruna Affonso</given-name><initials>B.A.</initials><afid>60013877</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:36440109200</author-url><authid>36440109200</authid><authname>Nunes R.</authname><surname>Nunes</surname><given-name>Rafael Amorim Belo</given-name><initials>R.A.B.</initials><afid>60013877</afid></author><author seq="5"><author-url>http://api.elsevier.com/content/author/author_id:7004058551</author-url><authid>7004058551</authid><authname>Cuoco M.</authname><surname>Cuoco</surname><given-name>Marco Antonio Romeo</given-name><initials>M.A.R.</initials><afid>60013877</afid></author><author seq="6"><author-url>http://api.elsevier.com/content/author/author_id:7004345195</author-url><authid>7004345195</authid><authname>De Paula R.</authname><surname>De Paula</surname><given-name>Rogério Silva</given-name><initials>R.S.</initials><afid>60013877</afid></author><author seq="7"><author-url>http://api.elsevier.com/content/author/author_id:8382882300</author-url><authid>8382882300</authid><authname>Yamada A.</authname><surname>Yamada</surname><given-name>Alice Tatsuko</given-name><initials>A.T.</initials><afid>60013877</afid></author><author seq="8"><author-url>http://api.elsevier.com/content/author/author_id:7004626740</author-url><authid>7004626740</authid><authname>Sandoval M.</authname><surname>Sandoval</surname><given-name>Monica Carneiro</given-name><initials>M.C.</initials><afid>100526378</afid></author><author seq="9"><author-url>http://api.elsevier.com/content/author/author_id:6603099771</author-url><authid>6603099771</authid><authname>Botter D.</authname><surname>Botter</surname><given-name>Denise Aparecida</given-name><initials>D.A.</initials><afid>100526378</afid></author><author seq="10"><author-url>http://api.elsevier.com/content/author/author_id:7102306668</author-url><authid>7102306668</authid><authname>Mansur A.</authname><surname>Mansur</surname><given-name>Alfredo J.</given-name><initials>A.J.</initials><afid>60013877</afid></author><authkeywords>Heart failure | Lymphocyte count | Outpatients</authkeywords><intid>1535944211</intid><source-id>23774</source-id></entry><entry><link ref="self" href="http://api.elsevier.com/content/abstract/scopus_id:84929358997"/><link ref="author-affiliation" href="http://api.elsevier.com/content/abstract/scopus_id:84929358997?field=author,affiliation"/><link ref="scopus" href="http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&amp;scp=84929358997&amp;origin=inward"/><link ref="scopus-citedby" href="http://www.scopus.com/inward/citedby.url?partnerID=HzOxMe3b&amp;scp=84929358997&amp;origin=inward"/><link ref="full-text" href="http://api.elsevier.com/content/article/eid:1-s2.0-S0167527315007470"/><prism:url>http://api.elsevier.com/content/abstract/scopus_id:84929358997</prism:url><dc:identifier>SCOPUS_ID:84929358997</dc:identifier><eid>2-s2.0-84929358997</eid><dc:title>The predictive value of non-invasive cardiac output at rest in discharged heart failure patients</dc:title><dc:creator>Feola M.</dc:creator><prism:publicationName>International Journal of Cardiology</prism:publicationName><prism:issn>01675273</prism:issn><prism:eIssn>18741754</prism:eIssn><prism:volume>188</prism:volume><prism:issueIdentifier>1</prism:issueIdentifier><prism:pageRange>50-51</prism:pageRange><prism:coverDate>2015-08-01</prism:coverDate><prism:coverDisplayDate>1 August 2015</prism:coverDisplayDate><prism:doi>10.1016/j.ijcard.2015.04.028</prism:doi><citedby-count>0</citedby-count><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:101428498</affiliation-url><afid>101428498</afid><affilname>Ospedale 4</affilname><name-variant>Ospedale 4</name-variant><affiliation-city/><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:60012259</affiliation-url><afid>60012259</afid><affilname>Universita degli Studi di Torino</affilname><name-variant>University of Torino</name-variant><affiliation-city>Torino</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><affiliation><affiliation-url>http://api.elsevier.com/content/affiliation/affiliation_id:108868177</affiliation-url><afid>108868177</afid><affilname>ASL CN1</affilname><name-variant>ASL CN1</name-variant><affiliation-city>Cuneo</affiliation-city><affiliation-country>Italy</affiliation-country></affiliation><prism:aggregationType>Journal</prism:aggregationType><subtype>ar</subtype><subtypeDescription>Article</subtypeDescription><author-count limit="100">4</author-count><author seq="1"><author-url>http://api.elsevier.com/content/author/author_id:7006806859</author-url><authid>7006806859</authid><authname>Feola M.</authname><surname>Feola</surname><given-name>Mauro</given-name><initials>M.</initials><afid>101428498</afid></author><author seq="2"><author-url>http://api.elsevier.com/content/author/author_id:55315484000</author-url><authid>55315484000</authid><authname>Testa M.</authname><surname>Testa</surname><given-name>Marzia</given-name><initials>M.</initials><afid>60012259</afid></author><author seq="3"><author-url>http://api.elsevier.com/content/author/author_id:6506162138</author-url><authid>6506162138</authid><authname>Leto L.</authname><surname>Leto</surname><given-name>Laura</given-name><initials>L.</initials><afid>60012259</afid></author><author seq="4"><author-url>http://api.elsevier.com/content/author/author_id:8327469200</author-url><authid>8327469200</authid><authname>Rosso G.</authname><surname>Rosso</surname><given-name>Gian Luca</given-name><initials>G.L.</initials><afid>108868177</afid></author><authkeywords>Cardiac output | Heart failure | Prognosis</authkeywords><intid>2035938448</intid><source-id>23774</source-id></entry></search-results>
